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The Bcl-2 protein family regulates the intrinsic apoptotic pathway through an intricate 
network of protein:protein and protein:membrane interactions. The pathway culminates 
in the permeabilisation of the mitochondrial outer membrane by the pro-apoptotic 
effector proteins Bak and Bax, an event that irreversibly commits a cell to death. To 
facilitate membrane permeabilisation, Bak and Bax undergo a series of conformational 
changes to convert from inert monomers to membrane-embedded homodimers that 
nucleate and propagate apoptotic oligomers. While great strides have been made in 
structurally characterising these conformational changes, questions remain surrounding 
homodimer interactions with the membrane, oligomerisation, and membrane pore 
formation. This thesis addresses these questions by providing structures of lipids bound 
to Bak BH3:groove core homodimers (Chapter 2). These are the first structures of any 
Bcl-2 family protein in complex with lipid. They reveal symmetric binding sites for 
phospholipid headgroups and acyl chains. In one structure, adjacent Bak homodimers 
are cross-linked by the acyl chains of single phospholipids, suggesting homodimer 
oligomerisation could be mediated by lipid. Bak oligomers could be dissociated with 
phospholipase A2, supporting a role for lipid in oligomer stability. Collectively, the 
structures presented here indicate that lipids may play a direct role in Bak 
oligomerisation. 
Like Bak, Bax homodimerises and oligomerises on the mitochondrial outer membrane. 
The original Bax BH3:groove core homodimer structure was solved as a GFP fusion at 
low resolution. Here, a tetrameric structure consisting of two Bax BH3:groove core 
homodimers alone was solved at high resolution (Chapter 3), providing details for 
canonical interactions in atomic detail. A crystal structure of Bax BH3:groove core 
homodimers containing lipid was also solved, although the structure could not be 
refined due to severe twinning. This result demonstrates that Bax core domains also 
associate with lipid, and provides a starting point for crystal optimisation. 
Pro-survival Bcl-2 family proteins antagonise the apoptotic function of Bak and Bax by 
preventing their activation and sequestering their activated forms. Sequestration of 
activated Bak and Bax in heterodimeric Mode 2 complexes involves binding of the 
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Bak/Bax BH3 domain to a conserved hydrophobic groove. Beyond this, little is known 
regarding the topology of these complexes. The pro-survival protein Bcl-XL can 
undergo similar conformational changes to Bak and Bax, but whether it forms 
BH3:groove heterodimers with Bak/Bax was unknown. Using cysteine cross-linking 
on mitochondria, I show that Bcl-XL can form reciprocal BH3:groove heterodimers 
with Bax, and possibly Bak (Chapter 4). These results challenge a simplistic view of 
Mode 2 complexes, implicating more extensive interactions beyond the canonical BH3 
in groove interface. 
Bok is a third potential pro-apoptotic effector protein that shares sequence similarity 
with Bak and Bax, but its role in apoptosis remains unresolved. To investigate the 
structure and function of Bok, I developed a recombinant expression system to produce 
human, rat, and chicken Bok. The first crystal structure of Bok, from the chicken, 
reveals the canonical Bcl-2 family fold, with deviations that may explain its proposed 
constitutive activity (Chapter 5). The structure paves the way for mutagenesis studies 
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In 1972, John Kerr, Andrew Wyllie and Alastair Currie coined the term “apoptosis” to 
describe a “little recognised mechanism of controlled cell deletion” (Kerr et al., 1972). 
The significance and indispensability of this fundamental biological process in 
multicellular organisms would become apparent in the years to follow. Though cell 
death had been described previously as a normal part of embryonic development 
(Glucksmann, 1951; Lockshin and Williams, 1965; Saunders, 1966), Kerr and 
colleagues were the first to characterise the distinct morphological and biochemical 
changes that occur during this process, including nuclear and cytoplasmic 
condensation, fragmentation of the cell and engulfment of cell fragments by 
phagocytosis (Kerr, 1971; Kerr et al., 1972). 
Closely connected to the story of apoptosis is the study of cell lineage and fate in the 
flatworm Caenorhabditis elegans by John Sulston and H. Robert Horovitz in the lab of 
Sydney Brenner (Sulston and Horvitz, 1977). In this work, the authors observed that of 
the total number of cells generated during development, 131 were missing from the 
healthy adult worm. These missing cells underwent programmed cell death, though the 
genes responsible for execution and regulation of this program were unknown at the 
time (Sulston and Horvitz, 1977). The genes controlling the worm’s apoptotic program 
were later identified in Horovitz’s own lab, including the apoptosis-inducing ced-3 (cell 
death abnormal-3) and ced-4 (cell death abnormal-4) and the apoptosis-inhibiting ced-9 
(cell death abnormal-9) (Ellis and Horvitz, 1986; Hengartner and Horvitz, 1994). 
Meanwhile, the bcl-2 (B-cell lymphoma 2) gene was identified in a human acute 
pre-B-cell leukaemia cell line (Tsujimoto et al., 1984). The gene, situated on 
chromosome 18, was placed under the control of the immunoglobulin heavy chain 
promoter due to the t(14;18) chromosome translocation often observed in B-cell 
follicular lymphomas (Bakhshi et al., 1985; Bakhshi et al., 1987). This translocation 
was proposed to result in altered expression of the otherwise native Bcl-2 protein by 
both transcriptional activation and abnormal posttranscriptional regulation of bcl-2 
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mRNA (Cleary et al., 1986). The oncogenic potential hinted at in these studies was 
demonstrated in 1988, when David Vaux, in the lab of Jerry Adams and Suzanne Cory, 
reported the anti-apoptotic and tumorigenic activity of the bcl-2 gene in haematopoietic 
cells (Vaux et al., 1988). Bcl-2 was unique among known oncogenes at the time in that 
it prevented cell death rather than promoting cell division and differentiation. The work 
on Bcl-2 and apoptosis in C. elegans came together when Vaux et al. showed that 
overexpression of Bcl-2 prevented apoptosis in worm cells (Vaux et al., 1992). 
Following cloning of the ced-9 gene, sequence homology was established between 
Bcl-2 and ced-9, demonstrating aspects of the cell death program were evolutionarily 
conserved in vertebrates and invertebrates, with increasing complexity in higher 
organisms (Hengartner and Horvitz, 1994). 
Apoptosis is essential in multicellular organisms for many physiological processes 
including normal tissue development, maintenance of homeostasis and defence against 
disease and cytotoxic insults, such as viral infection or UV irradiation. Unsurprisingly 
then, dysregulation and disruption of the apoptotic program is observed in many 
different diseases. Viral and bacterial infections often suppress apoptosis to allow for 
replication in infected cells (Lamkanfi and Dixit, 2010). There are a number of viral 
homologues of Bcl-2 pro-survival proteins that block the apoptotic pathway to promote 
infected cell survival (Kvansakul and Hinds, 2013). Suppression of apoptosis is also 
one of several hallmarks of cancer (Hanahan and Weinberg, 2011). On the other hand, 
aberrant apoptosis has also been implicated in neurodegenerative disease 
(Ghavami et al., 2014). 
A deep and comprehensive understanding of certain aspects of intrinsic apoptosis at the 
molecular level has led to the development of novel therapeutics; most notably the 
BH3-mimetic drug Venetoclax that inhibits Bcl-2 (Souers et al., 2013). Venetoclax has 
significantly improved the prognosis for patients with chronic lymphocytic leukaemia 
bearing the 17p deletion (Roberts et al., 2016). The molecular mechanisms that govern 
apoptosis are a key area of research for treating disease, and further elucidation of these 
mechanisms will likely lead to more breakthrough treatments. 
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1.2 The Bcl-2 Protein Family 
There are two apoptotic pathways found in mammals that converge at the activation of 
caspases. Death-receptor mediated, or “extrinsic”, apoptosis involves the ligation of 
death receptors of the tumour necrosis factor receptor gene superfamily by their cognate 
ligands, leading to activation of caspase-8 and downstream caspases. Mitochondrial, or 
“intrinsic”, apoptosis is mediated by Bcl-2 and related proteins collectively referred to 
as the Bcl-2 protein family. Bcl-2 family proteins primarily localise to the 
mitochondrial outer membrane (MOM) where homo- and hetero-typic interactions 
between these proteins either antagonise or activate apoptosis. Activation of the 
intrinsic pathway culminates in mitochondrial outer membrane permeabilisation 
(MOMP), releasing apoptogenic molecules from the intermembrane space (IMS) and 
committing the cell to death. The subject of this thesis is the Bcl-2 protein family. 
Bcl-2 family proteins exhibit either pro-survival or pro-apoptotic functions. There are 
6 known pro-survival proteins in mammals: Bcl-2, Mcl-1, Bcl-XL, Bcl-w, Bfl-1 and 
Bcl-B. Pro-apoptotic Bcl-2 proteins are divided into two groups. The first group, called 
the BH3-only proteins, sense and convey apoptotic stimuli and include Bid, Bim, Puma, 
Noxa, Bad, Bmf, Bik and Hrk. The pro-apoptotic effector proteins Bak and Bax that 
cause MOMP comprise the second group, and are structurally similar to the 
pro-survival proteins. Bok, another potential pro-apoptotic effector protein, may also 
cause MOMP. A delicate balance of protein-protein interactions between these family 





Figure 1. Regulation of intrinsic apoptosis by the Bcl-2 protein family. Apoptosis is 
initiated when stress stimuli upregulate and activate BH3-only proteins, (yellow). 
Pro-survival proteins (blue) sequester and repress Bak and Bax (purple) and are 
neutralised by BH3-only proteins. Bax and Bak are directly activated by certain 
BH3-only proteins, inducing conformational changes that lead to homodimerisation. 
Homodimers assemble into higher-order oligomers and permeabilise the MOM, 
releasing cytochrome c and other apoptogenic factors and committing the cell to death 
by apoptosis. 
Bcl-2 family members share short stretches of sequence homology known as Bcl-2 
homology (BH) domains (Figure 2A). The pro-survival proteins and Bak, Bax and Bok 
contain BH domains 1-4. BH3-only proteins, on the other hand, contain only the BH3 
domain, an amphipathic α-helix important for inter-family interactions that is common 
to all Bcl-2 family proteins. Structurally, the pro-survival proteins, multi-BH domain 
effector proteins Bak and Bax, and the BH3-only protein Bid (before it is activated by 
cleavage) are highly similar despite having different functional roles. Seven α-helices 
fold around a central hydrophobic helix forming a globular bundle that is, in most cases, 
anchored to the MOM by a single transmembrane (TM) helix (Figure 2B and C). A 
key feature of the fold, formed by amino acids of the BH domains, is a hydrophobic 
surface groove bounded primarily by α-helices 3, 4 and 5 (Figure 2C). Overwhelming 
binding of pro-apoptotic BH3 domains to both pro-survival and pro-apoptotic 




Figure 2. Domain architecture and tertiary structure of Bcl-2 family proteins. 
A) Domain organisation of the 3 sub-families of Bcl-2 proteins. BH domains 1-4 are 
present in both pro-survival proteins and Bak/Bax/Bok while BH3-only proteins 
contain only the BH3 domain. The α-helices of the pro-survival proteins and 
Bak/Bax/Bok are labelled, including the α9 TM helix. B) and C) X-ray crystal structures 
of Bak (PDB code: 2IMS (Moldoveanu et al., 2006)) and Bcl-XL (PDB code: 1MAZ 
(Muchmore et al., 1996)), respectively, in cartoon representation coloured in rainbow 
(from blue N- to red C-terminus). Each α-helix from 1 to 8 in Bak is labelled and the 
hydrophobic surface groove that binds BH3-domains is labelled with a red dotted line 
on Bcl-XL. 
The intrinsic apoptotic pathway is initiated by a wide range of stimuli that upregulate 
BH3-only proteins at a transcriptional and/or post-translational level. All BH3-only 
proteins promote apoptosis by binding to and antagonising the function of pro-survival 
proteins and some are capable of directly activating Bak and Bax. When pro-survival 
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proteins, which normally restrain Bak and Bax, are overwhelmed by BH3-only 
proteins, Bak and Bax homodimerise and oligomerise on the MOM. Oligomerisation 
results in MOMP, leading to the release of proteins such as cytochrome c and SMAC 
from the IMS (Kluck et al., 1997). Cytochrome c forms a complex with Apaf-1 and 
ATP that binds to and activates caspase-9, forming the “apoptosome”. The apoptosome 
activates effector caspases leading to the degradation of cellular contents. 
Chemical inhibition of caspases only slows cell death after MOMP is initiated, and 
while genetic ablation of caspase activation (by removal of Apaf-1 or caspase 9) 
prevents short-term apoptotic cell death, it does not confer long-term clonogenic 
survival of cells (Chautan et al., 1999; Ekert et al., 2004). On the other hand, Bcl-2 
overexpression or genetic co-ablation of both Bak and Bax confers long-term 
clonogenic survival or resistance to a wide range of apoptotic stimuli, respectively 
(Ekert et al., 2004; Lindsten et al., 2000; Wei et al., 2001). Thus, MOMP is the critical 
event that commits a cell to death. 
1.2.1 Bak and Bax 
The tightly regulated effectors of apoptosis Bak and Bax are responsible for MOMP. 
Both proteins undergo homologous structural transitions during activation and 
oligomerisation. From inert monomers they transform, via a series of large 
conformational changes, into membrane-permeabilising oligomers that grow to very 
large sizes on the MOM. 
The first known effector of apoptosis, Bcl-2 Associated X Protein (Bax), was 
discovered in 1993 by co-immunoprecipitation experiments with Bcl-2 (Oltvai et al., 
1993). Overexpression of Bax both accelerated cell death following growth factor 
removal and countered the protective pro-survival effect of overexpressed Bcl-2 
(Oltvai et al., 1993). The authors correctly predicted that Bax was an effector of cell 
death that was neutralised by the repressor of cell death, Bcl-2 (Oltvai et al., 1993). 
Two years later, back-to-back publications in Nature independently identified Bcl-2 
homologous antagonist/killer (Bak) as a Bax-like protein with pro-apoptotic activity 
(Chittenden et al., 1995b; Farrow et al., 1995; Kiefer et al., 1995). Chittenden et al. 
went on to characterise a motif (the BH3 domain) in Bak, Bax and Bip1 (also known 
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as the BH3-only protein Bik) critical for both heterodimerisation with Bcl-XL and the 
pro-apoptotic activity of the 3 proteins (Chittenden et al., 1995a). The BH3 domain is 
responsible for the major protein-protein interactions between Bcl-2 family proteins 
and is discussed further in Section 1.3. 
The importance of the pro-apoptotic effectors is evident in many contexts. Other than 
male sterility in Bax singly deficient mice, mice lacking Bax or Bak display few 
phenotypic abnormalities (Knudson et al., 1995; Lindsten et al., 2000). The compound 
loss of both Bax and Bak, on the other hand, has severe consequences including 
perinatal death and extensive developmental abnormalities (Lindsten et al., 2000). As 
mentioned above, genetic knockout of both effectors in cells results in resistance to 
intrinsic apoptotic stimuli, including drug treatment with etoposide and staurosporine, 
ultraviolet and gamma irradiation, growth factor deprivation and treatment with 
endoplasmic reticulum (ER) stress-inducing drugs such as tunamycin and thapsigargin 
(Lindsten et al., 2000; Wei et al., 2001). 
The functional redundancy exhibited in studies of Bak/Bax double knockout (DKO) 
animals and cells is matched by a conserved mechanism of action that has been 
structurally characterised at the atomic level up to the stage of homodimerisation by 
X-ray crystallography and nuclear magnetic resonance (NMR) spectroscopy 
(Brouwer et al., 2014; Czabotar et al., 2013; Moldoveanu et al., 2013). A wealth of 
cross-linking, electron paramagnetic resonance (EPR) spectroscopy and, more recently, 
super-resolution microscopy data have contributed to our understanding of the 
subsequent steps of the MOMP pathway: oligomerisation of Bak and Bax and 
formation of the apoptotic pore. Many attempts have been made to determine the atomic 
structures of Bak and Bax oligomers and the apoptotic pore. Unfortunately, due to 
difficulties in sample preparation and the heterogeneity of Bak and Bax oligomers, our 
picture of the pore remains low resolution. What is known about Bak and Bax 
inhibition, activation, homodimerisation and oligomerisation is discussed in Section 
1.3. 
A balance between survival and cell death by apoptosis is essential for maintenance of 
homeostasis. In cells required for the continued healthy existence of a given organism, 
the pro-apoptotic effector proteins are held in check by the pro-survival proteins. 
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1.2.2 Pro-survival Proteins 
The pro-survival proteins repress the apoptotic function of Bak and Bax. These 
structurally similar proteins set the apoptotic threshold that must be overcome in order 
for a cell to undergo apoptosis. Removal of pro-survival proteins by gene knockout has 
demonstrated their importance in mammalian development and maintenance of 
homeostasis. bcl-2-deficient mice, for example, survive to birth but die around 2-3 
weeks of age, with the primary cause of mortality being severe polycystic kidney 
disease that results in renal failure (Fedorov et al., 2006; Veis et al., 1993). Osteoblasts 
from bcl-2-deficient mice are morphologically abnormal and defective in depositing 
collagen and effecting bone growth (Boot-Handford et al., 1998). The mice also exhibit 
high levels of apoptosis of lymphoid cells in the spleen and thymus, demonstrating the 
importance of Bcl-2 in lymphocyte survival (Veis et al., 1993). Deletion of other 
pro-survival proteins results in phenotypic abnormalities ranging from mild to 
catastrophic. 
The gene for one of these proteins, Mcl-1, was identified in a search for early induction 
genes during chemically-induced differentiation of a myeloid cell leukaemia cell line 
(Kozopas et al., 1993). It was the first gene discovered with homology to Bcl-2 and 
hence the subject of great interest due to the known oncogenic potential of Bcl-2 
(Kozopas et al., 1993; Vaux et al., 1988). Knockout of the Mcl-1 gene in mice results 
in peri-implantation embryonic lethality and a failure to implant in utero, necessitating 
the use of conditional knockout systems to investigate its role in adult animals 
(Rinkenberger et al., 2000). Mcl-1 is widely required for survival of diverse cell types 
including lymphocytes, hematopoietic stem cells, neutrophils, neuronal progenitors, 
hepatocytes and cardiomyocytes (Arbour et al., 2008; Dzhagalov et al., 2007; 
Opferman et al., 2005; Opferman et al., 2003; Thomas et al., 2013; Vick et al., 2009; 
Wang et al., 2013). 
The bcl-x gene was the first Bcl-2 homologue to be identified by low stringency 
hybridisation using a bcl-2 DNA probe (Boise et al., 1993). Interestingly, alternative 
splicing of the gene generates two proteins with opposing functions: a pro-survival 
splice variant (Bcl-XL) and a pro-apoptotic splice variant (Bcl-XS) (Boise et al., 1993). 
The Bcl-XS variant is less well characterised and not discussed further. Bcl-XL, on the 
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other hand, has been extensively studied in the context of health and disease. Mice 
deficient for bcl-x die around embryonic day 13, displaying extensive apoptotic death 
of immature neuronal and hematopoietic cells (Motoyama et al., 1995). 
Bcl-XL-deficient mice are thrombocytopenic, and the degradation of a limited pool of 
Bcl-XL sets the lifespan of mature, circulating platelets (Mason et al., 2007). 
Far less is known about the other pro-survival proteins, primarily because their roles 
appear less critical or because of experimental barriers. Bcl-W knockout mice are 
healthy but defective in spermatogenesis (Print et al., 1998). Bfl-1/A1 has proven 
difficult to investigate in mice due to the presence of 3 functional A1 genes, but appears 
to play a role in lymphocyte survival (Ottina et al., 2012). The mouse homologue of 
Bcl-B (Boo/Diva) is unusual in that it lacks a BH3 domain and has an altered BH1 
domain that is missing a conserved arginine residue critical for pro-survival function 
(Rautureau et al., 2010). Consequently, mouse Bcl-B does not bind to and sequester 
pro-apoptotic BH3 domains (Rautureau et al., 2010). 
Together, the pro-survival proteins ensure survival of a cell until stress levels reach a 
critical point and the threshold for apoptosis is overcome. The conveyors of the stress 
signal are the BH3-only proteins. 
1.2.3 BH3-only Proteins 
Various stress stimuli upregulate BH3-only proteins at the transcriptional and/or 
post-translational level. BH3-only proteins repress the anti-apoptotic function of 
pro-survival proteins, and some are able to directly activate the effector proteins Bak 
and Bax. Certain BH3-only proteins, including Bim, PUMA and tBid, bind 
promiscuously to pro-survival proteins, while others display a restricted binding 
repertoire. With the notable exception of Bim, deletion of individual BH3-only proteins 
appears to be compensated for by functional redundancy with other BH3-only proteins 
(Bouillet et al., 1999; Happo et al., 2012). 
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1.3 Bcl-2 Family Protein-Protein Interactions 
The primary protein-protein interaction that conveys the intrinsic apoptotic signal is the 
binding of BH3 domains to the conserved hydrophobic surface groove (α3-5) present 
on both pro-survival proteins and multi-BH domain pro-apoptotic effector proteins (see 
Figure 2B and C). Hereafter, binding of a BH3 domain to a hydrophobic groove will 
be referred to as BH3:groove binding. BH3:groove binding events may form stable 
complexes or induce large conformational change depending on the specific Bcl-2 
family proteins involved in the interaction. This section will discuss both cases in 
structural detail. 
1.3.1 Inhibition of Apoptosis by Pro-survival Proteins 
The pro-survival proteins inhibit apoptosis primarily by binding and sequestering the 
BH3 domains of pro-apoptotic Bcl-2 family proteins. Pro-survival protein-mediated 
inhibition of apoptosis can be categorised as Mode 1 or Mode 2 (Figure 3) 
(Llambi et al., 2011). Mode 1 inhibition involves sequestration of activator BH3-only 
proteins by pro-survival proteins via a BH3:groove interaction, thereby preventing 
activation of Bak and Bax. In Mode 2, pro-survival proteins bind to the BH3 domains 
of activated Bak and/or Bax and prevent their homodimerisation. The relative 






Figure 3. Schematic of Mode 1 vs. Mode 2 inhibition of intrinsic apoptosis. In Mode 
1 inhibition, pro-survival proteins bind the BH3 domain of activator BH3-only proteins, 
preventing activation of Bak and Bax. Once BH3-only proteins are freed from Mode 1 
complexes they activate Bak/Bax. Activation results in exposure of the Bak/Bax BH3 
domain that can be sequestered by pro-survival proteins in Mode 2 complexes. 
The first structural view of the BH3:groove interaction was provided in 1997 by Sattler 
et al., who determined the NMR solution structure of Bcl-XL in a Mode 2 complex with 
the Bak BH3 peptide (Figure 4A) (Sattler et al., 1997). The stable nature of the 
BH3:groove interaction has allowed elucidation of many structures of pro-survival 
proteins in complex with pro-apoptotic BH3 peptides in subsequent years, including 
X-ray crystal structures showing the canonical BH3:groove interaction at atomic 
resolution (Figure 4B). The BH3 motif is characterised by a series of hydrophobic 
residues (h1-h4) and a conserved aspartic acid residue that forms an essential salt bridge 
with an arginine residue in the BH1 domain of its binding partner (Figure 4C). The 
h1-h4 residues project from one side of the α-helical BH3 domain and are received by 
4 complementary binding pockets that form the hydrophobic surface groove of an 





Figure 4. Structural view of the BH3:groove interaction. A) and B) X-ray crystal 
structures of BH3 peptides from Bak (purple) and Bim (yellow) bound to the 
hydrophobic grooves of Bcl-XL (PDB code: 1BXL (Sattler et al., 1997)) and Mcl-1 
(PDB code: 2NL9 (Czabotar et al., 2007)) (both blue), respectively. C) Bim BH3 
peptide binding to Mcl-1 groove as in B. The conserved hydrophobic residues h1-h4 
and D to R salt bridge residues are labelled and shown as sticks. 
Sequence differences within BH3 domains determine the suite of pro-survival proteins 
that a given pro-apoptotic protein can bind to. For example, Bad binds selectively to 
Bcl-2, Bcl-XL and Bcl-W, while Noxa binds Mcl-1 and A1 (Certo et al., 2006; 
Chen et al., 2005; Kuwana et al., 2005). Bim, tBid and Puma, on the other hand, are 
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promiscuous and appear to bind to and neutralise all pro-survival proteins (Certo et al., 
2006; Chen et al., 2005; Kuwana et al., 2005). Pro-survival proteins also bind to the 
multi-BH domain effector proteins Bak and Bax to inhibit the pro-apoptotic activity of 
these proteins (Chittenden et al., 1995a; Fletcher et al., 2008; Oltvai et al., 1993; 
Sattler et al., 1997; Wang et al., 1998). Of the effector proteins, the Bak BH3 domain 
has a more restricted binding profile, with selectivity for Bcl-XL, Mcl-1 and A1, 
whereas Bax binds to those pro-survival proteins as well as to Bcl-2 and Bcl-W 
(Simmons et al., 2008; Willis et al., 2005; Willis et al., 2007). Though their binding 
repertoires are somewhat restricted, structural studies have demonstrated that the 
substantial structural plasticity of the hydrophobic groove of pro-survival proteins is 
likely what allows them to bind BH3 domains that differ in sequence (Lee et al., 2009; 
Smits et al., 2008). 
Historically, it has proven difficult to produce and work with full-length multi-BH 
domain proteins and BH3-only proteins due to hydrophobic TM domains and lack of 
tertiary structure, respectively. In addition, working with these proteins in the 
physiologically relevant context of a phospholipid bilayer is challenging. Therefore, 
high-resolution structural studies of the BH3:groove interaction have been performed 
with C-terminally truncated pro-survival proteins and pro-apoptotic BH3 peptides. Due 
to this limited view, the BH3 domain:pro-survival protein interaction is often depicted 
as an α-helical BH3 domain binding to pro-survival protein that is largely unchanged 
from its apo form. However, some studies have suggested that in the biologically 
relevant context of a membrane, certain pro-survival proteins also change conformation 
in order to bind BH3 domains (Dlugosz et al., 2006). Overall, the physiological 
relevance of conformational change in pro-survival proteins has received limited 
attention. 
The various specificities of certain Bcl-2 family proteins and the promiscuity of others 
allow fine-tuning of the apoptotic response to the multitude of stresses that a cell may 
encounter. In addition, the potential for specificity in these interactions has facilitated 
the successful development of BH3 mimetic drugs that target a single pro-survival 
protein, circumventing the wide-reaching toxicity that would be associated with 




1.3.2 Activation and Dimerisation of Bak and Bax 
The primary role of pro-survival proteins is to antagonise the function of the 
pro-apoptotic effector proteins Bak and Bax. In non-apoptotic cells, monomeric Bak 
and Bax shuttle between the mitochondria and the cytosol at different rates 
(Edlich et al., 2011; Schellenberg et al., 2013; Todt et al., 2015). Bax exhibits a 
predominantly cytosolic localisation pattern while Bak is found primarily at the 
mitochondria, with its TM helix traversing the MOM (Griffiths et al., 1999; 
Suzuki et al., 2000). Bax is able to remain cytosolic because of its ability to sequester 
its TM helix in the canonical BH3-binding groove (Suzuki et al., 2000). The TM 
domain appears to dictate localisation patterns, as swapping TM helices renders Bak 
cytosolic and Bax MOM-associated (Todt et al., 2015). 
Upon BH3-only protein upregulation following apoptotic stimuli, Bax accumulates on 
the MOM (Schellenberg et al., 2013). A proposed initial activation site for Bax is 
formed by α-helices 1 and 6 on the side of the protein opposite to the canonical 
hydrophobic groove site (Gavathiotis et al., 2008). This “rear site” was mapped using 
chemically stapled activator BH3 peptides, and it was suggested that binding triggers 
dissociation of the Bax TM helix from the canonical groove (Gavathiotis et al., 2008). 
Such an event could increase Bax shuttling to the mitochondria, but mutation of 
residues in the rear site does not prevent apoptosis, suggesting that rear-site activation 
is dispensable for the pro-apoptotic activity of Bax (Okamoto et al., 2013; Peng et al., 
2013). 
Once at the mitochondria, both Bak and Bax are engaged by activator BH3-only 
proteins that bind transiently to the canonical hydrophobic groove and induce 
conformational change (Brouwer et al., 2014; Czabotar et al., 2013; Moldoveanu et al., 
2013). Structural details of this conformational change were first elucidated using a Bax 
construct lacking its TM domain by Czabotar and Westphal et al. in 2013. Addition of 
activator BH3 peptides to truncated Bax induced homodimerisation of the protein in 
the presence of detergent (Czabotar et al., 2013). The crystal structure of the resulting 
homodimer revealed a domain-swapped conformation, with the “latch” domain (α6-8) 
of one Bax molecule wrapped around the “core” domain (α2-5) of a second Bax 
molecule, and vice versa (Czabotar et al., 2013). The homodimer therefore contained 
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two Bax globules resembling the monomeric protein joined at the junction of α5 and 
α6 (Czabotar et al., 2013). Though the domain-swapped dimer is likely an artefact of 
the use of truncated Bax in the absence of membrane, the domain-swapping event 
demonstrated that activator BH3 peptide binding had induced separation of the α5-6 
helical hairpin (Czabotar et al., 2013). This “unlatching” of monomeric Bax induced 
by activator BH3-only proteins and peptides was shown to be an essential event for 
MOMP, when full-length Bax with the α5 and α6 locked together via a disulphide bond 
failed to permeabilise mitochondria and release cytochrome c (Czabotar et al., 2013). 
Domain-swapped Bax dimers also presented a unique opportunity to study the 
BH3:groove interaction between BH3 domains and the Bax hydrophobic groove. In 
contrast to BH3:pro-survival protein complexes, BH3:groove interactions with Bax or 
Bak had proven difficult to study structurally due to the transient nature of BH3 domain 
binding to these proteins. As the domain-swapped dimer had already undergone 
conformational change but still resembled monomeric Bax protein, it provided a 
platform for stable binding of BH3 peptides. The structures of the Bid BH3 peptide and 
Bax BH3 peptide bound to the hydrophobic grooves of domain-swapped Bax dimers 
revealed the canonical BH3:groove interactions seen in pro-survival:BH3 peptide 
complexes (Czabotar et al., 2013). The h1-h4 positions of the BH3 peptides bound 
deeply into the groove, and a salt-bridge was formed between the conserved aspartic 
acid residue of the BH3 peptides and Arg109 in the BH1 domain of Bax (Czabotar et al., 
2013). Apart from the canonical interactions, additional interactions were noted at the 
base of the hydrophobic groove involving two residues at the N-terminus of the BH3 
domain (Czabotar et al., 2013). Mutation of these residues, termed h0, drastically 
reduced the activating potency of both the Bid and Bim BH3 peptides (Czabotar et al., 
2013). Following this work, further structures of domain-swapped Bax bound to the 
Bim BH3 peptide and NMR structure of Bak bound to a stapled Bid BH3 peptide 
confirmed that the conserved BH3:groove binding interactions occurred in both of the 
multi-BH domain pro-apoptotic proteins (Moldoveanu et al., 2013; Robin et al., 2015). 
Interestingly, in cells lacking the 8 known BH3-only proteins, Bak and Bax activation 
occurred spontaneously when pro-survival proteins were neutralised (O'Neill et al., 
2016). The kinetics of cell death were similar when BH3-only proteins were present, 
suggesting Bak and Bax may be constitutively active, or that other undiscovered factors 
may influence their activation. This also suggests that Mode 1 inhibition may not play 
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an essential role in preventing apoptosis, and that Mode 2 complexes are critical for 
apoptosis inhibition. However, the genetic abnormality of the cells in this study 
preclude determination of the physiological relevance of BH3-only protein-mediated 
activation of Bax and Bak in genetically normal animals. 
The separation of the latch and core domains induced by activator BH3-only proteins, 
as well as the requisite dissociation of α1, is posited to result in the collapse of initially 
globular full-length Bax onto the MOM, and Bax homodimerisation (Alsop et al., 2015; 
Czabotar et al., 2013; Westphal et al., 2014). Bax and Bak homodimers on the MOM 
have been characterised by cysteine cross-linking studies in apoptotic cells 
(Dewson et al., 2008; Dewson et al., 2012). Unlike the domain-swapped dimers that 
form in solution, full-length membrane-bound Bax and Bak homodimerise via 
symmetric exchange of their BH3 domains into the hydrophobic grooves of a partner 
molecule (Dewson et al., 2008; Dewson et al., 2012). 
Given that homodimerisation involved the BH3 domain (α2) and the hydrophobic 
groove (α3-5), the N-terminus of the newly coined core domain (α2-5) of Bax was fused 
to green fluorescent protein (GFP) for high-resolution structural studies. The rationale 
for the use of a fusion construct was that the core domain would likely exhibit large, 
exposed hydrophobic surfaces, and fusion to GFP could increase solubility, prevent 
aggregation and aid crystallisation of the core (Czabotar et al., 2013). The fusion 
protein ran as a tetramer on gel filtration (GF) and crystallised in the presence of 
detergent (Czabotar et al., 2013). The crystal structure revealed two GFP homodimers 
linked by homodimers of the Bax core domain, forming a fusion protein tetramer 
(Czabotar et al., 2013). Bax core domains assumed a symmetric BH3:groove fold, 
where the BH3 domains of each monomer bound symmetrically to the hydrophobic 
groove of a partner Bax molecule (Czabotar et al., 2013). The structure was in 
agreement with cysteine cross-linking data mentioned above, and has since been further 
validated by double electron-electron resonance (DEER) spectroscopy (Bleicken et al., 
2014; Czabotar et al., 2013; Dewson et al., 2012). Interestingly, the core homodimers 
presented hydrophilic (α2-3) and hydrophobic (α4-5) surfaces on opposite sides of the 
dimer. Given the enrichment of aromatic residues on the hydrophobic side of the dimer, 
it was proposed that this might represent a membrane-interacting surface 
(Czabotar et al., 2013). 
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Subsequently determined crystal structures of Bak demonstrated identical core/latch 
separation and symmetric BH3:groove homodimerisation (Brouwer et al., 2014). As 
with Bax, a GFP:Bak core domain fusion protein formed tetramers consisting of two 
GFP homodimers and two Bak BH3:groove core homodimers (Brouwer et al., 2014). 
Again, the Bak core homodimers were consistent with cysteine cross-linking and EPR 
spectroscopy experiments (Aluvila et al., 2014; Dewson et al., 2008). The core 
homodimer of Bak also exhibited hydrophilic (α2-3) and hydrophobic (α4-5) surfaces 
with enrichment of aromatic residues on the hydrophobic side. The hydrophobic surface 
of the Bak dimer was curved in comparison to the Bax dimer, and was suggested to 
play a role in membrane disruption by inducing membrane curvature (Brouwer et al., 
2014). A schematic representation of the structural changes in Bax and Bak that lead to 
MOMP is presented in Figure 5, along with high-resolution structures that informed 










Figure 5. Schematic and structural representation of the Bax/Bak-mediated MOMP 
pathway. Schematic representation (see key at top right) and corresponding structures 
of Bax and Bak shown as ribbons (top and middle rows of structures, respectively), 
depicting conformational changes that occur along the MOMP pathway. The structure 
of cytochrome c (PDB code: 3ZCF (Rajagopal et al., 2013)) in the IMS is depicted as 
green ribbons in the bottom row of structures. Both Bax and Bak constantly shuttle 
between the cytosol and the MOM. In step 1, Bax and Bak accumulate on the MOM 
following an apoptotic stimulus. Step 2 involves activation of Bax and Bak via transient 
binding of the BH3 domain of an activator BH3-only protein to the hydrophobic groove 
of Bax and Bak. BH3 binding induces separation of the core and latch domains in step 
3. In step 4, the freed core domains homodimerise. Homodimers oligomerise and cause 
MOMP in step 5. 
BH3:groove homodimers are now well accepted as the building blocks of the oligomers 
that permeabilise mitochondria (Aluvila et al., 2014; Bleicken et al., 2010; 
Bleicken et al., 2014; Brouwer et al., 2014; Cosentino and Garcia-Saez, 2017; 
Czabotar et al., 2014; Czabotar et al., 2013; Dewson et al., 2009; Dewson et al., 2012; 
Gilbert, 2016; Mandal et al., 2016; Oh et al., 2010; Subburaj et al., 2015; Uren et al., 
2017; Zhang et al., 2016). The nature of said oligomers, however, remains elusive. 
Several inter-dimer protein:protein interfaces have been proposed between Bax and/or 
Bak BH3:groove homodimers, including in the latch between α6 helices (Dewson et al., 
2009; Dewson et al., 2012; Ma et al., 2013), between the corners of core domain dimers 
consisting of the C-termini of α3 and α5 helices (hereafter referred to as the α3/α5 
corners) (Aluvila et al., 2014; Mandal et al., 2016), and between the TM domain α9 
helices (Iyer et al., 2015; Zhang et al., 2016). Despite the proximity of these linkage 
sites in oligomeric Bak or Bax on the membrane, detergent-solubilised Bak oligomers 
from the MOM collapse to homodimers on blue native PAGE (Ma et al., 2013). The 
collapse of oligomers suggests that the protein:protein interactions at the inter-dimer 
interface are unstable when removed from the membrane environment (Ma et al., 
2013). 
However it is that the homodimers assemble into an oligomer, a consequence of 
activation and oligomerisation of Bak and Bax is permeabilisation of the MOM. 
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Membrane permeabilisation likely occurs via the formation of pores by Bax and Bak 
oligomers. 
1.4 Pore-forming Proteins 
Cellular membranes are physical boundaries between both the cell and its environment 
and between different cellular compartments such as the cytosol and mitochondria. The 
lipid bilayers that constitute these membranes are impermeable to water and 
water-soluble molecules. Integral membrane proteins, including ion channels and 
transporters, allow passage of specific molecules across these barriers without 
compromising their integrity. Pore-forming proteins (PFPs), on the other hand, can 
allow non-specific passage of ions, small molecules, and even macromolecules by 
binding to membranes and forming pores through the bilayer. Pores formed by PFPs 
range in size from 1-2 nm across for S. aureus α-haemolysin to up to 500 nm for rings 
of Bax observed on mitochondria by stimulated emission depletion super-resolution 
microscopy (Grosse et al., 2016; Song et al., 1996). All kingdoms of life produce PFPs 
that can function as toxins, in the immune response to pathogens, and in other less lethal 
roles (Gilbert et al., 2014). 
Structurally, PFPs are a diverse group of proteins that are broadly divided into α-PFPs 
and β-PFPs (Iacovache et al., 2010). In α-PFPs, the lumen of the pore is lined with 
α-helices, whereas pores created by β-PFPs are lined by β-hairpins that form a β-barrel. 
Common to both α- and β-PFPs is the conversion from a soluble form (usually 
monomeric) to a membrane-inserted, oligomeric form where each protomer may 
contribute one or more α-helices or β-hairpins to the pore. Bak and Bax are unusual and 
potentially unique among PFPs in that the building block of the oligomeric pores 
formed by these proteins are dimers that bear little structural resemblance to their inert 
monomeric forms. 
1.4.1 Proteinaceous vs. Toroidal Pores 
PFPs can also be categorised based on the type of pore that they form. Pores in which 
the lumen is lined entirely by protein are known as proteinaceous pores. Both α-PFPs 
and β-PFPs can form proteinaceous pores that are usually of a defined size (e.g. the 
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dodecameric α-helical pore formed by cytolysin A from E. coli (Mueller et al., 2009)). 
Proteolipidic toroidal pores, on the other hand, incorporate lipid as well as protein into 
the pore structure. In toroidal pores, the lamellar structure of the bilayer is disrupted, 
resulting in the lipids of the inner and outer leaflets bending to fuse and form a 
continuous hydrophilic surface (Figure 6A). The hydrophilic surface, made up of lipid 
headgroups, protects the hydrophobic membrane core, reducing line tension (the 
biophysical force responsible for closing toroidal pores) at the pore edge 
(Karatekin et al., 2003; May, 2000). Toroidal pores can be induced by different stimuli 
including the transition of electrical charge across membranes and by certain PFPs. 
Thus, the difference between proteinaceous and proteolipidic pores can be simply 
summarised: proteinaceous pores maintain the lamellar structure of the bilayer while 
proteolipidic pores disrupt it. 
There are two known architectures of proteolipidic pores: arc-type pores and 
matrix-type pores (Gilbert, 2016; Gilbert et al., 2014). In arc-type pores, such as those 
formed by the MACPF/CDC protein superfamily, a growing arc of oligomerising 
protein subunits line one side of the pore while the other side consists of a toroidal 
arrangement of lipids (Figure 6C). These pores may eventually form a closed, fully 
proteinaceous ring, but opening of a pore in the membrane precedes ring formation in 
some cases (Sonnen et al., 2014). Matrix-type pores consist of protein interspersed with 
lipids at the pore lumen, and are thought to be formed by antimicrobial peptides such 
as melittin (Figure 6D) (Gilbert, 2016; Gilbert et al., 2014). Despite what would at first 
appear to be a very energetically unfavourable pore structure, both arc- and matrix-type 
PFPs achieve pore stability by relieving the curvature stress at the pore edge, resulting 
in a reduction in line tension (Garcia-Saez et al., 2007; Gilbert et al., 2014). 
Though clear examples exist of PFPs that form only arc- or matrix-type pores, these 
architectures are not necessarily mutually exclusive. It is possible that composite 
arc/matrix pores exist that exhibit features of both types, as well as other types of 





Figure 6. Architecture of toroidal pores and proteolipidic pores. A) Cartoon 
cross-section of the membrane showing the architecture of a toroidal pore. Lipid 
headgroups bend around the pore lumen with negative curvature and positive 
curvature, parallel and perpendicular to the membrane plane, respectively. 
B) Top-down view of the toroidal lipidic pore in A. C) Top-down view of an arc-type 
proteolipidic pore lined by protein on one side (purple rectangles) and toroidal lipids 
on the other. D) Top-down view of a matrix-type proteolipidic pore lined by protein 
(purple circles) interspersed with toroidal lipids. Adapted from (Gilbert, 2016). 
1.4.2 Pore Formation by Bak and Bax 
Overwhelmingly, data in the literature support the formation of toroidal proteolipidic 
pores by Bak and Bax. In early experiments, Bax decreased membrane planarity 
lifetime and line tension of the membrane (Basanez et al., 1999). Intrinsic membrane 
curvature, along with line tension, is a property of membranes dependent on their lipid 
composition (Gruner, 1985; May, 2000). Certain lipids promote positive curvature 
while others promote negative curvature, both of which are favourable for stabilisation 
of toroidal lipidic and proteolipidic pores (see Figure 6A). Lysophospholipids have 
only one acyl chain and generally promote positive curvature by allowing closer 
packing of acyl chains as compared to diacyl phospholipids. In contrast, cardiolipin 
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possesses 4 acyl chains, expanding the hydrophobic portion of the molecule and 
promoting negative curvature. Artificial membranes with positive or negative intrinsic 
curvature were found to promote or inhibit Bax pore formation, respectively, supporting 
the proteolipidic pore hypothesis (Basanez et al., 2002). Direct observation of Bak and 
Bax pores in liposomes by cryo-electron microscopy (cryo-EM) revealed pores sized 
between 25-100 nm (Bleicken et al., 2010; Landeta et al., 2011; Schafer et al., 2009). 
The heterogeneity and concentration-dependency of Bak and Bax pore size is 
suggestive of toroidal proteolipidic pores, as opposed to proteinaceous pores such as 
those of tetanolysin, that are generally uniform in size at different concentrations and 
protein:lipid ratios (Bleicken et al., 2013a; Bleicken et al., 2013b; Landeta et al., 2011). 
Nanogold-labelled Bax was observed incompletely lining the rim of pores in liposomes 
with gaps between the Bax particles, again suggesting a proteolipidic pore arrangement 
(Kuwana et al., 2016). 
Only recently, with the advent of super-resolution microscopy techniques, have the 
supramolecular structures formed by Bax on the MOM been revealed. Bax appears to 
form several distinct structures on the MOM after induction of apoptosis, including 
lines, double lines, arcs, rings and large aggregates (Grosse et al., 2016; Salvador-
Gallego et al., 2016). In a similar study of Bak, only small and large clustered 
aggregates were observed, with no discernible lines, double lines, arcs or rings 
(Nasu et al., 2016). This could be due to the comparatively lower fluorescence intensity 
fluorophore used in the Bak study that may have limited resolution (Nasu et al., 2016). 
Large aggregates have previously been observed for both Bak and Bax 
(Zhou and Chang, 2008). Importantly however, apoptogenic molecules cytochrome c 
and Smac were released from mitochondria by small clusters of Bak/Bax prior to 
formation of larger aggregates (Zhou and Chang, 2008). Indeed, atomic force 
microscopy (AFM) experiments demonstrated that both the arc and ring structures lined 
pores formed by Bax in supported lipid bilayers (Salvador-Gallego et al., 2016). That 
arcs of Bax were able to form pores is the first direct evidence that Bax pores are 
proteolipidic. 
These microscopy studies have provided vital information, showing for the first time 
that Bax can form complex supramolecular structures, and that these structures are 
associated with membrane pores. Questions remain regarding the mechanism of initial 
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membrane disruption and how Bak and Bax homodimers interact with one another and 
with the membrane at a molecular level. 
Disordered clustering of BH3:groove homodimers has recently been proposed to 
generate sufficient membrane tension to induce rupturing of the MOM (Uren et al., 
2017). Subsequent to membrane disruption and pore opening, models for stabilisation 
of growing pores by the stable core domains of BH3:groove homodimers have been 
proposed. The “clamp model” for Bax, based on DEER spectroscopy experiments, 
involves Bax homodimers forming a clamp at the pore rim, with the core dimer’s 
hydrophobic α4-5 surface in contact with the hydrophobic membrane core and the 
α6 helices shallowly inserted parallel to the membrane plane on opposite leaflets 
(Bleicken et al., 2014). A caveat of this model is that it assumes symmetry in the 
membrane plane and does not explain or provide evidence for flipping of the α6-9 
helices from one side of the membrane to the other. Nevertheless, stabilisation of the 
pore edge is critical for maintaining an open toroidal pore, and the core dimer’s polarity, 
in terms of hydrophilicity/hydrophobicity, makes it an attractive pore stabilising unit. 
In a different model, Bak core homodimers have been proposed to line the rim of pores 
(Aluvila et al., 2014; Mandal et al., 2016). In contrast to the clamp model, this model 
does not assume flipping of the α6-9 helices to the inner leaflet. Both models were 
created based on cysteine cross-linking and EPR spectroscopy experiments. While 
these techniques are valuable in informing the gross spatial and conformational 
arrangement of Bak and Bax in membrane pores, the dynamic nature and flexibility of 
Bak/Bax homodimers in the membrane can complicate interpretation of results. As 
such, the models remain our best guesses at the structure of Bak and Bax pores in lieu 
of high-resolution structural information from techniques such as X-ray crystallography 
and cryo-EM. 
In general, it seems that pore formation by Bak and Bax likely involves two separate 
events: membrane disruption and pore stabilisation (Cosentino and Garcia-Saez, 2017). 
These two events may involve different conformations of Bak and Bax homodimers. 
However, the core homodimer at least seems to maintain its fold for all events 
subsequent to homodimerisation. The main barrier to determining a high-resolution 
structure of Bak or Bax pores is the difficulty of preparing a highly homogenous sample 
of Bak or Bax oligomers of a distinct size. Until such a sample can be prepared, 
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BH3:groove core domain homodimers remain our only high-resolution view of the 
activated forms of Bak and Bax. 
While many questions surround the mechanism of pore formation by Bak and Bax, still 
less is clear in the case of the third multi-BH domain pro-apoptotic protein: Bok. 
1.5 Bcl-2-related Ovarian Killer Protein 
Of all known Bcl-2 family proteins, Bcl-2-related ovarian killer protein (Bok) remains 
one of the most enigmatic. Shortly after the discovery of Bak and Bax, Bok was 
identified in a yeast two-hybrid screen using the pro-survival protein Mcl-1 as bait 
(Hsu et al., 1997). Bok also hybridised with A1 but not Bcl-2 or Bcl-XL (Hsu et al., 
1997; Inohara et al., 1998). Overexpression of Bok induced apoptosis in mammalian 
cells that could not be rescued by Bcl-2 or Bcl-XL overexpression (Hsu et al., 1997; 
Inohara et al., 1998). Taken together with sequence similarity to Bak and Bax, these 
findings suggested that Bok could be a third pro-apoptotic effector protein (Hsu et al., 
1997; Inohara et al., 1998). 
In early studies, Bok appeared to show tissue-restricted expression in reproductive 
tissues as well as the liver, brain, appendix and lymphoid tissues (Hsu et al., 1997; 
Inohara et al., 1998). More recent studies confirmed higher expression levels in 
reproductive tissues and the brain, but also wider low-level expression in almost all 
tissues (Ke et al., 2012). The pro-apoptotic effector function of Bok was called into 
question following findings that cells lacking Bak and Bax were highly resistant to 
most, if not all, intrinsic apoptotic stimuli (Lindsten et al., 2000). Bak, Bax or Bok 
singly-deficient mice all developed relatively normally with minimal phenotypic 
abnormalities (Ke et al., 2012; Knudson et al., 1995; Lindsten et al., 2000). However, 
while Bax can compensate during development for combined Bok/Bak loss, and Bak 
compensates for combined Bok/Bax loss, Bok cannot compensate for the combined 
loss of Bak and Bax that leads to a severe developmental phenotype resulting in 
perinatal death (Ke et al., 2013; Lindsten et al., 2000). Therefore, it appears that the 
roles of Bak and Bax largely overlap during development, while Bok function is likely 
non-essential or may be compensated for by an as yet unidentified protein. 
 
28 
Bok also differs from Bak and Bax in its subcellular localisation pattern. Bok localises 
primarily to the ER and Golgi membranes, with some protein at the nuclear outer 
membrane and the MOM (Bartholomeusz et al., 2006; Echeverry et al., 2013). This 
unique localisation pattern is due to an atypical TM domain. The Bok TM helix contains 
two positively charged residues and lacks the net positive charge on the C-terminus that 
acts as a mitochondrial targeting signal (Echeverry et al., 2013; Horie et al., 2002; 
Kaufmann et al., 2003). At the ER membrane, Bok binds to the 
inositol 1,4,5-trisphosphate receptors (IP3Rs) and has been linked to the ER-associated 
degradation (ERAD) pathway (Llambi et al., 2016; Schulman et al., 2016; 
Schulman et al., 2013). Further to this, Bok-/- mice and cells derived therefrom appeared 
to be resistant to intrinsic apoptosis induced by ER-stressing drugs such as thapsigargin 
(Carpio et al., 2015, 2016). This finding is controversial, as Bok-/- cell lines and mice 
from two independent groups showed no defect in ER stress-related apoptosis 
(Echeverry et al., 2013; Fernandez-Marrero et al., 2016; Ke et al., 2012; Llambi et al., 
2016). Whatever the case, the physiological role of Bok is certainly linked to its ER 
localisation. Overexpression of Bok causes early fragmentation of the ER and Golgi 
membranes prior to caspase activation, suggesting a membrane-related role for the 
protein (Echeverry et al., 2013). 
Whether Bok requires Bak and/or Bax for induction of the intrinsic apoptotic pathway 
is also controversial. In initial experiments with Bak and Bax doubly-deficient cells, 
Bok overexpression did not activate the intrinsic apoptotic pathway, nor did it sensitise 
the cells to intrinsic apoptotic stimuli such as etoposide (Echeverry et al., 2013). It was 
thus hypothesised that Bok acts upstream of Bak and Bax. This notion has been 
challenged in experiments from other groups, demonstrating that in specific conditions 
Bok does induce intrinsic apoptosis independently of Bak and Bax (Einsele-
Scholz et al., 2016; Llambi et al., 2016). Still, it is clear that cells lacking Bak and Bax 
are almost completely resistant to intrinsic apoptotic stimuli including ER-stress 
inducing agents, despite detectable Bok in these cells (Echeverry et al., 2013; 
Lindsten et al., 2000; Wei et al., 2001). 
Bok may be a non-canonical effector of apoptosis, regulated not by other Bcl-2 proteins 
but by components of the ERAD pathway (Llambi et al., 2016). ERAD is part of the 
unfolded protein response (UPR) that is engaged when a cell is under ER stress 
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(Walter and Ron, 2011). In the proposed model (Figure 7), Bok is constantly produced 
by cells and is ubiquitylated by the E3 ubiquitin ligase AMFR/gp78, extracted from the 
ER by the AAA-ATPase VCP/p97, and then degraded by the proteasome (Llambi et al., 
2016). Proteasome inhibition or silencing of gp78 or VCP stabilised overexpressed Bok 
protein in Bak/Bax DKO mouse embryonic fibroblasts (MEFs) and endogenous Bok in 
HCT116 Bak/Bax DKO cells (Llambi et al., 2016). Stabilisation of Bok led to 
caspase-mediated cell death, though cytochrome c release was not directly assayed 
(Llambi et al., 2016). Interestingly, unlike Bak and Bax, recombinant Bok did not 
require BH3 peptide stimulation to permeabilise large unilamellar vesicles (LUVs), and 
permeabilisation was neither enhanced by treatment with several BH3 peptides nor 
inhibited by Bcl-2 and Bcl-XL (Llambi et al., 2016). Though Mcl-1 slightly inhibited 
Bok activity on liposomes, overexpression of Bcl-2, Bcl-XL or Mcl-1 failed to inhibit 
apoptosis upon proteasome inhibition with MG132 in DKO MEFs with enforced Bok 






Figure 7. Model of Bok-mediated MOMP vs. canonical Bak/Bax-mediated MOMP. 
MOMP by canonical Bcl-2 effector proteins Bak and Bax is regulated by other Bcl-2 
proteins. Bok, on the other hand, initiates apoptosis when the ERAD pathway or the 
proteasome are inhibited (Llambi et al., 2016), leading to Bok accumulation followed 
presumably by MOMP and caspase activation.  
A model of constant Bok degradation in order to mitigate oligomerisation and cell death 
is difficult to reconcile with the fact that endogenous Bok protein is detectable in many 
different tissues (D'Orsi et al., 2016; Echeverry et al., 2013; Ke et al., 2012; 
Llambi et al., 2016; Schulman et al., 2016). It has been suggested that most cellular 
Bok is stably bound to the IP3Rs, and that the constantly produced and degraded pool 
of free Bok is responsible for apoptosis observed in the Llambi et al. 2016 study 
(Schulman et al., 2016). Although an apoptotic phenotype has been observed in cells 
lacking Bak and Bax but expressing Bok, whether Bok itself mediates cytochrome c 
release is contentious (Fernandez-Marrero et al., 2017; Haschka and Villunger, 2017). 
Indeed, a C-terminally truncated form of Bok was unable to release cytochrome c from 
mitochondria isolated from Bak/Bax DKO MEFs, despite membrane association of the 
protein in Bok knockout MEFs (Fernandez-Marrero et al., 2017). This may be due to 
some sort of inhibitory factor on the mitochondria, but it is also possible that Bak and 
Bax are required to recruit C-terminally truncated Bok to the MOM, as membrane 
association was only shown in the setting where Bak and Bax were present (Fernandez-
Marrero et al., 2017). Interestingly, this C-terminally truncated Bok can permeabilise 
liposomes and shows cooperativity in liposome permeabilisation with cBid but not Bid 
BH3 peptide, unlike Bak and Bax where peptide is sufficient (Fernandez-Marrero et al., 
2017). Whether the TM domain of Bok might be required for MOMP was not 
investigated in this study (Fernandez-Marrero et al., 2017). It is also important to note 
that in experiments with recombinant C-terminally truncated Bok, the monomeric or 
oligomeric state of the protein was not known due to the lack of a gel filtration step 
during purification (Fernandez-Marrero et al., 2017). Hence, the authors may have been 
experimenting with pre-oligomerised or aggregated, rather than monomeric, Bok. 
Non-apoptotic cytoprotective roles have been proposed for Bok, including suppression 
of poly ADP-ribose polymerase-dependent cell death and maintenance of Ca2+ 
homeostasis in neurons (D'Orsi et al., 2016). On top of this, and somewhat 
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counterintuitively, Bok-/- cells are more sensitive to cell death induced by Brefeldin A, 
a drug that causes collapse of the Golgi into the ER and activates the UPR 
(Echeverry et al., 2013). 
The literature on Bok is rife with perplexing contradictions, and the roles and 
physiological relevance of Bok remain murky. As a recent review so eloquently put it: 
“there is something about Bok we just don’t get yet” (Haschka and Villunger, 2017). 
Determination of the 3D structure of the Bok protein would certainly be a boon to 
further research, and could reveal anomalies in the Bok fold that may explain its 
constitutive activity. 
1.6 Thesis Outline 
During apoptosis, Bak and Bax homodimerise and subsequently oligomerise on the 
MOM, leading to its permeabilisation. Recently, crystal structures of the core domains 
of both Bak and Bax have demonstrated that the proteins homodimerise via a reciprocal 
exchange of BH3 domains into the hydrophobic groove of a partner molecule, as 
predicted by earlier cysteine cross-linking studies (Brouwer et al., 2014; Czabotar et al., 
2013; Dewson et al., 2008; Dewson et al., 2012). Formation of these BH3:groove 
homodimers is an essential step in MOMP. 
How BH3:groove homodimers interact with the membrane and form oligomers remains 
an area of great interest in the field. In Chapter 2, I employ X-ray crystallography to 
examine these processes in molecular detail using a novel Bak core domain expression 
construct where the scaffolding GFP fusion protein is replaced by a cleavable 
purification tag. 
The original structure of the Bak core homodimer was solved at high resolution, 
allowing precise characterisation of important molecular interactions (Brouwer et al., 
2014). The Bax core homodimer structure was solved at a much lower resolution, with 
particularly poor electron density in the Bax portions of the maps (Czabotar et al., 
2013). In Chapter 3, I aim to improve the resolution of the Bax core homodimer 
structure in order to gain a clearer picture of the Bax BH3:groove homodimer. 
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Pro-survival proteins inhibit apoptosis by sequestering pro-apoptotic proteins. In the 
case of Mode 1 inhibition, pro-survival proteins bind the BH3 domain of BH3-only 
proteins. In Mode 2 inhibition, pro-survival proteins bind the BH3 domain of Bak or 
Bax. Unlike the BH3-only proteins, Bak and Bax are multi-BH domain proteins, and it 
is possible that the interactions between Bak or Bax and a pro-survival protein are more 
extensive than just the BH3 domain binding to the pro-survival groove. The aim of 
Chapter 4 is to investigate the possibility of pro-survival:Bax/Bak BH3:groove 
heterodimers similar to the Bax and Bak BH3:groove homodimers. 
Bok is an enigmatic multi-BH domain pro-apoptotic Bcl-2 protein. One challenge in 
attempts to better understand this protein is the lack of a 3D structure. Chapter 5 details 
the expression, purification and characterisation of recombinant human, rat and chicken 










Investigation of Interactions Between Bak and Lipids 
Bak is intimately associated with the MOM in localisation and function. Once activated 
by transient BH3-only protein binding, globular membrane-anchored Bak separates 
into the core (α2-5) and latch (α6-8) domains (Brouwer et al., 2014). Subsequently, the 
freed core domain homodimerise with the core domain of a second Bak molecule via a 
symmetric exchange of the α2 BH3 helix of one Bak molecule into the α3-5 
hydrophobic groove of another (Brouwer et al., 2014; Dewson et al., 2008). Bak 
BH3:groove homodimers nucleate formation of membrane-permeabilising Bak 
oligomers that incorporate more homodimers as they grow (see Figure 5) 
(Aluvila et al., 2014; Brouwer et al., 2014; Dewson et al., 2009; Ma et al., 2013; 
Mandal et al., 2016; Uren et al., 2017). Despite intense investigation, the molecular 
mechanisms by which Bak homodimers oligomerise and permeabilise the MOM 
remain unclear. 
A well-defined and requisite protein:protein interface between Bak homodimers within 
an oligomer is yet to be described. Cysteine cross-linking and EPR spectroscopy studies 
have suggested that interactions between α6 helices (Dewson et al., 2009; Ma et al., 
2013), between the α3/α5 corners of core domain dimers (Aluvila et al., 2014; 
Mandal et al., 2016), and between α9 TM helices may be involved in oligomerisation 
(Iyer et al., 2015). However, any protein-mediated oligomerisation interfaces are 
unstable when removed from the membrane, as Bak oligomers dissociate to 
homodimers when extracted from the MOM with detergent (Ma et al., 2013). In 
addition, no Bak mutations capable of disrupting oligomerisation without also 
disrupting homodimerisation have yet been found, suggesting that protein-mediated 
interactions may be dispensable for Bak homodimer oligomerisation. Disordered 
clustering of Bak homodimers has been proposed to cause membrane rupture and may 
explain the absence of well-ordered protein:protein oligomeric interfaces (Uren et al., 
2017). 
The lack of evidence for a tight protein:protein interface between Bak homodimers 
suggests that the MOM itself may play a role in oligomerisation (Uren et al., 2017). 
Indeed, other membrane proteins with few interactions at protein:protein interfaces 
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require lipids at interfacial regions for multimerisation (Gupta et al., 2017). The 
possibility that lipids mediate or contribute to oligomerisation of Bak or Bax 
homodimers has not been investigated. 
The core domains (α2-5) of BH3:groove homodimers are the most rigid, stable unit 
within Bak oligomers (Aluvila et al., 2014; Mandal et al., 2016; Uren et al., 2017). As 
such, the truncated Bak core domain construct presents a unique opportunity to explore 
a component of activated Bak in high-resolution structural studies (Brouwer et al., 
2014). Of particular interest is the hydrophobic surface formed by the α4 and α5 helices 
of the core domain homodimer that could interact with the MOM. 
To investigate the Bak core homodimer and its relationship with the membrane, I 
determined several X-ray crystal structures of Bak core homodimers in complex with 
lipids and detergents. The results described here have implications for Bak 
oligomerisation and its interactions with the membrane. 
2.1 Crystal Structure of Bak Core Homodimers in Complex with Lipids 
The crystal structure of the Bak core domain homodimer was originally solved by 
fusing the α2-5 core sequence to GFP to increase solubility and aid crystallisation 
(Brouwer et al., 2014). The fusion protein crystallised in the presence of the detergent 
octyl glucoside, revealing a tetramer consisting of two pairs of GFP homodimers linked 
by two Bak BH3:groove core homodimers (Brouwer et al., 2014). The arrangement of 
the core domain homodimers was consistent with previous cysteine cross-linking 
studies and has since been validated by EPR spectroscopy experiments (Aluvila et al., 
2014; Brouwer et al., 2014; Dewson et al., 2008; Mandal et al., 2016). 
It was thought that core domain homodimers would aggregate in the absence of a fusion 
protein partner because of large exposed hydrophobic surfaces (Brouwer et al., 2014). 
Nevertheless, I attempted to move away from the potentially restrictive scaffolding of 
the GFP construct by instead fusing Bak(α2-5) to a cleavable N-terminal glutathione 
S-transferase (GST) tag. The fusion protein was expressed in Escherichia coli and 
purified on a glutathione column. Surprisingly, the Bak core domain remained soluble 
following cleavage from GST, and was further purified by anion exchange and GF 
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chromatography (Figure 8). The protein eluted from a Superdex 200 (S200) 10/300 GF 
column at a size consistent with a hexamer, based on the predicted monomer molecular 
weight of ~9.5 kDa (Figure 8C). This molecular weight is slightly outside the accurate 
resolution range of the SDS-PAGE gels used, hence it appeared smaller than expected 
on the gel with a relative mobility similar to the 6 kDa molecular weight marker 
(Figure 8B and D). Peak fractions containing Bak(α2-5) from the GF column were 





Figure 8. Purification of Bak(α2-5) following cleavage from GST. A) Chromatogram 
trace of Bak(α2-5) cleaved from GST and run on a HiTrap Q FastFlow 1 mL column 
in Tris pH [8.0] with a NaCl gradient from 0.03 to 1 M (% buffer B gradient shown in 
green). Bak eluted in one major peak at ~25% buffer B and two smaller peaks at higher 
salt concentrations (labelled as *). B) SDS-PAGE analysis of peak fractions from A. 
Fractions from the major peak were pooled for further purification by GF (PC = 
pre-column sample). C) Pooled fractions were run on an S200 GF column. 
D) SDS-PAGE analysis of peak fractions from C show highly pure Bak(α2-5). 
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The Bak(α2-5) core domain crystallised in the triclinic space group P1. Analysis with 
Xtriage in PHENIX predicted 5 copies of Bak(α2-5) in the unit cell of the crystal with 
~50% solvent content (Adams et al., 2010). Peaks in the self-rotation function of the 
data, 1 in the 𝜅 = 120º section and 3 at intervals of 60º in the 𝜅 = 180º section, were 
indicative of a particle with point group symmetry 32 (Figure 9). As the triclinic crystal 
system contains only lattice translations with no rotational symmetry, the symmetry 
arrangement in the self-rotation function was suggestive of three Bak homodimers in 
the unit cell related by a non-crystallographic 3-fold axis, consistent with the hexameric 
assembly predicted by elution volume from size exclusion chromatography. 
 
Figure 9. Self-rotation function of the Bak(α2-5) hexamer crystal. A) and B) 𝜅 = 120º 
and 𝜅 = 180º sections, respectively, of the self-rotation function generated from the 
Bak(α2-5) hexamer crystal data with the UCLA Self Rotation Function Sever 
(http://services.mbi.ucla.edu/selfrot/). The single peak in the	𝜅 = 120º section and three 
peaks orthogonal to it at intervals of 60º in the 𝜅 = 180º section are suggestive of a 
particle with point group symmetry 32. 
Based on this, initial attempts at molecular replacement in PHASER were performed 
searching for 3 core homodimers from the GFP:Bak(α2-5) structure (PDB code: 4U2V) 
(Brouwer et al., 2014; McCoy et al., 2007). No solutions were found with this strategy. 
Therefore, a globular monomeric entity was constructed from the homodimer 
containing the α2 BH3 helix of one polypeptide of Bak in the α3-5 hydrophobic groove 
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of the partner. PHASER placed 6 copies of this search object into homodimer pairs with 
a translation function Z-score (TFZ) of 19.6 and a log-likelihood gain (LLG) value of 
1460. The α2 and α3-5 helices of each copy of Bak were joined in COOT and the 
structure was refined by iterative rounds of building in COOT and refinement in 
PHENIX to 2.5 Å (data collection and refinement statistics are presented in Table 1) 
(Adams et al., 2010; Emsley and Cowtan, 2004). Failure to find the core homodimers 
is attributable to the fact that the dimer structures discovered here are less bent than 
those described earlier. 
The hexamer consisted of three BH3:groove homodimers in a cylinder-like 
arrangement with D3 symmetry, matching the interpretation of the self-rotation 
function (Figure 10A-D). One of the three homodimers is shown in Figure 10E 
demonstrating the BH3:groove fold where the α2 helices are reciprocally exchanged 
from one chain into the hydrophobic groove (α3-5) of the other. The three homodimers 
that formed the hexameric cylinder were highly similar in fold and are overlayed in 
Figure 10F. The hydrophilic α2-3 faces (depicted for one homodimer in Figure 10G) 
formed the outer surfaces of the cylinder while the hydrophobic α4-5 surfaces (depicted 




Table 1. Data collection and refinement statistics for Bak(α2-5) hexamer. 
Wavelength 0.9537 
Resolution range 25.66 ‑ 2.491 (2.58 ‑ 2.491) 
Space group P 1 
Unit cell 46.7 55.04 56.5 116.134 109.665 97.02 
Total reflections 146199 (13487) 
Unique reflections 15486 (1481) 
Multiplicity 9.4 (9.1) 
Completeness (%) 98.13 (93.03) 
Mean I/sigma(I) 15.04 (1.45) 
Wilson B-factor 66.40 
R-merge 0.0905 (1.727) 
R-meas 0.09588 (1.831) 
CC1/2 0.999 (0.617) 
CC* 1 (0.873) 
Reflections used in refinement 15459 (1454) 
Reflections used for R-free 1546 (142) 
R-work 0.1931 (0.3049) 
R-free 0.2521 (0.4012) 
Protein residues 469 
RMS(bonds) 0.002 
RMS(angles) 0.35 
Ramachandran favoured (%) 98.68 
Ramachandran allowed (%) 1.32 
Ramachandran outliers (%) 0.00 
Rotamer outliers (%) 1.04 
Clashscore 2.74 
Average B-factor 94.68 
macromolecules 94.79 
ligands 91.77 










Figure 10. X-ray crystal structure of the Bak(α2-5) hexamer. A) and B) Asymmetric 
unit of the Bak(α2-5) hexamer crystal viewed down the non-crystallographic 3-fold axis 
shown in ribbon representation (A) and surface representation (B). The hexamer 
consists of three BH3:groove homodimer pairs (coloured dodger blue and deep sky 
blue, turquoise and aquamarine, and spring green and light green) with a hole through 
the assembly at the 3-fold axis. C) and D) 90º rotation of structure as represented 
in A and B, respectively. One of three non-crystallographic 2-fold axes is labelled at 
the centre of the blue homodimer. E) One of the three homodimers with the α-helices 
of one chain labelled. F) Overlay of the three homodimers that form the hexamer. 
G) Vacuum electrostatic surface of the isolated homodimer in E generated in PyMOL 
(Delano, 2002) (blue positive potential (-60 kT), red negative potential (60 kT)). 
H) 180º rotation of model in G shows the hydrophobic nature of the α4-5 surface. 
As mentioned above, the homodimers were flattened in the cylinder structure 
(Figure 11A) in comparison to the published GFP:Bak(α2-5) structure (PDB code: 
4U2V) (Figure 11B) (Brouwer et al., 2014). The arrangement of helices α2 and α3-5 
in the globular BH3:groove entities used to solve the structure were similar between 
the two structures, but the angle between the globules increased in the flattened 
homodimers. As a consequence of dimer flattening, two symmetric hydrophobic 
indentations (hereafter referred to as the α5/5’ grooves), delineated by residues I123, 
V128, L132 and Y136, opened up on the hydrophobic α4-5 surfaces of each homodimer 
of the cylinder structure (Figure 11C and Figure 10H). These were not present in the 
original GFP:Bak(α2-5) structure (Figure 11D). During refinement, large and 
distinctively shaped positive peaks were observed in the difference density maps at 6 
equivalent positions in the α5/5’ grooves (Figure 11E). The large peak with a forked 
tail was reminiscent of the phosphodiester group and fatty acid tails of a diacyl 
phospholipid. Endogenous lipids are known to copurify and crystallise with membrane 
proteins expressed in E. coli (Hunte and Richers, 2008). 
Based on the difference density peaks, our collaborators at the Bio21 Molecular Science 
and Biotechnology Institute performed mass spectrometric analysis on purified Bak 
hexamer and dissolved Bak hexamer crystals to identify lipids present in the samples 
(for Methodology see Appendix) (Figure 12). Phosphatidylethanolamine (PE), 
phosphatidylglycerol (PG) and phosphatidylinositol (PI) were identified in the purified 
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Bak hexamer sample (Figure 12A and C). Both PE and PG were also present in the 
crystal sample but PI was completely excluded (Figure 12B and D). In both cases, there 
was no obvious preference for acyl chain length or saturation. 
As the most abundant lipid in the crystal sample (85.8%), PE was chosen as the ligand 
to model into the difference density shown in Figure 11E. Adding lipids to the structure 
resulted in a significant improvement in R-factors after refinement. After several rounds 
of refinement, carbon atoms in the acyl chains that did not have convincing density in 
the 2Fo-Fc map contoured at 0.7 σ were set to zero occupancy. Ligands in all 
subsequent structures in this chapter were also treated in this way. To confirm the 
presence of lipids in the structure, the PE ligands were removed from the final model 
and refinement with simulated annealing was performed. Clear positive density for the 
phosphodiester and glycerol moieties was observed at all PE positions in the Fo-Fc 
map, with varying lengths for the acyl chains (Figure 11F). The final model containing 
lipid is shown in Figure 11G and H. The zero occupancy acyl chain atoms of the PE 
ligands were included in this depiction based on the chain lengths seen in the mass spec 
analysis. The acyl chains are likely flexible and disordered beyond a certain length in 
the crystal and are therefore not seen in the electron density. Each lipid headgroup sits 
between two adjacent homodimers, with the one acyl chain bound to the α5/5’ groove 
of one homodimer and the other bound in a shallow groove created by the α4-5 surface 









Figure 11. Bak(α2-5) homodimer vs. published structure with evidence for bound 
phospholipid. A) Bak(α2-5) homodimer (dodger blue and deep sky blue) from novel 
hexamer structure shown as ribbons with a transparent white surface. Two symmetric 
grooves (α5/5’ grooves) are formed at the dyad axis on the hydrophobic α4-5 surface. 
B) Previously published structure of Bak(α2-5) homodimer (green and chartreuse, 
PDB code: 4U2V (Brouwer et al., 2014)) in the same orientation as A (N-terminal GFP 
fusion protein not shown). C) Structure in A focused on the hydrophobic α4-5 surface. 
The α5/5’ grooves (red dotted line) formed between the α5 helices are delineated by 
residues Ile123, Val128, Leu132 and Tyr136 (labelled and shown as sticks). D) The 
Brouwer et al., 2014 structure displayed as in C. The α5/5’ grooves observed in C are 
absent, due to the curved nature of the dimer in this structure. E) Density (2Fo-Fc in 
grey and Fo-Fc in green contoured at 1 and 3 σ, respectively) resembling a diacyl 
phospholipid (modelled at the time as a sulphate ion, yellow) was observed during the 
early stages of refinement at 6 identical positions in the α5/5’ grooves of the 3 
homodimers present in the hexamer. F) One homodimer from the final model of the 
hexamer overlayed with simulated annealing omit map (Fo-Fc contoured at 3 σ) 
generated from the model that had been refined with 6 PE ligands. All 6 PE ligands 





Figure 12. Lipid composition of purified and crystallised Bak(α2-5) samples. 
A) and B) Mole percent composition of lipid classes identified in purified Bak(α2-5) 
(A) and Bak(α2-5) crystals (B). C) and D) Mole percent composition of individual lipid 
species identified in purified Bak(α2-5) (C) and Bak(α2-5) crystals (D). 
PE=phosphatidylethanolamine, PG=phosphatidylglycerol, PI=phosphatidylinositol. 
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Small-angle X-ray scattering (SAXS) experiments were performed on purified 
Bak(α2-5) hexamer to further evaluate whether the presence of lipids in the structural 
model is most consistent with in solution structure (data collection and analysis 
statistics are presented in Table 2). The theoretical scattering curve generated in 
CRYSOL with the crystal structure coordinates for the Bax cylinder structure 
corresponded well with the measured experimental scattering curve (Figure 13C). In 
support of the presence of lipids in the Bak cylinder in solution, removing the PE 








Instrument Australian Synchrotron 
SAXS/WAXS beamline 
Beam geometry 120 micron point source 
Wavelength (Å) 1.033 
Exposure time  2 sec exposures 
Temperature (K) 285 
  
q range (Å-1)a 0.0106 to 0.400 
Protein concentration 50 µL of 17 mg/ml protein 
via inline gel filtration 
chromatography 
0.2 M NaCl, 20 mM 
HEPES pH [7.5], 5% v/v 
glycerol 
Structural parameters  
I(0) (cm-1) [from P(r)] 0.03726 ± 0.0001 
Rg (Å) [from P(r)] 24.59 ± 0.064 
Dmax (Å) 75 
I(0) (cm-1) (from Guinier) 0.03749 ± 0.0001 
Rg (Å) (from Guinier) 25.10 ± 0.11 
  
Software employed  
Primary data reduction Scatterbrain (Australian 
Synchrotron) 
Data processing PRIMUS, GNOM 
Computation of model 
intensities 
CRYSOL 
a q is the magnitude of the scattering vector, which is related to the scattering angle (2θ) 




Figure 13. SAXS analysis of Bak(α2-5) hexamer. A) Pairwise interatomic distance 
distribution (P(r)) determined with GNOM (Svergun, 1992). B) Guinier plot of the 
SAXS data for q.Rg ≤ 1.3 performed with PRIMUS (Konarev et al., 2003). The linearity 
of a Guinier plot of Bak α2-5 scattering data shows that higher molecular weight 
aggregates do not measurably contribute to scattering. C) and D) Experimental 
scattering curve measured for Bak α2-5 (black) overlayed with the theoretical 
scattering curve (red) generated with CRYSOL (Svergun et al., 1995) using the crystal 
structure of the Bak(α2-5) hexamer including PE lipids (C) and with lipids deleted from 
the model (D). The χ values of 0.933 and 1.597 indicate that the inclusion of lipids 
better represents the structure of the complex in solution.
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2.2 Investigation of Lipid Binding Site by X-ray Crystallography 
Having demonstrated conclusively that Bak core domains associate with lipid, I went 
on to investigate the binding site further using X-ray crystallography. Concomitantly 
with refinement of the Bak hexamer structure and experiments to confirm the presence 
of lipid, an additive screen on a different set of conditions produced large crystals in a 
well containing the non-ionic detergent n-Dodecyl-β-D-maltoside (DDM). The 
structure was solved by molecular replacement using a homodimer from the cylinder 
structure as a search model and refined to 1.9 Å in the monoclinic space group C2 (data 
collection and refinement statistics are presented in Table 3). Six Bak core homodimers 
were present in the asymmetric unit, arranged in two near-identical hexameric 
funnel-like assemblies, one of which is depicted in Figure 14A and B. In contrast to 
the Bak hexamer cylinder, the inner and outer surfaces of the funnel were hydrophilic 
(α2-3 helices) and hydrophobic (α4-5 helices), respectively (Figure 14C and D). A 
sulphate ion coordinated by six Arg88 residues (two from each homodimer) plugged 
the funnel stem at a non-crystallographic 3-fold axis. The α5/5’ grooves that bound 
E. coli lipids in the cylinder structure were replaced by DDM molecules that were 
well-resolved in the electron density, demonstrating for a second time the lipophilicity 
of the grooves (Figure 14E). DDM was also bound less consistently to secondary sites 




Table 3. Data collection and refinement statistics for Bak(α2-5) in complex with 
DDM. 
Wavelength 0.9537 
Resolution range 39.45 ‑ 1.799 (1.863 ‑ 1.799) 
Space group C 1 2 1 
Unit cell 158.941 91.835 95.716 90 107.518 90 
Total reflections 458431 (43684) 
Unique reflections 121091 (11835) 
Multiplicity 3.8 (3.7) 
Completeness (%) 99.22 (94.54) 
Mean I/sigma(I) 12.03 (0.58) 
Wilson B-factor 31.44 
R-merge 0.07763 (2.416) 
R-meas 0.09051 (2.82) 
CC1/2 0.999 (0.226) 
CC* 1 (0.607) 
Reflections used in refinement 120587 (11383) 
Reflections used for R-free 1993 (188) 
R-work 0.2129 (0.3515) 
R-free 0.2487 (0.3789) 
Protein residues 1019 
RMS(bonds) 0.008 
RMS(angles) 0.92 
Ramachandran favoured (%) 99.46 
Ramachandran allowed (%) 0.54 
Ramachandran outliers (%) 0.00 
Rotamer outliers (%) 1.65 
Clashscore 6.58 











Figure 14. Crystal structure of Bak(α2-5) funnel in complex with DDM. A-D) Surface 
representation (A and B) and charge distribution (C and D, (blue positive potential 
(-63.5 kT), red negative potential (63.5 kT)) of three Bak(α2-5) homodimers (dodger 
blue and deep sky blue, spring green and light green, and turquoise and aquamarine) 
that formed a funnel in complex with DDM (purple, shown as sticks). The hydrophilic 
faces of the homodimers (α2-3) form the funnel’s inner surface, with a sulphate ion, 
coordinated by several arginine residues, plugging the funnel stem at a 
non-crystallographic 3-fold symmetry axis. The exterior funnel surface made up of the 
α4-5 helices is hydrophobic and partially covered by detergent molecules. E) Ribbon 
diagram with transparent surface of one of the three homodimers in the funnel. DDM 
bound to the α5/5’ grooves (red dotted lines) seen in the Bak cylinder structure and to 
secondary sites on the α4-5 surface. 
An analysis of the crystal packing of the Bak(α2-5):DDM funnels is presented in 
Figure 15. Layers of hexameric funnels build the crystal, exhibiting a packing 
arrangement similar to type-1 packing seen in crystals grown in lipidic cubic phase. In 
type-1 packing, the molecules are arranged in sheets as though inserted into a lipid 
bilayer, with transmembrane proteins traversing the hydrophobic core of the sheet and 
forming hydrophilic contacts between sheet layers. Figure 15A depicts two such sheets 
formed by the two funnels in the asymmetric unit, one of which is coloured while the 
other is shown in grey. The non-crystallographic 3-fold axes of the two hexamers in the 
asymmetric unit are antiparallel along the funnel axes, with a non-crystallographic 
2-fold relating the two funnels (Figure 15B). Two dimers from each funnel partially 
enter the wide end of the other funnel in the asymmetric unit. The layering of 
hydrophilic and hydrophobic regions, as demonstrated by the positions of the 
hydrophilic sugar groups and hydrophobic alkyl chains, is reminiscent of a lipid bilayer 
with funnels inserted into and spanning the hydrophobic core. The distance of a 
detergent bilayer in the crystal (measured from sugar headgroups on one side of the 
hydrophobic region to the other side) is roughly commensurate with the thickness of a 
lipid bilayer. Figure 15C depicts the stacking of funnel layers that extends in the y 
direction, with sheets alternating between the two funnels in the asymmetric unit. In the 
XZ plane, the crystal grows via “hydrophobic sandwiching” of DDM molecules 
between pairs of homodimers on adjacent funnels (Figure 15D). As a consequence of 
the funnel asymmetry, each funnel in a layer is surrounded by three other funnels in an 
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antiparallel orientation (Figure 15D). In a single layer, the chain A/B and E/F dimers 
form sandwiches between adjacent funnels, while the C/D dimer forms a sandwich with 
itself through a crystallographic 2-fold axis. Similar interactions occur in the adjacent 
layers of funnels, with the chain G/H dimer at a crystallographic 2-fold axis and the I/J 
and K/L dimers forming sandwich pairs. The sandwiches overlay well with one another 
(Figure 15E and F), and the A/B E/F homodimer pair is shown in surface 










Figure 15. Packing analysis of the Bak(α2-5):DDM crystal structure. A) Two layers 
of funnels from the crystal lattice demonstrating the hydrophilic/hydrophobic layering 
pattern. Chains A, B, C, D, E and F that make up one funnel are coloured dodger blue, 
deep sky blue, turquoise, aquamarine, spring green and light green, respectively. The 
second funnel in the asymmetric unit is coloured grey and DDM molecules are shown 
in purple as spheres. B) The asymmetric unit of the crystal coloured as in A. The 
non-crystallographic 2-fold that relates the two hexameric funnels is labelled. Arrows 
indicate the direction of non-crystallographic 3-fold axes down the centre of the funnels 
from the wide end to the narrow end. C) Surface representation of funnel layers 
depicted in A. D) 90º rotation of funnel layers in C. Large orange circles and small 
yellow circles denote the wide and narrow ends of funnels, respectively. Each funnel is 
surrounded by 3 antiparallel funnels, extending the crystal in the XZ plane. The 
contacts between funnels in this plane are formed by the hydrophobic surfaces of dimers 
that sandwich DDM molecules between them. E) and F) Overlay of all the unique pairs 
of homodimers that form the sandwiches. The A/B, C/D, E/F, G/H, I/J, and K/L dimers 
are coloured dodger blue, turquoise, spring green, yellow, orange, and red orange, 
respectively. DDM molecules are shown as sticks and coloured according to which 
homodimer they are associated with. G) and H) Surface representation of the sandwich 
created by the A/B and E/F homodimers. 
Protein:lipid complexes of Bak and phospholipids would be of greater physiological 
relevance than the complex with the detergent DDM. Crystal screens of Bak(α2-5) with 
different lipids yielded crystals of complexes with the short chain diacyl phospholipid 
1,2-dihexanoyl-sn-glycero-3-phosphocholine (6:0 DHPC), the monoacyl 
lysophospholipid 1-palmitoyl-2-hydroxy-sn-glycero-3-phosphocholine (16:0 LysoPC), 
and the physiologically relevant diacyl phospholipid 
1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (16:0-18:1 POPC) dissolved in the 
non-ionic detergent tetraethylene glycol monooctyl ether (C8E4) (data collection and 




Table 4. Data collection and refinement statistics for Bak(α2-5):ligand complexes. 
Statistics for the highest-resolution shell are shown in parentheses.  
 Bak(α2-5):DHPC Bak(α2-5):POPC/C8E4 Bak(α2-5):LysoPC 
Wavelength 0.9537 0.9537 0.9537 
Resolution range 
38.34  - 2.703 
(2.8  - 2.703) 
42.6  - 1.696 
(1.757  - 1.696) 30.04 ‑ 1.8 (1.865 ‑ 1.8) 
Space group C 1 2 1 C 2 2 21 C 2 2 21 
Unit cell 
126.73 96.344 52.939 
90 91.651 90 
84.318 150.086 51.749 
90 90 90 
55.921 89.949 77.572 
90 90 90 
Total reflections 63917 (6494) 263056 (23778) 267364 (25351) 
Unique reflections 17437 (1713) 36562 (3405) 18436 (1785) 
Multiplicity 3.7 (3.8) 7.2 (7.0) 14.5 (14.2) 
Completeness (%) 99.53 (97.44) 99.19 (93.23) 99.41 (97.57) 
Mean I/sigma(I) 10.02 (1.44) 11.70 (1.31) 28.11 (0.89) 
Wilson B-factor 73.03 24.73 39.59 
R-merge 0.08836 (0.9562) 0.1041 (1.741) 0.05922 (3.184) 
R-meas 0.1039 (1.114) 0.1123 (1.88) 0.06139 (3.302) 
CC1/2 0.997 (0.646) 0.999 (0.56) 1 (0.609) 
CC* 0.999 (0.886) 1 (0.847) 1 (0.87) 
Reflections used in refinement 17425 (1711) 36542 (3399) 18381 (1765) 
Reflections used for R-free 1739 (162) 1992 (188) 1838 (191) 
R-work 0.2134 (0.3142) 0.1828 (0.3888) 0.2094 (0.4933) 
R-free 0.2470 (0.3427) 0.2099 (0.4242) 0.2394 (0.6021) 
Protein residues 471 333 162 
RMS(bonds) 0.002 0.003 0.005 
RMS(angles) 0.43 0.61 0.71 
Ramachandran favoured (%) 98.47 100.00 100.00 
Ramachandran allowed (%) 1.53 0.00 0.00 
Ramachandran outliers (%) 0.00 0.00 0.00 
Rotamer outliers (%) 0.51 1.43 0.00 
Clashscore 5.09 4.72 3.38 
Average B-factor 91.34 34.12 58.82 
macromolecules 90.86 32.17 56.17 
ligands 107.02 56.60 86.66 
solvent 73.40 41.60 56.53 
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Bak(α2-5) in complex with DHPC crystallised in the monoclinic space group C2. The 
structure was solved by molecular replacement using a Bak(α2-5) homodimer from the 
DDM structure as a search model, and was refined to 2.7 Å. As in the Bak:DDM crystal 
structure, the homodimers assembled into a funnel, with a single hexameric funnel in 
the asymmetric unit (Figure 16A and B). The packing of the crystal was identical to 
that observed in the DDM structure, except that the 2-fold axis (see Figure 15B) 
relating funnels on alternating layers of the crystal was a crystallographic 2-fold in this 
case (Figure 16C and D). Two unique hydrophobic sandwiches were formed in the 
crystal: one by the chain A/B and E/F homodimers, and one by the chain C/D 
homodimer at a crystallographic 2-fold. 
Again, a sulphate ion plugged the funnel at the non-crystallographic 3-fold 
(Figure 16A). Four of the six α5/5’ grooves were occupied by DHPC that bound in an 
analogous manner to the E. coli lipids in the cylinder structure (Figure 16F). The 
phosphodiester and glycerol moieties were within hydrogen bonding distance of the 
hydroxyl group of Y136 on α5 and the free backbone amide of W125 at the N-terminus 
of α5’ (discussed below, Figure 19C and D). The aromatic ring of Y136 on α5 and 
residue V128 α5’ acted as a brace for the hydrophobic acyl chain that bound to the 







Figure 16. Crystal structure of Bak(α2-5) hexamer funnel in complex with DHPC. 
A) and B) Bak core homodimers (coloured dodger blue and deep sky blue, turquoise 
and aquamarine, and spring green and light green) formed a hexameric funnel in 
complex with DHPC (salmon, shown as sticks) that is almost identical to the funnel 
seen in the Bak:DDM complex. The exterior surface of the funnel is hydrophobic, made 
up of the α4-5 helices of the homodimers with bound DHPC. C) and D) Two layers of 
funnels from A and B that make up the crystal lattice (divided by a black line in C) 
shown in cartoon and surface representation, respectively. In D, large orange circles 
and small yellow circles denote the wide and narrow ends of funnels, respectively. The 
arrangement of funnels is identical to that seen in the Bak(α2-5):DDM crystal 
structure. E) Overlay of the two unique hydrophobic sandwich structures formed by the 
homodimers which link in-plane, antiparallel funnels. The A/B, C/D, and E/F dimers 
are coloured dodger blue, turquoise, and spring green, respectively. DHPC molecules 
are shown as sticks and coloured according to which homodimer they are associated 
with. F) Ribbon diagram with transparent surface depicting the hydrophobic surface 
of the chain C/D Bak core homodimer. DHPC bound to the α5/5’ grooves (red dotted 
lines) in a similar position to the E. coli lipids seen in the cylinder structure. The 
phosphate of the phosphodiester group is within hydrogen bonding distance of Y136 on 
α5 and the backbone amine at the N-terminal end of α5’. 
A third arrangement of homodimers appeared in tetragonal crystals grown in the 
presence of POPC and C8E4. The structure was solved by molecular placement using 
a Bak(α2-5) homodimer from the DDM structure as a search model and refined to 1.7 Å. 
Two homodimers in the asymmetric unit sat side-by-side with C8E4 detergent 
molecules at the homodimer junction (Figure 17A and B). The aliphatic chains of the 
C8E4 molecules bound to the adjacent α5/5’ grooves of each homodimer, and the 
ethylene glycol moieties of each C8E4 formed hydrogen bonds with both homodimers, 
creating a protein:detergent:protein interface (Figure 17B). As with the funnel 
structures, both homodimers in the asymmetric unit formed a hydrophobic sandwich 
with a symmetry-related homodimer, sandwiching the aliphatic and acyl chains of 
C8E4 and POPC between them (Figure 17C-F). The homodimers differed in the 
distance to their symmetry-related sandwich partners and in the angle between the dyad 
axes of each homodimer in the sandwich (Figure 17D and F). The chain C/D 
homodimer in Figure 17E and F was close to its symmetry partner, whereas the chain 
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A/B homodimer in Figure 17C and D was further away from its symmetry partner. In 
the case of the C/D homodimer, the density in both α5/5’ grooves clearly indicated the 
presence of C8E4 molecules. On the other hand, the density in α5/5’ groove of the A/B 
homodimer distal to the junction between the homodimers was consistent with 
phospholipid. The larger area between the symmetry-related A/B homodimers also 
contained six detergent molecules running parallel to the POPC acyl chains 
(Figure 17D). Again, aliphatic chains of lipid and detergent were bound to the α5/5’ 
grooves of the homodimers (Figure 17G and H). As with the cylinder and 
DHPC-bound structures, the phosphodiester and glycerol moieties of POPC were 
within hydrogen bonding distance of the hydroxyl group of Y136 on α5 and the 










Figure 17. Crystal structure of Bak(α2-5) in complex with POPC and C8E4. 
A) and B) Surface representation of the α2-3 (A) and α4-5 (B) surfaces of Bak core 
homodimers (chains A and B in dodger blue and deep sky blue, chains C and D in 
spring green and light green) in the asymmetric unit of the crystal. Two C8E4 molecules 
(rosy brown, shown as sticks) sit at the junction of the dimers, each with its aliphatic 
chain bound to an α5/5’ groove and the ethylene glycol moiety bridging the 
homodimers. At the α5/5’ groove site distal to the dimer junction, POPC (orange, 
shown as sticks) and C8E4 are present on the left- and right-hand dimers, respectively. 
Additional C8E4 molecules surround the POPC and bind to shallow clefts on the 
right-hand dimer. C-F) Ribbon representation of each homodimer with their respective 
symmetry partners (coloured grey, surface representation). G) and H) Ribbon diagram 
with transparent surface of the A/B and C/D homodimers, respectively. POPC and 
C8E4 bound to the α5/5’ grooves (red dotted lines) in a similar position to the E. coli 
lipids seen in the cylinder structure. The phosphate of the POPC phosphodiester group 
is within hydrogen bonding distance of the backbone amine at the N-terminal end of 
α5’ and hydroxyl group of Y136 on α5. 
A hydrophobic sandwich arrangement of Bak homodimers also occurred within another 
tetragonal crystal grown from Bak core domains mixed with LysoPC. A Bak(α2-5) 
homodimer from the DDM structure was used as a search model for molecular 
replacement, and the structure was refined to 1.8 Å (Figure 18). Unlike the previous 
structure, only one homodimer was present in the asymmetric unit of the crystal, 
forming a sandwich with a symmetry-related homodimer (Figure 18A and B). The acyl 
chains of two LysoPC molecules bound to the α5/5’ grooves while a third LysoPC 
bound along the α4-5 face of one chain of the homodimer (Figure 18C). Tubular 
density was also observed on the α4-5 face of the other chain. Polyethylene glycol 
(PEG) molecules were built into these positions, but the density could also correspond 
to acyl chains of LysoPC (Figure 18C). Despite the high resolution of this structure, 
and in contrast to the cylinder, DHPC, and POPC/C8E4 structures, the headgroups of 
the two lipids bound in the α5/5’ grooves were not resolved in the electron density and 
are shown as lines in Figure 18. The density in the α5/5’ grooves was modelled as 
LysoPC rather than PEG because of the hydrophobicity in the region and based on the 




Figure 18. Crystal structure of Bak(α2-5) in complex with LysoPC. A) and B) The 
Bak core homodimer in the asymmetric unit (dodger blue and deep sky blue) forms a 
hydrophobic sandwich in complex with LysoPC (yellow, shown as sticks, atoms with 
zero occupancy shown as lines) similar to the sandwiches seen in the Bak:POPC/C8E4 
complexes. C) Ribbon diagram of the homodimer with transparent surface. The acyl 
chains of LysoPC bound to the α5/5’ grooves (red dotted lines) but the headgroups 
were not resolved in this structure. 
Based on cysteine cross-linking and EPR spectroscopy data (discussed in Section 2.4), 
the quaternary arrangements of Bak homodimers observed in all of the structures 
presented in this chapter do not occur in the mature oligomer, and may be artefacts that 
arise due to both severe truncation of the protein and the lack of an orientating planar 
phospholipid bilayer. Importantly however, the symmetric α5/5’ hydrophobic grooves 
were consistently occupied by the aliphatic hydrocarbon tails of lipid or detergent. In 
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addition, the phosphodiester and glycerol moieties of phospholipids bound to a similar 
position on the homodimers (excluding the Bak:LysoPC complex), forming hydrogen 
bonds with the backbone amide of residue W125 at the N-terminal end of α5 on one 
chain of the homodimer and the hydroxyl group of the Y136 side chain at the C-terminal 
end of α5 on the partner chain (Figure 19). The positively charged residue R137 was 
also in proximity to the phosphodiester group, though the position of the guanidinium 
group was inconsistent between structures and the electron density for the side chain 
was ambiguous in the cylinder structure. Whether this constitutes a bona fide headgroup 






Figure 19. Phospholipid binding sites on Bak core homodimers. 
A), C) and E) Vacuum electrostatic surface of phospholipid binding sites on a Bak core 
homodimer from the cylinder (A), DHPC (C), and POPC/C8E4 (E) structures. For 
clarity, the ethanolamine and choline headgroups have been removed from lipids in 
this depiction, as they do not form significant interactions with the protein. Bars show 
kT values for positive (blue) and negative (red) potential for each structure. 
B), D) and F) Ribbon representation of panels A, C and E, respectively. Hydrophobic 
α5/α5’ groove-forming helices are labelled in B. The peptide backbone of W125 on α5’, 
side chains of residues delineating the α5/5’ grooves, and residues in proximity to the 
phosphodiester moiety of the lipids are shown as sticks. Bonding distances between the 
protein and lipid are shown as dotted black lines. 
2.3 Evidence for Lipid-mediated Oligomerisation of Bak 
A robust secondary protein:protein interface between Bak homodimers within 
oligomers is yet to be identified. The homodimer structures presented here hint at a 
different type of oligomerisation that may be mediated by lipids. Lipid-mediated 
oligomerisation of membrane proteins with weak protein:protein interfaces has recently 
been demonstrated by native mass spectrometry experiments (Gupta et al., 2017). 
Indeed, the acyl chains of lipids cross-link homodimers in the Bak(α2-5) hexameric 
cylinder structure (Figure 20A-D). The headgroup of each lipid sits at the interface 
between homodimers, with the first acyl chain bound to the α5/5’ groove of one 
homodimer and the second chain running down a shallower hydrophobic groove 
between α4-5 helices of a Bak molecule in the adjacent homodimer 
(Figure 20B and D). The acyl chains of DHPC in the funnel structure are also 
positioned such that cross-linking could occur between Bak homodimers paired as 
hydrophobic sandwiches in a similar α5/5’ to α4-5 groove fashion, if the chains were 
longer. These observations suggest diacyl phospholipids could act as bridges between 
homodimers via acyl chain binding to the α5/5’ grooves and the hydrophobic α4-5 







Figure 20. Lipid cross-linking of Bak homodimers. A) Bak(α2-5) cylinder structure 
depicted in ribbon representation with PE ligands shown as sticks (homodimers 
coloured dodger blue and deep sky blue, spring green and light green, and turquoise 
and aquamarine). B) Cross section of cylinder in A rotated 90º. The PE lipids cross-link 
the blue and green homodimers via their acyl chains. C) and D) Surface representation 
of A and B, respectively. E) A simple schematic model of Bak homodimers 
oligomerising through the acyl chains of diacyl phospholipids (core homodimer model 
taken from Bak(α2-5) cylinder structure). Oligomerisation could occur via acyl chains 
binding to the α5/5’ and α4-5 grooves as depicted, or to other positions on the 
hydrophobic α4-5 surfaces of the homodimers. 
To investigate this possibility, I used the calcium-dependent enzyme phospholipase A2. 
Phospholipase A2 hydrolyses diacyl phospholipids at the sn-2 acyl bond, releasing a 
lysophospholipid and a free fatty acid (Figure 21A). Phospholipase A2 treatment 
would be expected to dissociate oligomeric Bak if the oligomerisation interface 
between homodimers required diacyl phospholipids. 
Oligomeric Bak can be obtained in a minimal reconstituted liposomal system. 
Full-length Bak is difficult to express in vitro because of its hydrophobic TM anchor. 
Therefore, I used N- and C-terminally truncated Bak lacking its native cysteine (C166S) 
and with a C-terminal hexahistidine tag (His-tag), that expresses in high quantities. The 
C-terminal His-tag serves as a surrogate TM anchor by targeting the protein to 
liposomes incorporating 5% of the nickel-chelating lipid 
1,2-dioleoyl-sn-glycero-3-[(N-(5-amino-1-carboxypentyl)iminodiacetic acid)succinyl] 
(DGS-NTA) (Oh et al., 2010). Removal of the native cysteine increases protein yields 
and does not affect Bak function (Dewson et al., 2008). 
His-tagged Bak was added to liposomes made up of POPC and doped with 5% 
DGS-NTA at a molar ratio of ~1:20 protein:lipid, to ensure liposomes would be covered 
in protein. Oligomerisation was initiated by addition of human Bid BH3 peptide and 
the reaction was incubated at 37°C for two hours. Following incubation, EDTA was 
added to the reaction to release the protein from DGS-NTA and the mixture was 
injected into an S200 GF column to isolate oligomerised Bak from lipids not associated 
with the protein as well as any remaining intact liposomes (Figure 21B). Fractions 
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containing oligomeric Bak were pooled and treated with phospholipase A2 or left 
untreated. As a control for enzyme activity, EDTA was used to inactivate the 
calcium-dependent phospholipase in one sample. Following incubation, 
phospholipase-treated and untreated samples were rerun on the S200 column 
(Figure 21C). 
A clear shift of the peak was observed in the sample treated with active phospholipase 
A2 (i.e. in the absence of EDTA) (red trace in Figure 21C). The presence of Bak in the 
peaks from each run was confirmed by Western blot (Figure 21D). Bak was not 
detected in the A2 peaks at the end of the S200 runs where phospholipase A2 was 
present (Figure 21D). These results demonstrate that the oligomeric species of Bak 











Figure 21. Phospholipase A2 treatment of oligomeric Bak. A) Chemical reaction 
catalysed by phospholipase A2. The sn-2 acyl bond of POPC is hydrolysed to release 
LysoPC (16:0) and oleic acid. B) S200 GF chromatogram trace of oligomerised Bak. 
Indicated fractions were pooled for digestion with phospholipase A2. C) S200 GF 
chromatogram of oligomeric Bak either untreated (blue trace), treated with 
phospholipase A2 and EDTA (green trace) or treated with active phospholipase A2 (red 
trace). The peak shift to a smaller size indicates that the oligomer decreased in 
molecular weight following treatment with active phospholipase A2. Fractions marked 
by the black bar were analysed by Western blot. D) Western blot for Bak demonstrating 
that Bak was present in the corresponding peaks from the chromatograms in C. 
B=10 µg monomeric Bak as a positive control. 
2.4 Discussion 
Structural and functional studies of Bak and Bax have provided great insight into the 
molecular mechanisms of activation and homodimerisation. However, despite a 
significant investment of research effort, details on oligomerisation of homodimers and 
the mechanism of membrane disruption remain largely elusive. In particular, the search 
for a secondary protein:protein interface between Bak or Bax homodimers has proven 
difficult, and random clustering of Bak homodimers has recently been proposed to 
facilitate MOMP (Uren et al., 2017). Here, I have shown that lipids bind to Bak core 
domain homodimers on the hydrophobic α4-5 surface. The structures suggest that lipid 
binding may facilitate oligomerisation of Bak homodimers. In support of this, Bak 
oligomers decreased in size following treatment with phospholipase A2. These results 
could explain the lack of a robust protein:protein interface and are consistent with the 
idea of Bak forming toroidal proteolipidic pores. 
A growing body of evidence has led to a general consensus that Bak and Bax oligomers 
form proteolipidic rather than proteinaceous pores (Bleicken et al., 2013a; Epand et al., 
2002; Gillies et al., 2015; Qian et al., 2008; Salvador-Gallego et al., 2016; 
Schafer et al., 2009; Terrones et al., 2004). The idea that lipids could contribute to the 
formation and structural integrity of the oligomer has not been explored previously. 
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Lipids were recently shown to be required for the multimerisation of α-helical 
membrane proteins with weak inter-subunit protein:protein interfaces (Gupta et al., 
2017). Among other α-helical pore-forming proteins, the crystal structure of the pore 
formed by the actinoporin FraC contained lipids at the oligomerisation interface 
(Tanaka et al., 2015). The surface area contributed to the interface by lipid was almost 
equivalent to the buried protein:protein surface area between protomers (Tanaka et al., 
2015). Unlike the well-ordered octameric FraC pore, Bak and Bax pores have proven 
exceptionally difficult to produce for high-resolution structural studies, due to 
heterogeneity in form and variability in size (Bleicken et al., 2013a; Salvador-
Gallego et al., 2016). 
While the structure of the full-length oligomer remains undetermined, the truncated Bak 
core homodimer structure provided a high-resolution view of a part of activated Bak 
that could associate with the MOM (Brouwer et al., 2014). Cysteine cross-linking 
studies had predicted what was observed in the structure: symmetric exchange of BH3 
domains into the canonical hydrophobic groove of the two Bak chains in the homodimer 
(Brouwer et al., 2014; Dewson et al., 2008). A GFP fusion tag was used to express and 
crystallise the Bak core homodimer, as well as the Bax and mouse Bak core 
homodimers, based on the prediction that truncation of the protein would expose large 
hydrophobic surfaces (Brouwer et al., 2014; Czabotar et al., 2013; Mandal et al., 2016). 
Indeed, growth of crystals of all three homodimers required detergent, and the 
structures revealed a large exposed hydrophobic surface made up of the α4 and α5 
helices of the core domains. 
It was therefore surprising that the Bak core domain remained soluble following 
cleavage of the GST solubility tag and grew crystals in the absence of detergent. The 
crystal structure explained how the core domains remained soluble, by forming a 
hexameric cylindrical complex of three homodimers with their α4-5 surfaces facing the 
centre of the cylinder. The disordered acyl chains of the lipids bound to the structure 
likely fill the central hole. Size exclusion chromatography and SAXS experiments 
agreed with the size and shape of the lipid-filled cylinder seen in the crystal structure. 
Mass spec analysis confirmed the presence of E. coli lipids of various classes and acyl 
chain lengths were present in both the purified and crystallised protein samples. 
Interestingly, of the lipids present, only PI was excluded from the crystal. The 
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headgroup of PI is bulkier than the other lipids detected and may have prevented 
incorporation of PI-containing Bak hexamers due to steric clashes at crystal contacts. 
Another possibility is that Bak homodimers do not directly bind PI lipids and that PI 
was only peripherally associated with purified hexamers. Commercially available lipid 
strips could be used to assay binding of Bak core homodimers to different lipid classes. 
The lipid class and chain length/saturation preference of the α5/α5’ grooves could also 
be further investigated using techniques such as isothermal titration calorimetry, 
microscale thermophoresis or surface plasmon resonance with Bak core homodimers 
and different lipids. 
The E. coli lipids present in α5/5’ grooves of the cylinder structure could be exchanged 
for other lipids and detergents, resulting in vastly different quaternary arrangements of 
core homodimers. A hydrophobic sandwich arrangement formed in all crystals of Bak, 
excluding the cylinder, and is likely an artefact resulting from the use of truncated 
protein in the absence of membrane. The two homodimers in the asymmetric unit of 
the POPC/C8E4 crystal were side-by-side, with the PEG groups of the two C8E4 
molecules forming hydrogen bonds with both homodimers and the aliphatic C8 chains 
binding to the α5/5’ grooves. This is also unlikely to be a physiologically relevant 
interface, as cysteine cross-linking and EPR spectroscopy studies place the α3/α5 
corners of Bak core domains in close proximity within Bak oligomers (Aluvila et al., 
2014; Mandal et al., 2016). 
At first glance, the hexameric funnel structure formed by Bak homodimers in the DDM 
and DHPC co-crystal structures appeared a good candidate for an intermediate 
arrangement assumed by oligomerising Bak homodimers on the pathway to pore 
formation. The polar lumen of the funnel and hydrophobic outer surfaces is reminiscent 
of an integral membrane protein channel. The distance between the DDM and DHPC 
headgroups at the top and bottom of the funnel is commensurate with the thickness of 
a bilayer, and the orientation of the hydrophilic headgroups and hydrophobic tails is 
consistent with insertion of the funnel into a planar bilayer. Models proposed for both 
Bak and Bax pores involve the core domains of BH3:groove homodimers lining the 
pore lumen, and this structure would be in rough agreement with these models 
(Aluvila et al., 2014; Bleicken et al., 2014; Mandal et al., 2016). However, on closer 
inspection, the positions of the homodimers in relation to one another are inconsistent 
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with cysteine cross-linking and EPR spectroscopy data. For example, the H99 residues 
in the structure are isolated from one another but can be cross-linked in Bak 
homooligomers on mitochondria (Brouwer et al., 2014). Conversely, I80 residues 
appear to be in favourable positions to cross-link Bak homodimers in the funnel 
structure, but did not form cysteine cross-links on the MOM (Brouwer et al., 2014). 
The α3/α5 corners of core dimers, which are juxtaposed in the oligomer, are not 
proximal to one another in the funnel structure (Aluvila et al., 2014; Mandal et al., 
2016). 
Both crystals grew in similar conditions containing ammonium sulphate and sodium 
acetate at low pH. Three identical charge networks are formed at interfaces between 
homodimers in the funnel, involving D83 and R127 from one homodimer and Q77 and 
E92 of a second homodimer. The network is deficient by one proton and the deficiency 
is compounded by the presence of an acetate ion within bonding distance of the two 
negatively charged residues. Hence, funnel formation may be dependent on pH while 
also requiring a coordinating ion (a sulphate in both crystal structures) at the central 
3-fold axis. Such requirements are unlikely to be met at the MOM. However, because 
most cysteine cross-linking and EPR spectroscopy experiments have been performed 
on mature oligomers, the possibility that the funnel represents an early pathway 
intermediate cannot be discounted. Further investigation of residue I80 could answer 
this question. Including an oxidant prior to induction of oligomerisation of Bak I80C 
expressed on isolated mitochondria may help to capture potential intermediate states 
such as the funnel that occur after Bak becomes activated but before the terminal 
oligomer is formed. 
Regardless of the quaternary arrangement assumed by Bak core homodimers, their 
consistent fold and association with lipids and detergents across several structures is 
informative. In integral membrane protein structures, lipid molecules have been shown 
to bind to protein via their polar headgroups, hydrophobic acyl chains, or both (Yeagle, 
2014). Both polar and non-polar interactions occur between phospholipid and the α5/5’ 
grooves of Bak homodimers in the crystal structures containing E. coli lipids, POPC, 
and DHPC. Tyrosine residues are often found at lipid binding sites in membrane protein 
structures, coordinating acyl chains with its aromatic ring and hydrogen bonding via 
the hydroxyl group to the polar headgroup (Palsdottir and Hunte, 2004; Yeagle, 2014). 
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In the aforementioned structures, the phosphodiester group of the lipid forms hydrogen 
bonds with the hydroxyl group of Y136 on α5 and the free amide at the N-terminal end 
of α5’ (Figure 19). Tyrosine 136 and other hydrophobic residues that line the α5/5’ 
grooves coordinate the acyl chain of the lipid, which is ejected from the grooves by a 
bridge formed by L132 residues. Based on the crystal structures presented here, the 
α5/5’ grooves may represent the first bone fide lipid binding sites observed in a Bcl-2 
family protein. 
The symmetric binding of lipid to two sides of the Bak core homodimer could facilitate 
oligomerisation of homodimers via the acyl chains of diacyl phospholipids (Figure 20). 
The acyl chains may bind to α5/5’ grooves and/or other sites on the α4-5 surfaces of 
adjacent homodimers as observed in the cylinder crystal structure. Lipid cross-linking 
of membrane protein subunits has not been widely reported but is observable in some 
crystal structures. For example, the acyl chains of one of the integral lipids in the 
structure of bovine heart cytochrome c oxidase (PDB code: 2DYR) run at almost 180º 
in opposite directions, forming interactions with adjacent subunits (Shinzawa-
Itoh et al., 2007). There are other instances of acyl chains binding to different integral 
membrane protein subunits, though the example mentioned is particularly pertinent 
given the “split” conformation taken by the acyl chains that could facilitate 
cross-linking of Bak homodimers on the surface of, and in-plane with, the MOM. 
Promisingly, lipid-mediated stabilisation of weak protein:protein interfaces has been 
observed in multimeric membrane proteins, and the interface between Bak homodimers 
would certainly seem to fit this category (Gupta et al., 2017). 
In the model presented here, the diacyl nature of the phospholipid is integral to oligomer 
formation. Phospholipase A2 is specific for the sn-2 acyl bond of phospholipids, 
converting diacylglycerols into monoacyglycerols. Bak oligomers isolated from 
liposomes could be partially dissociated by phospholipase A2, lending weight to the 
lipid-mediated oligomerisation hypothesis. However, there are several important 
caveats to this experiment. While the oligomers decreased in size, the peak from GF 
suggested they were still much larger than dimers. It is possible that once lipid is 
digested away, the exposed hydrophobic surfaces of activated Bak homodimers 
collapse on one another, forming an artificial oligomer. The decrease in size could also 
be due to removal of large amounts of lipid peripherally associated with the oligomer, 
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rather than dissociation of homodimers from other homodimers. It is important to note 
that apparent molecular weight as measured by GF is also affected by the flexibility of 
proteins. A large flexible oligomer (or perhaps dimer) cannot be accurately sized by 
this method. While the results support a role for lipids in oligomerisation, more direct 
experiments are needed to determine whether lipids are required for oligomerisation. 
Native mass spectrometry experiments with oligomerised Bak, as in Gupta et al. 2017, 
could demonstrate conclusively the importance of lipids for Bak oligomerisation. 
In addition to insights into oligomerisation, the structures presented here also have 
potential implications for pore formation. In the paper reporting the first structure of 
the Bak core homodimer, it was speculated that the curved nature of the dimer could be 
important for pore formation (Brouwer et al., 2014). While, the structures presented 
here show less pronounced curvature, they provide another possible mechanism of 
curvature induction and membrane destabilisation. Monotopic membrane proteins bind 
to one side of the bilayer without traversing the membrane itself, often via shallow 
insertion of amphipathic α-helices and charged interactions with lipid headgroups. 
Certain monotopic membrane proteins such as cyclooxygenase(COX)-1 and -2 
significantly perturb the local lamellar structure of bilayers in molecular dynamics 
simulations (Balali-Mood et al., 2009; Fowler et al., 2007). 
The Bak BH3:groove homodimer is in many ways similar to monotopic membrane 
proteins, particularly for the core domain dimers. Binding of lipid to the α5/5’ grooves 
and shallow in-plane insertion of the α4-5 surface (and potentially latch helices 
(Westphal et al., 2014)) would displace headgroups from a large area (roughly 23 Å by 
35 Å) of the outer leaflet of the MOM and thin the membrane underneath, bringing the 
inner and outer leaflets closer together. In-plane insertion of amphipathic helices creates 
curvature in membrane bilayers, particularly when multiple helices are inserted 
(Campelo et al., 2008; McMahon and Boucrot, 2015). The effect could be compounded 
in areas of the MOM where Bak forms clusters, such that a rupturing event might occur 
as a result (Uren et al., 2017). A possible schematic model for membrane disruption by 











Figure 22. Possible models for membrane disruption and pore edge stabilisation by 
Bak. A) Top-down view of a Bak BH3:groove homodimer on a patch of the MOM. One 
homodimer from the Bak(α2-5) cylinder structure is shown in surface representation 
with PE (tan, coloured by heteroatom) shown as spheres. Shallow in-plane insertion of 
the α4-5 surface could displace a large number of headgroups in the outer leaflet of the 
MOM. Positions of flexible latch helices (α6-8) and TM helix α9 are purely speculative. 
B) Cross section of membrane in A. The depth of insertion is based on the position of 
lipid headgroups in the structures and results in disruption of the lamellar structure of 
the bilayer and thinning of the membrane underneath the homodimer. C) Following 
disruption and rupture of the membrane, Bak core homodimers could reduce the stress 
of non-lamellar lipids arrangements at the pore edge. A Bak core homodimer is shown 
lining part of the pore lumen. The other side of the pore could be lined with more Bak, 
forming protein rings with interfacial lipids (i.e. matrix-type pore), or with toroidal 
lipids (i.e. arc-type pore). It is also possible that Bak could exhibit aspects of both the 
matrix- and arc-type pore. All components of each model are roughly to scale. 
Following membrane rupture, stabilisation of the pore edge is required to keep the pore 
open (Cosentino and Garcia-Saez, 2017; Gilbert, 2016). A model for pore stabilisation 
by Bak BH3:groove homodimers is presented in Figure 22C. Lining of the pore lumen 
with core homodimers has been proposed in pore models of both Bak and Bax to relieve 
stress caused by non-lamellar arrangements of lipids at the pore edge (Aluvila et al., 
2014; Bleicken et al., 2014; Mandal et al., 2016). The orientation of the homodimers 
shown in Figure 22C is loosely based on the model generated from EPR distance 
measurements on human and mouse Bak (Aluvila et al., 2014; Mandal et al., 2016). 
Lipid-mediated oligomerisation and protein:lipid:protein interfaces could occur in both 
of the events depicted in Figure 22. Whatever the case, the lipid-binding capacity of 
the Bak core homodimer, demonstrated here for the first time in five crystal structures, 
is likely important in the interactions between BH3:groove homodimers and the MOM. 
The structures presented here provide the first high-resolution details of the interactions 
between activated Bak and membrane lipids, with implications for oligomerisation, 




2.5.1 Recombinant Protein Cloning, Expression and Purification 
The sequence encoding the core domain of Bak (α2-5, residues D68-T148) was cloned 
into the pGEX-6P-3 vector and transformed into BL21 (DE3) E. coli cells. Cells were 
grown at 37°C in Luria Super Broth (SB) to an Optical Density (O.D.) (600 nm) of ~1.0 
and induced to express for 3 hours at 37°C with 1 mM isopropylthio-β-galactosidase 
(IPTG). Cells were lysed in GST buffer (100 mM Tris pH [8.0], 150 mM NaCl, 2 mM 
EDTA) and lysates were filtered through a 0.45 µm pore size filter then passed over 
glutathione agarose column. The column was washed with GST buffer and Bak(α2-5) 
was cleaved from the GST fusion partner on-column for at least 40 hours at 4°C with 
PreScission Protease (0.02 mg/mL). Bak(α2-5) was eluted from the column in GST 
buffer and buffer exchanged into a low-salt buffer (20 mM Tris pH [8.0], 30 mM NaCl). 
The protein was purified by anion exchange on a HiTrap Q FastFlow 1 mL column in 
20 mM Tris pH [8.0] with a NaCl gradient of 0.03 to 1 M. All chromatogram trace 
images were generated in GraphPad Prism version 7 for Mac, GraphPad Software, La 
Jolla California USA, www.graphpad.com. The protein was further purified by GF 
(S200 10/300) in Tris-buffered saline (TBS) (20 mM Tris pH [8.0], 150 mM NaCl). 
Fractions containing Bak(α2-5) were concentrated and used in crystallisation trials. 
The human Bak sequence lacking the dispensable N-terminus (ΔN22) 
(Moldoveanu et al., 2006), native cysteine (C166S) and with a His-tag replacing the 
C-terminal TM anchor (ΔC25) was cloned into the pTYB1 vector and transformed into 
E. coli BL21 (DE3) cells. Cells were grown in SB to an O.D. (600 nM) of ~1.0 then 
cooled at 4ºC for 30 minutes. Expression was induced with 1 mM IPTG and cells were 
incubated with shaking overnight at 18ºC. Cells were lysed in TEN buffer (20 mM Tris 
pH [8.0], 1 mM EDTA, 500 mM NaCl) and lysate was passed over a column containing 
chitin resin. Cleavage of the C-terminal intein tag was initiated on-column with TEN 
buffer + 50 mM DTT and left to incubate at 4ºC for at least 40 hours. Bak was eluted 
from the column and further purified by GF on a Superdex 75 (S75) 10/300 column run 





Protein samples were heated at 95°C for 5 minutes with reducing protein-loading dye. 
After heating, samples were loaded into pre-cast NuPAGE 12% Bis-Tris gels (Life 
Technologies). Gels were submerged in 2-(N-morpholino)ethanesulfonic acid (MES) 
running buffer and electrophoresed for 40 minutes at 200V. Gels were fixed and stained 
with Coomassie stain (2% Coomassie R250 Brilliant Blue w/v, 10% acetic acid v/v, 
40% ethanol v/v) for 30 minutes before removal of excess Coomassie with a destaining 
buffer (10% acetic acid v/v, 40% ethanol v/v). Molecular weight of protein bands was 
estimated using SeeBlue Plus2 Prestained Protein Standard (Life Technologies). 
2.5.3 Bak(α2-5) Crystallisation, Data Collection and Processing 
Crystallisation trials were performed in 96-well sitting drop plates at the CSIRO C3 
facility in Parkville. 
Bak(α2-5) crystallised at 10 mg/ml in 0.1 M ammonium sulphate, 15.3% PEG 10000, 
90 mM sodium acetate, 90 mM bis-tris chloride pH [5.5] in the triclinic space group 
P1. The crystal was frozen in well solution supplemented with 20% ethylene glycol, 
and three X-ray datasets were collected at different positions along a single crystal at 
the MX2 beamline of the Australian Synchrotron. Diffraction images were processed 
with XDS and scaled with XSCALE (Kabsch, 2010). Data were converted to mtz 
format with POINTLESS and merged with AIMLESS (Evans and Murshudov, 2013). 
A self-rotation function was generated with the UCLA Self Rotation Function Server 
(http://services.mbi.ucla.edu/selfrot/). The structure was solved by molecular 
replacement in PHASER (McCoy et al., 2007) by searching for six Bak core globules. 
The globules consisted of the α2 BH3 domain of one Bak core domain bound to the 
hydrophobic α3-5 groove of a partner core domain, and were constructed from a Bak 
core homodimer in the GFP:Bak(α2-5) structure, PDB code: 4BDU (Brouwer et al., 
2014). The PE ligand model and crystallographic information file (CIF) restraints used 
were taken from the PDB (PDB ligand ID: PEE), and chirality restraints were generated 
with eLBOW (Moriarty et al., 2009). 
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Bak(α2-5) in complex with DDM crystallised at 7.7 mg/ml in 1.8 M ammonium 
sulphate, 0.5% DDM, 90 mM sodium acetate pH [4.6]. Crystals were frozen in well 
solution supplemented with 25% ethylene glycol, and data were collected at the MX2 
beamline of the Australian Synchrotron. Data were processed with XDS, converted to 
mtz format with POINTLESS and merged and scaled with AIMLESS 
(Evans and Murshudov, 2013; Kabsch, 2010). The structure was solved by molecular 
replacement with PHASER (McCoy et al., 2007). A Bak homodimer from the Bak 
cylinder structure was used as a search model, and six homodimers were placed. 
DHPC was mixed with Bak(α2-5) to a final concentration of 10 mM and 5.5 mg/ml, 
respectively, to obtain crystals of the complex. Crystals grew in 100 mM sodium acetate 
pH [3.76], 172 mM ammonium sulphate and 24% PEG monomethyl ether 2000, and 
were frozen in well solution supplemented with 20% glycerol. Data were collected at 
the MX1 beamline of the Australian Synchrotron, processed with XDS and converted 
with XDSCONV (Kabsch, 2010). The structure was solved using a Bak homodimer 
from the Bak:DDM structure as a search model in PHASER (McCoy et al., 2007). NCS 
restraints were used during refinement. The atomic model and CIF restraints for DHPC 
were taken from the PDB (PDB ligand ID: HXG) and chirality restraints were generated 
with eLBOW (Moriarty et al., 2009). 
To grow crystals of Bak(α2-5) in complex with POPC, I adapted a dry 
protein:compound co-crystallisation technique (developed by (Gelin et al., 2015)) for 
protein:lipid co-crystallisation. First, 300 nL of 0.25% (w/v) POPC dissolved in ethanol 
was dispensed onto a 96-well sitting drop plates at the CSIRO C3 facility and allowed 
to dry. Bak(α2-5) at 5.5 mg/ml was dispensed on top of dried POPC and crystals grew 
in 150 mM trisodium citrate pH [5.5], 1.5 M ammonium sulphate and 80 mM C8E4. 
Crystals were frozen in well solution supplemented with 20% ethylene glycol, and 
diffraction data were collected at the MX2 beamline of the Australian Synchrotron. 
Data were processed with XDS and converted with XDSCONV (Kabsch, 2010). The 
structure was solved by molecular replacement with PHASER (McCoy et al., 2007) by 
searching with a Bak homodimer from the Bak:DDM structure. The POPC ligand 
model and CIF restraints were generated by entering a SMILES string into the Grade 
Web Server (Global Phasing Ltd.). Chirality restraints were generated with eLBOW 
(Moriarty et al., 2009). 
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Bak(α2-5) was mixed with 16:0 LysoPC to a final concentration of 5.5 mg/ml and 
10 mM, respectively, prior to crystal tray setup. The protein:lipid mixture crystallised 
in 18 mM sodium acetate, 10 mM calcium chloride, 22.5% PEG 3350 and 90 mM 
HEPES pH [7.5]. Crystals were frozen in in well solution and data were collected at the 
MX2 beamline of the Australian Synchrotron. Data were processed with XDS and 
converted with XDSCONV (Kabsch, 2010). The structure was solved by molecular 
replacement with PHASER (McCoy et al., 2007) searching using a single Bak 
homodimer from the Bak:DDM structure as a model. The LysoPC ligand PDB file and 
CIF were generated on the Grade Web Server using a SMILES string. 
Models for all structures were refined with iterative rounds of building in COOT 
(Emsley and Cowtan, 2004) and refinement with PHENIX (Adams et al., 2010). 
2.5.4 Structure Analysis and Figure Generation 
Molecular graphics images for structural figures were generated primarily with the 
USCF Chimera Package (Pettersen et al., 2004). Models of qualitative electrostatic 
representation were generated in PyMOL with the vacuum electrostatics tool (Delano, 
2002). Molecular graphics images containing electron density were generated in 
PyMOL (Delano, 2002). 
2.5.5 Liposome Preparation 
A mixture of lipids (95% POPC and 5% DGS-NTA(Ni)) were dissolved in chloroform 
and 0.01% butylated hydroxytoluene, then dried under N2 gas before resuspension in 
Mg-free small unilamellar vesicle/liposome (SUV) buffer (10 mM HEPES pH [7.5], 
135 mM KCl). Resuspended liposomes were extruded through a 100 nm pore size 
membrane and stored at 4°C. 
2.5.6 Bak Oligomerisation and Purification 
To prepare Bak oligomers for digestion with phospholipase A2, 100 µL of 85 µM Bak 
(ΔN22ΔC25 C166S C-terminal His-tag) was added to 67.6 µL of 2.5 mM liposomes 
and mixed gently. To initiate oligomerisation, 3.4 µL of 10 mM human Bid BH3 
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peptide was added to the reaction and gently mixed. The reaction was incubated for 
2 hours at room temperature then stored at 4°C overnight. Twenty µL of 500 mM EDTA 
was added and the reaction was incubated for 10 minutes at room temperature to 
dissociate the His-tag from the DGS-NTA. The entire reaction was then injected and 
run on a S200 10/300 GF column in Mg-free SUV buffer, and fractions from a portion 
of the oligomeric peak were pooled. 
2.5.7 Phospholipase A2 Treatment of Bak Oligomer 
To test the effect of a lipase on the Bak oligomer, pooled oligomeric Bak was incubated 
with phospholipase A2 (from Honey Bee (Apis mellifera) venom, purchased as 
lyophilised powder from Sigma-Aldrich) in the presence (experimental) or absence 
(control 1) of EDTA. EDTA inactivates the calcium-dependent phospholipase A2 
enzyme. As a second control, pooled oligomeric Bak was incubated with CaCl2 in the 
absence of phospholipase A2 (control 2). Reactions all contained 150 µL of the pooled 
oligomer. CaCl2 was added to the experimental and control 2 samples and EDTA was 
added to the control 1 sample to a final concentration of 500 nM and 20 µM, 
respectively. Phospholipase A2 (4.5 units) was added to the experimental and control 
1 samples. All reactions were made up to 1 mL with Mg-free SUV buffer and incubated 
for 1 hour and 20 minutes at room temperature. Reactions were loaded onto a S200 
10/300 GF column and run in Mg-free SUV buffer. Peak fractions were run on 
SDS-PAGE for immunoblotting. 
2.5.8 Immunoblotting 
SDS-PAGE gels were transferred to nitrocellulose membranes by Western transfer. 
Membranes were blocked overnight in 5% skim milk TBS-Tween (0.1% Tween 20) 
(TBS-T). Membranes were washed with TBS-T then incubated with anti-Bak rabbit 
antibody (DF9) at 1/2000 in 5% skim milk TBS-T for 1 hour at room temperature on a 
roller. After incubation, membranes were washed 4 times with 5% skim milk TBS-T 
over 30 minutes, then probed with anti-rabbit IRDye 800CW secondary antibody 
(Li-Cor) at 1/15000 for 1 hour in 5% skim milk TBS-T. Membranes were washed once 
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in 5% skim milk TBS-T, then 3 times over 30 minutes with TBS-T. Blots were scanned 










Structural Investigation of Bax Homodimerisation 
Transient encounters between Bax and activator BH3-only proteins induce a large 
conformational change in Bax, causing separation of the latch (α6-8) from the core 
(α2-5) (Czabotar et al., 2013). Dissociation of the latch from the core and exposure of 
the BH3 domain leads to core domain homodimerisation through the symmetrical 
exchange of BH3 domains (α2) into the hydrophobic groove (α3-5) of the partner 
molecule (see Figure 5) (Czabotar et al., 2013; Dewson et al., 2012). The resulting 
BH3:groove homodimer nucleates oligomerisation of Bax and growth of oligomers on 
the MOM, leading to MOMP (Czabotar et al., 2013; Dewson et al., 2012). 
The structure of the Bax core homodimer was solved using a truncated construct of 
Bax(α2-5) with an N-terminal GFP fusion tag (Czabotar et al., 2013). The fusion tag 
was used because the Bax core domain lacking the latch was predicted to have large 
exposed hydrophobic surfaces that could promote aggregation (Czabotar et al., 2013). 
The GFP proteins dimerised and formed a scaffold with two Bax core homodimers 
bridging two GFP dimers (Czabotar et al., 2013). 
The electron density maps of the Bax component of the structure are of similar quality 
to maps at ~4 Å resolution. At this resolution, α-helices resemble tubes of density with 
little to no detail on side chain orientation. To improve the resolution of the Bax core 
homodimer structure, I took two approaches. The first was to crystallise the GFP:Bax 
tetramer in the presence of bicelles; the second was to express the Bax core as a GST 
fusion protein and remove the GST tag. While I had some success with the first 
approach, a significant improvement in resolution was achieved with the second. Here 
I describe the first crystal structure of a Bax core homodimer at atomic resolution. 
3.1 Crystal Structures of GFP:Bax(α2-5) Tetramer 
Czabotar and Westphal et al. 2013 determined the structure of the Bax core homodimer 
using a Bax core construct fused to GFP. Using the same expression and purification 
systems, I produced the GFP:Bax(α2-5) tetramer for crystallisation trials with lipid 
bicelles in an attempt to improve the resolution of the structure. Bicelles are small discs 
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of lipid in a planar bilayer arrangement ringed by detergent or short chain lipid that 
have been used as membrane mimetic systems in the successful crystallisation of a 
number of membrane proteins (Ujwal and Bowie, 2011). We reasoned that the planar 
hydrophobic surface presented by Bax core homodimers (consisting of α-helices 4 and 
5) could be stabilised by associating with a bilayer mimetic like the bicelle. 
Several different bicelle compositions were trialled in crystallisation conditions similar 
to the original hit, and data were collected on several crystals. A dataset from a crystal 
belonging to a novel space group (P21212) was obtained at ~3.2 Å resolution. The 
crystal was grown from protein pre-incubated with bicelles made up of 
1,2-ditetradecanoyl-sn-glycero-3-phospho-(1'-rac-glycerol) (DMPG) and 
3-([3-cholamidopropyl]dimethylammonio)-2-hydroxy-1-propanesulfonate 
(CHAPSO). The structure was solved by molecular replacement and the 
GFP:Bax(α2-5) tetramer arrangement appeared similar to what was observed in the 
original P64 crystal form. However, the density for the Bax region of the structure and 
for two of the GFP molecules was extremely poor. Therefore, the structure was not 
pursued past some initial rounds of refinement. 
The best diffraction data were obtained from a crystal of GFP:Bax(α2-5) pre-incubated 
with bicelles made up of 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC) and 
CHAPSO. Like the original structure, the crystal belongs to the hexagonal space group 
P64 and the effective resolution was 2.7 Å (based on corresponding I/σ value of 1.9; 
data collection and refinement statistics are presented in Table 5). The structure was 
solved by molecular replacement by searching for and placing 4 GFP molecules 
initially, followed by searching for two Bax core homodimers from the published 
structure (PDB code: 4BDU) (Czabotar et al., 2013). The electron density for the Bax 
regions of the structure was markedly improved from the published structure 
(Figure 23). However, the density was still not sufficient to accurately place the 
majority of amino acid side chains with confidence (Figure 23D). Further refinement 
of the structure was abandoned once it became clear that the density for the Bax(α2-5) 
homodimers did not reach atomic resolution.  
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Table 5. Data collection and refinement statistics for partially refined 





























Reflections used in refinement 
80172 (7758) 












Ramachandran favoured (%) 
91.80 
Ramachandran allowed (%) 
6.51 
Ramachandran outliers (%) 
1.69 

















Figure 23. Electron density in the published GFP:Bax(α2-5) structure vs. newly 
solved structure. A) and B) Equivalent 2Fo-Fc maps from the final refinement 
(contoured at 1 σ) of one Bax core homodimer in the published (PDB code: 4BDU 
(Czabotar et al., 2013)) (A) and novel (B) structures. C) and D) Homodimer chains 
from published (C, coloured pale green and aquamarine) and novel (D, coloured pale 
yellow and pink) structures built into electron density shown in cartoon representation 
with side chains shown as lines.  
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3.2 Crystal Structure of the Bax Core Domain Tetramer 
As bicelles produced only a modest improvement in resolution, I moved away from the 
scaffolding GFP construct and took a different approach. In this case, the same Bax 
core sequence was fused to a cleavable N-terminal GST tag. The protein expressed 
well, and after on-column cleavage the Bax core domain remained soluble. The Bax 
core domain was further purified by anion exchange chromatography and GF 
chromatography for crystallisation trials. Bax core domains eluted from the anion 
exchange column in two peaks (Figure 24A and B) sized at approximately 40 kDa and 
63 kDa based on size exclusion GF elution volumes (Figure 24C). These peaks would 
be expected to contain tetramers and hexamers of Bax core domains, respectively, 
assuming BH3:groove homodimers are formed (predicted MW of homodimer: 
17.9 kDa). The 40 kDa and 63 kDa peaks are hereafter referred to as the tetramer and 
hexamer, respectively. 
Both the Bax core tetramer and hexamer crystallised in a number of conditions. The 
most promising crystals for the tetramer were obtained in 1.6 M trisodium citrate, and 
an additive optimisation screen yielded crystals for data collection. The best diffracting 
crystal belonged to the monoclinic space group P21. The structure was solved by 
molecular replacement using a Bax core homodimer from the published Bax core 
domain structure (PDB code: 4BDU) as a search model and refined to 2 Å 






Figure 24. Purification of Bax(α2-5) following cleavage from GST. 
A) Chromatogram trace of Bax(α2-5) cleaved from GST and run on a HiTrap Q 
FastFlow 1 mL column in Tris pH [8.0] with a NaCl gradient from 0 to 1 M (% buffer 
B gradient shown in green). Bax(α2-5) primarily eluted in two peaks labelled peak 1 
and 2. B) SDS-PAGE analysis of peak fractions from A. Bax(α2-5) ran at a smaller 
than expected MW (predicted ~9 kDa) but was of a high purity in both peaks (PC = 
pre-column sample). C) Fractions from peak 1 (purple) and peak 2 (orange) were run 
separately on an S75 10/300 GF column. Molecular weights of 40 kDa and 63 kDa for 
peaks 1 and 2, respectively, were calculated from a standard curve derived from GF of 
proteins of known molecular weight.  
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Table 6. Data collection and refinement statistics for Bax(α2-5) tetramer. 
Wavelength 0.9537 
Resolution range 30.4 ‑ 2.092 (2.167 ‑ 2.092) 
Space group P 1 21 1 
Unit cell 60.363 70.374 62.784 90 90.139 90 
Total reflections 112743 (10290) 
Unique reflections 30871 (2935) 
Multiplicity 3.7 (3.5) 
Completeness (%) 98.85 (93.36) 
Mean I/sigma(I) 9.05 (1.05) 
Wilson B-factor 41.78 
R-merge 0.1016 (1.811) 
R-meas 0.1194 (2.129) 
CC1/2 0.997 (0.33) 
CC* 0.999 (0.705) 
Reflections used in refinement 30812 (2881) 
Reflections used for R-free 2029 (183) 
R-work 0.2103 (0.3636) 
R-free 0.2502 (0.3924) 
Protein residues 556 
RMS(bonds) 0.004 
RMS(angles) 0.59 
Ramachandran favoured (%) 97.17 
Ramachandran allowed (%) 2.83 
Ramachandran outliers (%) 0.00 
Rotamer outliers (%) 0.42 
Clashscore 5.96 








The asymmetric unit of the monoclinic crystal containing 8 Bax(α2-5) chains is 
presented in Figure 25A. In most chains, the α3-α4 loop could not be resolved. As the 
loop was resolved in the chain G and H homodimer, this homodimer was chosen as a 
comparative model and overlayed on the chain A and B homodimer of the 
GFP:Bax(α2-5) structure from Czabotar and Westphal et al., 2013 in 
Figure 25B and C. The overall fold of the BH3:groove core domain homodimer is 
maintained between the two structures and between copies of the homodimer in the 
new structure. 
The homodimers were further paired as tetramers, with the planar hydrophobic surfaces 
formed by the α4 and α5 helices of each of the homodimers (labelled in Figure 25C) 
sandwiched together (Figure 25D). The hydrophobic surface is enriched in aromatic 
residues and has been proposed to shallowly insert into the MOM in a similar manner 
to monotopic membrane proteins (Czabotar et al., 2013). At the interface, the α4 and 
α5 helices of one homodimer run antiparallel with the α4 and α5 helices of the other 
homodimer, respectively. Interdigitating aromatic residues create a tight interface 
between homodimers. This protection of the hydrophobic surface allows the tetramers 
to remain soluble after cleavage of the GST tag. However, these tetramers are not likely 
to be physiologically relevant, because on the MOM the α4-5 surface becomes buried 
in the membrane (Westphal et al., 2014). 
The vast improvement in resolution allows for accurate placement of most sidechains 
in the new structure. As expected, the conserved h1-h4 residues of the BH3 domain sit 
in the hydrophobic groove of the partner Bax molecule (Figure 25E). Likewise, the 
conserved salt bridge between BH3 residue D68 and groove residue R109 was also 







Figure 25. X-ray crystal structure of the Bax(α2-5) tetramer. A) The asymmetric unit 
of the crystal containing 2 tetramers that consist of 2 Bax core homodimers, shown in 
cartoon representation. The two chains of each homodimer are coloured in two shades 
of blue, green, yellow, or red. B) and C) The BH3:groove core homodimer consisting 
of chains G (salmon) and H (red) (representative of the other core homodimers in the 
structure) overlayed onto a Bax core homodimer from the GFP structure (grey, PDB 
code: 4BDU (Czabotar et al., 2013)). The BH3 domain (α2, labelled on chain G) is 
reciprocally exchanged into the hydrophobic groove (α3-5, labelled on chain G) of the 
partner chain. The hydrophilic/hydrophobic polarity of the homodimer is labelled in C. 
D) Tetramer consisting of the chains E (yellow) and F (orange) and chains G and H 
homodimers. The hydrophobic faces of the homodimers form an extensive interaction 
surface, with interdigitating aromatic residues (shown as sticks). The outer surface of 
the tetramer is largely polar. E) Canonical interactions occur between the BH3 domain 
(chain G) and the hydrophobic groove of the partner molecule (chain H, shown in 
cartoon representation with a transparent surface). Residues h1-4 sit in pockets in the 
hydrophobic groove, and a salt bridge is formed between D68 of the BH3 domain and 
R109 of the BH1 domain (labelled D-R). 
3.3 Twinned Crystal Structure of a Trimer of Bax Core Homodimers 
The hexamer of Bax core domains is reminiscent of the Bak core domain hexamer 
cylinder presented in Chapter 2. Thin-layer chromatography (TLC) was performed to 
determine if E. coli lipids had copurified with Bax core domains as they had with Bak 
core domains. Solubilisation, separation and detection of lipids by this method revealed 
two identically migrating spots in the Bak(α2-5) and Bax(α2-5) hexamer samples that 
were absent in the Bax(α2-5) tetramer sample (Figure 26). Given that lipid mass spec 
analysis of the Bak(α2-5) hexamer revealed an abundance of PE and PG, the upper spot 
that is stainable with amine binding dye ninhydrin is likely PE, while the lower band 
could be PG based on approximate retardation factor values from the same solvent 





Figure 26. Thin layer chromatography of Bax(α2-5) tetramer and hexamer and 
Bak(α2-5) hexamer samples. A) Phosphomolybdic acid (labelled Ph) and ninhydrin 
(labelled NIN) staining of purified Bax tetramer (labelled 40, referring to 40 kDa peak) 
and hexamer (labelled 63, referring to 63 kDa peak) samples run in 
chloroform/methanol/water (25:10:1 v/v) on TLC plates. Phosphomolybdic acid stains 
unsaturated bonds, revealing two spots (indicated with arrows) consistent with 
phospholipid in the hexamer sample but not the tetramer sample. Ninhydrin, which 
stains amines, reveals one spot consistent with the upper spot on the Ph stained plate 
that likely represents PE. B) Comparison of the phosphomolybdic acid stained spots in 
purified Bak hexamer (labelled 6) and Bax hexamer (labelled 8) samples run on a TLC 
plate in chloroform/methanol/water (25:10:1 v/v) demonstrates a consistent spot 
pattern between samples. The black line indicates where non-relevant samples have 
been cropped from the image. 
Crystals grown from the Bax(α2-5) hexamer peak diffracted to 2.2 Å but contained a 
significant twin fraction (estimated ~0.47-0.48 in PHENIX refine and REFMAC 5 
(Adams et al., 2010; Murshudov et al., 1997)). Despite this, the structure was solved in 
the monoclinic space group P21 by molecular replacement using a Bax globule from a 
homodimer in the tetramer structure as a search model. The globule consisted of the 
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BH3 α2 helix of one Bax chain sitting in the α3-5 groove of the partner chain. 
Encouragingly, PHASER placed 6 of these globules in 3 homodimer pairs, an 
arrangement unlikely to be placed by chance, with a TFZ of 9.1 and an LLG value of 
433 (McCoy et al., 2007). The arrangement is also structurally and chemically sensible, 
with the 3 homodimers assuming a donut-like shape. The assembly is similar to the Bak 
core domain cylinder in that the hydrophobic α4-5 faces were all pointing towards the 
centre of the donut while the α2-3 hydrophilic faces were arrayed around the outside of 
the donut. Unfortunately, the structure could not be refined beyond an R-free value of 
0.35, with no clear density for bound lipid. Nevertheless, lipid mass spectrometry was 
performed to identify any lipid in the crystals (for Methodology see Appendix). As with 
the Bak(α2-5) cylinder crystals, mass spec analysis detected both PE and PG, but not 
PI, in the Bax(α2-5) hexamer crystals, with a slightly lower ratio of PE to PG (Table 7).  
Table 7. Mole percent composition of lipid classes in Bax(α2-5) and Bak(α2-5) 
samples. Mole percentages of phosphatidylethanolamine (PE), phosphatidylglycerol 




PE PG PI 
Bax(α2-5) hexamer crystal 72.3% 27.7% 0% 
Bak(α2-5) hexamer crystal 85.8% 14.2% 0% 






Bax/Bak-mediated MOMP is the point of no return for a cell. The molecular details of 
this event have slowly emerged over decades of research. Homodimerisation of 
activated Bax and Bak is an essential event. Homodimers nucleate and are sequentially 
added to the growing oligomers that are responsible for MOMP (Aluvila et al., 2014; 
Bleicken et al., 2014; Brouwer et al., 2014; Czabotar et al., 2013; Dewson et al., 2009; 
Dewson et al., 2008; Dewson et al., 2012; Grosse et al., 2016; Ma et al., 2013; 
Mandal et al., 2016; Salvador-Gallego et al., 2016). The structures of the regions of 
Bax and Bak responsible for homodimerisation (the core domain α2-5) were solved by 
fusing them to GFP (Brouwer et al., 2014; Czabotar et al., 2013). The structures 
revealed what had been predicted by cysteine cross-linking studies: a reciprocal 
exchange of the BH3 α2 helix into the hydrophobic groove of a partner molecule 
(Dewson et al., 2008; Dewson et al., 2012). 
The Bak core homodimer structure was of sufficient resolution to reveal the molecular 
interactions holding the two Bak core domains together in atomic detail (Brouwer et al., 
2014). Such details were missing from the Bax core homodimer structure that was 
solved at a lower resolution and in which the density for the Bax component was 
particularly poor (Czabotar et al., 2013). The aim of this chapter was to gain a 
high-resolution picture of the Bax core homodimer. 
Towards this goal, the first approach taken was to attempt to stabilise the hydrophobic 
aromatically-enriched surface of the Bax homodimers with a bilayer mimetic. Bicelles 
of different compositions produced crystals of GFP:Bax(α2-5) in the original P64 space 
group, as well as in a new space group, P21212. Curiously, there was no evidence of 
bicelles in either crystal, and it is unclear why the addition of bicelles resulted in a new 
crystal form or an improvement in resolution. The P21212 crystal, grown in the presence 
of DMPG:CHAPSO bicelles, diffracted to a lower resolution than the original crystal 
form and was therefore abandoned after some initial refinement. The P64 crystal grew 
in conditions similar to the original crystal with the addition of DOPC:CHAPSO 
bicelles. While the overall resolution improved, the density for the Bax portion of the 
structure was still very poor. The scaffolding by GFP in this crystal form leaves the Bax 
core homodimers suspended in the crystal lattice with few crystal contacts. Large 
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negative difference map peaks above 5 σ are present at the centre of the Bax core 
homodimers and may indicate cavities in the protein that could cause instability and 
thus limit diffraction.  
In the original crystal structure of the Bax core domain, the degree of influence that the 
GFP molecules had on the fold of the BH3:groove core homodimers was not clear 
(Czabotar et al., 2013). The work presented in this chapter demonstrates that their 
influence was minimal, with overall fold maintained between the core domain 
homodimers in the presence or absence of GFP. The tetramer structure without GFP 
provides high-resolution structural information on the Bax core homodimer to 
complement the high-resolution data for the Bak core homodimer. As with Bak, the 
canonical interactions between the BH3 domains and the hydrophobic groove are 
conserved in Bax. 
The hydrophobic planar surface created by the α4-5 helices of both the Bax and Bak 
core homodimers has been proposed to be involved in membrane-binding 
(Brouwer et al., 2014; Czabotar et al., 2013). Indeed, based on the lipid-bound 
structures presented in Chapter 2, this appears likely to be the case with Bak. The 
preference of the Bax α4-5 surface for other hydrophobic surfaces is evident in the 
tetrameric Bax(α2-5) structure. In the crystal (and likely in solution, based on elution 
volume from a calibrated GF column), Bax core homodimers bury their hydrophobic 
surface by dimerising via said surface with a second Bax core homodimer. The resulting 
tetramer is likely an artefact of truncated protein expression in the absence of an 
orientating membrane and TM anchor. A similar tetrameric arrangement was seen in 
the case of Bak(α2-5) in complex with LysoPC, however apo Bak core domains only 
appeared as a hexamer on GF. Apo Bak core domains may be unable to assume the 
tetrameric assembly observed for Bax because the Bak α4-5 surface is more curved 
than the equivalent surface on Bax. 
Like Bak, Bax core domains also formed hexamers based on the elution volume from 
GF. Thin-layer chromatography suggested these hexamers could be in complex with 
E. coli lipids, as the Bak and Bax hexamer samples produced identically migrating spots 
consistent with PE and PG while the Bax tetramer did not. Excitingly, crystals grew 
from purified Bax hexamer, and lipids were identified in the crystals by lipid mass 
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spectrometry. Unfortunately, the crystals were severely twinned. The twinning is likely 
the result of a non-crystallographic 2-fold axis formed by one of the 3 symmetric 
homodimers that make up the asymmetric unit of the P21 crystal. The dyad axis runs 
parallel to the C axis of the unit cell and is probably the cause of the crystal pathology. 
Consequently, a solution containing half of the same donut-shaped assembly can be 
found by PHASER with a crystallographic 2-fold along the C axis in the space group 
P21212 (McCoy et al., 2007). The R-free value for this solution did not dip below 0.42 
during refinement, supporting the twinning conclusion. Even with a twin law (in this 
case -h, -k, l), twinned refinement is exceedingly difficult with a twin fraction 
approaching 50%. Optimising crystal growth conditions may therefore represent the 
best chance of obtaining a crystal that is not twinned or contains a smaller twinned 
fraction. Obtaining a refinable dataset of a Bax(α2-5):lipid complex could be very 
valuable. If a conserved lipid binding mechanism were found in both Bak and Bax, it 
would lend weight to the proposals made in Chapter 2 regarding the role of the α4-5 
surface of Bak and Bax homodimers in MOMP. 
In this chapter, I have provided the first high-resolution structure of the Bax core 
domain BH3:groove homodimer. The interactions in the structure are consistent with 
canonical BH3:groove interactions and provides structural information that will fuel 
further work, particularly in regard to the hydrophobic planar surface of the Bax and 
Bak core homodimers. The twinned crystal structure of a Bax core domain hexamer, 
potentially in complex with lipid, represents a good starting point for optimisation and 
will hopefully give greater insights into membrane and lipid interactions with Bax. 
3.5 Methodology 
3.5.1 GFP:Bax(α2-5) Expression and Purification 
GFP:Bax(α2-5) was expressed and purified following the protocol described in 
(Czabotar et al., 2013). The sequence encoding the core domain of Bax (α2-5, residues 
D53-K128, C62S, C126S) had been previously cloned into the pET28a-GFP vector and 
transformed into BL21 (DE3) E. coli cells (Czabotar et al., 2013). Cells were grown at 
37°C in SB to an O.D. (600 nm) of ~1.0 and induced to express for 3 hours at 37°C 
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with 1 mM IPTG. Cells were lysed in TBS pH [8.0] and lysates were filtered through a 
0.45 µm pore size filter then passed over a Ni-NTA column. The column was washed 
with TBS containing 30 mM imidazole to remove non-specific binders, and bound 
protein was eluted with TBS containing 250 mM imidazole. The 6xHis-tag was not 
removed as in (Czabotar et al., 2013). The protein was further purified by GF (S200 
10/300) in TBS pH [8.0]. 
3.5.2 SDS-PAGE 
Protein samples were heated at 95°C for 5 minutes with reducing protein loading dye. 
After heating, samples were loaded into pre-cast NuPAGE 12% Bis-Tris gels (Life 
Technologies). Gels were electrophoresed in MES running buffer for 40 minutes at 
200V. Gels were fixed and stained with Coomassie stain (2% Coomassie R250 Brilliant 
Blue w/v, 10% acetic acid v/v, 40% ethanol v/v) for 30 minutes before removal of 
excess Coomassie with a destaining buffer (10% acetic acid v/v, 40% ethanol v/v). 
Molecular weight of protein bands was estimated using SeeBlue Plus2 Prestained 
Protein Standard (Life Technologies). 
3.5.3 Bicelle Preparation 
Bicelles were prepared as described in (Ujwal and Bowie, 2011). Briefly, different dried 
long chain lipids (such as DMPG or DOPC) were resuspended in detergent (CHAPSO 
or 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate (CHAPS)) at 
different q ratios (q = ratio of long to short chain lipids which controls the bicelle 
diameter) and incubated at room temperature for 1 hour. Resuspended samples were 
frozen and thawed 5 times by cycling between liquid nitrogen and warm water, then 
sonicated in a water bath for 30-minutes. Final concentration of the bicelle mixture was 
10% (w/v) lipid and detergent. 
3.5.4 GFP:Bax(α2-5) Crystallisation, Data Collection and Processing 
Crystals GFP-Bax α2-5 fusion protein samples were incubated with 0.5% (w/v) 
DMPG:CHAPSO bicelles (q=0.8) or 0.5% (w/v) DOPC:CHAPSO bicelles (q=0.6) for 
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20 minutes on ice before setting up in 24-well hanging drop plates. Proteins were 
crystallised in 10% (w/v) PEG 3350, 20% MPD, 0.1 M Tris pH [7.5]. Crystals were 
frozen in cryoprotectant (well solution supplemented with 10% ethylene glycol). Data 
were collected at the MX2 beamline of the Australian Synchrotron and processed with 
XDS (Kabsch, 2010). Molecular replacement was performed with PHASER 
(McCoy et al., 2007) using GFP and the Bax core dimer from the published GFP-Bax 
α2-5 structure (PDB code: 4BDU (Czabotar et al., 2013)) as search models. The 
structures were refined by iterative rounds of building in COOT (Emsley and Cowtan, 
2004) and refinement with PHENIX (Adams et al., 2010). 
3.5.5 GST:Bax(α2-5) Cloning, Expression and Purification 
The sequence encoding the core domain of Bax (α2-5, residues D53-K128, C62S, 
C126S) was cloned into the pGEX-6P-3 vector and transformed into BL21 (DE3) 
E. coli cells. Cells were grown at 37°C in SB to an O.D. (600 nm) of ~1.0 and induced 
to express for 3 hours at 37°C with 1 mM IPTG. Cells were lysed in GST buffer pH [8.0] 
and lysates were filtered through a 0.45 µm pore size filter then passed over a GST 
column. The column was washed with GST buffer and on-column cleavage was 
performed for 2 nights at 4°C with PreScission Protease (0.02 mg/mL). Bax(α2-5) 
cleaved from the GST fusion protein was eluted from the column in GST buffer, then 
purified by anion exchange on a HiTrap Q FastFlow 1 mL column in 20 mM Tris 
pH [8.0] with a NaCl gradient of 0 to 1 M. Anion exchange yielded two peaks, both of 
which were further purified by GF (S200 10/300) in TBS pH [8.0]. Based on elution 
volumes, the two different Bax(α2-5) species from anion exchange were approximately 
40 kDa (tetramer) and 63 kDa (hexamer). Both species were taken forward for 
crystallisation. 
3.5.6 Thin-layer Chromatography 
Concentrated samples of the Bax core domain tetramer or hexamer or the Bak core 
domain hexamer were slowly pipetted onto marked spots near the base of 
aluminium-backed, Silica gel 60 TLC plates. Plates were placed in glass jars containing 
chloroform/methanol/water (25:10:1 (v/v)) to a level below where samples were 
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loaded. Samples were run until the solvent front was close to the top of the TLC plate, 
and plates were dried. Dried plates were stained with ninhydrin or phosphomolybdic 
acid, then dried and heated with a heat gun to reveal stained lipid species. 
3.5.7 Bax(α2-5) Crystallisation, Data Collection and Processing 
Crystallisation trials were performed in 96-well sitting drop plates at the CSIRO C3 
facility in Parkville. 
The Bax(α2-5) tetramer crystallised in 1.44 M trisodium citrate and 10 mM TCEP in 
the monoclinic space group P21. The crystal was frozen in well solution supplemented 
with 10% ethylene glycol and X-ray data were collected at the MX2 beamline of the 
Australian Synchrotron. Diffraction images were processed with XDS (Kabsch, 2010) 
and the structure was solved by molecular replacement with PHASER (McCoy et al., 
2007). The search model used was a Bax core homodimer from the published Bax core 
homodimer structure (PDB code: 4BDU) (Czabotar et al., 2014). Four core 
homodimers were placed into a pair of near-identical tetramers. The model was refined 
with iterative rounds of building in COOT (Emsley and Cowtan, 2004) and refinement 
with PHENIX (Adams et al., 2010). 
The Bax(α2-5) hexamer crystallised in 0.1 M trisodium citrate [pH 3.5], 0.02 M sodium 
HEPES [pH 6.8], 2 M ammonium sulphate, 0.33% (w/v) 1,3,5 pentanetricarboxylic 
acid, 0.33% (w/v) 5-sulfosalicylic acid, 0.33% (w/v) trimesic acid in the monoclinic 
space group P21. The crystal was frozen in well solution supplemented with 25% 
ethylene glycol, and X-ray data were collected at the MX2 beamline of the Australian 
Synchrotron. Diffraction images were processed with XDS (Kabsch, 2010). A 
significant twinning fraction was predicted in Xtriage of approximately 34% 
(Adams et al., 2010). The structure was solved by molecular replacement in PHASER 
(McCoy et al., 2007) by searching for 6 Bax globules (consisting of α2 from one chain 
of the homodimer in the α3-5 groove of the partner chain) constructed from the tetramer 
structure. Refinement was attempted with iterative rounds of building in COOT 
(Emsley and Cowtan, 2004) and refinement with PHENIX (Adams et al., 2010), but 
the R-free value did not drop below 0.35 with or without twinned refinement using the 
appropriate twin law of -h, -k, l. The twin fraction was estimated to be approximately 
 
114 
0.47 and 0.48 in PHENIX Refine and REFMAC5, respectively (Adams et al., 2010; 
Murshudov et al., 1997). 
3.5.8 Structure Analysis and Figure Generation 
Molecular graphics for structural figures were generated primarily with the USCF 
Chimera Package (Pettersen et al., 2004). Molecular graphics containing electron 






Mode 2 Inhibition of Bak and Bax by Bcl-XL 
Pro-survival proteins inhibit apoptosis by binding to and sequestering pro-apoptotic 
Bcl-2 family proteins. In the unified model of Bcl-2 family protein interactions, 
pro-survival proteins prevent apoptosis by two modes of action (see Figure 3) 
(Llambi et al., 2011). Mode 1 involves binding of the BH3 domain of activator 
BH3-only proteins such as Bid or Bim to the conserved hydrophobic groove (made up 
of α-helices 3, 4 and 5) on a pro-survival protein, thereby preventing direct activation 
of Bak and Bax (Llambi et al., 2011). Mode 2 inhibition occurs when pro-survival 
proteins bind to and sequester the BH3 domains of activated Bax and Bak in an 
analogous manner (Llambi et al., 2011). 
Many structures demonstrating these BH3:groove interactions have been solved using 
BH3 peptides in complex with pro-survival proteins that have been truncated to remove 
the C-terminal TM anchor (e.g. Refs (Czabotar et al., 2007; Day et al., 2008; Fire et al., 
2010; Follis et al., 2013; Petros et al., 2000; Rautureau et al., 2012; Sattler et al., 1997; 
Smits et al., 2008)). Mutations to the hydrophobic groove of pro-survival proteins that 
abrogate BH3:groove binding also greatly impair pro-survival function, illustrating the 
importance of this interface for inhibition of apoptosis (Sattler et al., 1997; Yin et al., 
1994). However, it is possible that the BH3:groove is not the only interaction interface 
between full-length proteins in complex on the membrane. Indeed, secondary sites of 
interaction have been proposed for both Bcl-2 and Bcl-XL in complex with Bax 
(Ding et al., 2014; Ding et al., 2010). The α6 helix of Bax could be photocross-linked 
to the BH4 domain of Bcl-2, and α1 of Bax could be photocross-linked and cysteine 
cross-linked to α1 of Bcl-XL (Ding et al., 2014; Ding et al., 2010). On top of this, Mode 
1 complexes are more readily disrupted than Mode 2 complexes, implicating factors 
other than affinity for BH3 domains (Llambi et al., 2011). 
The relevance of large conformational change to pro-survival protein function has not 
been widely investigated. Disulphide tethering of α-helices 5 and 6 of Bax and Bak 
prevents dissociation of the core and latch domains and inhibits cytochrome c release 
from isolated mitochondria (Brouwer et al., 2014; Czabotar et al., 2013). Interestingly, 
a similarly tethered Bcl-2 disulphide mutant was impaired in its ability to prevent 
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cytochrome c release by Bax from isolated mitochondria (Dlugosz et al., 2006). 
However, an oxidant was not used to induce the tether and it remains unclear whether 
Bcl-2 unlatches in a similar way to Bax and Bak. 
Though the same tethering experiments have not been performed with Bcl-XL, it is clear 
that Bcl-XL can undergo core/latch separation based on several crystal structures 
(Denisov et al., 2007; Follis et al., 2013; O'Neill et al., 2006; Rajan et al., 2015; 
Tanaka et al., 2013). The physiological relevance of this unlatching is ambiguous as it 
has only been observed in harsh conditions such as high pH, heat and the presence of 
isopropanol or detergent (Denisov et al., 2007; Follis et al., 2013; O'Neill et al., 2006; 
Rajan et al., 2015; Tanaka et al., 2013). 
Nevertheless, the potential of pro-survival proteins to unlatch does raise an interesting 
possibility. If Bcl-XL could unlatch in cells, its core domain could heterodimerise with 
the core domains of Bax or Bak, forming a pseudo-symmetric BH3:groove heterodimer 
similar to the BH3:groove homodimers formed by Bax and Bak (discussed in Chapter 2 
and Chapter 3). A schematic representation and structural models of core domain 
heterodimers of Bax:Bcl-XL and Bak:Bcl-XL are presented in Figure 27. The models 
were generated with SWISS-MODEL using one chain from the Bax or Bak core dimer 
structures (PDB codes: 4BDU and 4U2V) as templates (Biasini et al., 2014; 
Brouwer et al., 2014; Czabotar et al., 2013). The Bcl-XL chains generated from 
modelling were superposed in Chimera over one chain of the core homodimer structure 





Figure 27. Structural models of Bax:Bcl-XL and Bak:Bcl-XL core domain 
heterodimers. A) Schematic representation of a Bax/Bak:Bcl-XL core domain 
heterodimer. B) Structural model of the proposed Bax:Bcl-XL core domain heterodimer 
based on the structure of the Bax core dimer (PDB code: 4BDU). C) Structural model 
of the proposed Bak:Bcl-XL core domain heterodimer based on the structure of the Bak 
core dimer (PDB code: 4U2V). The schematic and models are coloured as indicated in 
the figure key. 
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To investigate the possibility of BH3:groove heterodimer formation, I used copper 
phenanthroline (CuPhe)-induced disulphide cross-linking of full-length proteins on 
mitochondria in attempts to cross-link the Bcl-XL BH3 domain to the hydrophobic 
groove of Bax or Bak. 
4.1 Disulphide Cross-linking of Bcl-XL and Bax 
To monitor possible Bax:Bcl-XL BH3:groove heterodimerisation, I employed an 
established disulphide cross-linking methodology used to cross-link both the Bax and 
Bak BH3:groove homodimers (Dewson et al., 2008; Dewson et al., 2012). 
Combinations of single cysteine mutant Bax (hemagglutinin (HA)-tagged) or Bcl-XL 
(FLAG-tagged) were co-transduced into Bak/Bax DKO MEFs. Cysteines were located 
in either the BH3 domain (Bax T56C, Bcl-XL M83C) or the hydrophobic groove (Bax 
R94C or V95C, Bcl-XL Q125C). The MEFs were permeabilised with digitonin 
detergent and the cytosol was discarded. The remaining heavy membrane fraction 
containing mitochondria was incubated with digitonin or Triton X-100. Triton X-100 
detergent artificially increases the association of Bax with Bcl-XL and was used to 
increase chances of detecting cross-linked heterodimers (Dewson, 2015; 
Hsu and Youle, 1998). Digitonin, on the other hand, does not appear to activate Bax, 
and thus more physiologically relevant complexes can be isolated with this detergent 
(Dewson, 2015). The proteins on the surface of the mitochondria were cross-linked 
using the oxidant CuPhe. Because only cysteines in close proximity are cross-linked, 
binding interfaces can be mapped with this technique (Pakula and Simon, 1992). 
After cross-linking, Bcl-XL was pulled down by immunoprecipitation (IP) using FLAG 
M2 affinity beads. Immunoprecipitated samples were heated in non-reducing loading 
dye to dissociate any non-covalently bound proteins and then run on SDS-PAGE. 
Immunoblotting for both Bcl-XL and Bax or Bak in the same samples was performed 
to identify cross-linked heterodimers. Successful cross-links are demonstrated by a 
band shift from a monomer to a heterodimer. 
The structural model and a schematic representation of a core domain heterodimer of 
Bax:Bcl-XL are shown in Figure 28A and B, with cysteine mutant locations highlighted 
in yellow. In an initial pilot experiment, two Bax groove mutants (R94C and V95C) 
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were tested for cross-linking to the Bcl-XL BH3 mutant M83C (Figure 28C). As 
mentioned above, pro-survival proteins such as Bcl-XL bind to and sequester the BH3 
domains of Bax or Bak in the hydrophobic groove on the pro-survival protein surface 
to inhibit apoptosis (Czabotar et al., 2011). Therefore, the combination of the Bax BH3 
domain mutant T56C and Bcl-XL hydrophobic groove mutant Q125C was used as a 
positive control for heterodimer formation. Bax T56C was successfully cross-linked to 
the Bcl-XL Q125C, as shown by the shift from monomer to heterodimer in both Bax 
and Bcl-XL blots (Figure 28C). Negative control combinations of Bax BH3 to Bcl-XL 
BH3 (M83C) and Bax groove to Bcl-XL groove demonstrated that this cross-linking 
was specific (Figure 28C). 
The experimental combination of Bax groove and Bcl-XL BH3 cysteine mutants 
cross-linked to form a heterodimer band of the same molecular weight as the band seen 
for the Bax BH3 and Bcl-XL groove cross-linked heterodimers (Figure 28C). The band 
was stronger for the V95C Bax groove mutant than the R94C mutant, again 
demonstrating specificity in cross-linking. Due to higher cross-linking efficiency, Bax 
groove mutant V95C was taken forward in subsequent experiments. As expected, 
samples incubated with Triton X-100 immunoprecipitated more total Bax and a larger 










Figure 28. BH3:groove cysteine cross-linking of Bax and Bcl-XL. A) Structural model 
and B) schematic representation of the proposed Bax:Bcl-XL core domain heterodimer 
based on the structure of the Bax core dimer (PDB code: 4BDU) coloured as indicated 
in the figure key. Sites of single cysteine mutations are shown as sticks in yellow. 
C) Immunoblots of protein samples immunoprecipitated with FLAG M2 beads from 
isolated heavy membranes of MEFs expressing different combinations of Bax and 
Bcl-XL probed with anti-HA (to detect Bax, upper blot) or anti-FLAG (to detect Bcl-XL, 
lower blot). Heavy membranes of the 6 sample lanes on the left- and right-hand sides 
of the blot were solubilised in digitonin and Triton X-100, respectively. Dashed black 
lines separate lanes containing either the Bcl-XL BH3 (M83C, green) or groove 
(Q125C, cyan) mutants in combination with one of 3 Bax mutants (BH3 in dark purple, 
groove in light purple). Disulphide bond formation was induced with CuPhe. Successful 
cross-links between Bcl-XL and Bax that result in a band shift from monomer (M) to 
heterodimer (HD) are represented schematically above their corresponding lanes. 
Complete cross-links (where all immunoprecipitated Bax runs as a heterodimer) and 
incomplete cross-links are indicated by solid and dashed yellow lines, respectively. 
To ensure cross-links seen in heterodimer complexes were physiologically relevant and 
not a detergent-induced artefact, digitonin-permeabilised cells were treated with two 
concentrations of tBid M97A prior to cross-linking and compared to samples incubated 
with Triton X-100 (Figure 29). The tBid M97A mutant is able to activate Bax, but has 
decreased affinity for Bcl-XL and Mcl-1 and therefore favours Mode 2 complex 
formation (Czabotar et al., 2013; Lee et al., 2016). A cys null Bcl-XL variant (C151S) 
lacking any cysteine residues was included as a negative control. As expected, it did 
not show any cross-link formation. The positive control combination of Bax BH3 
(T56A) and Bcl-XL groove (Q125C) mutants showed significant cross-link formation 
in both the Triton X-100 and tBid M97A treated samples. The combination of Bcl-XL 
BH3 (M83C) and Bax groove (V95A) mutants again showed cross-link formation in 
the Triton X-100 solubilised sample, as well as a dose-dependent level of cross-linking 
in the tBid M97A treated samples (Figure 29D). Surprisingly, limited cross-linking 
was seen in the negative control combinations of Bax BH3 and Bcl-XL BH3 mutants as 
well as Bax groove and Bcl-XL groove mutants when the samples were treated with 
tBid M97A (Figure 29C and D). These cross-links could occur between heterodimers 






Figure 29. Triton X-100- vs. tBid M97A-induced Bax:Bcl-XL heterodimerisation. 
A) Structural model and B) schematic representation of the proposed Bax:Bcl-XL core 
domain heterodimer based on the structure of the Bax core dimer (PDB code: 4BDU) 
coloured as indicated in the figure key. Sites of single cysteine mutations are shown as 
sticks in yellow. C) and D) Immunoblots of proteins immunoprecipitated with FLAG 
M2 beads from isolated heavy membranes of MEFs expressing different combinations 
of Bax and Bcl-XL mutants, probed with anti-HA (upper panels) or anti-FLAG (lower 
panels). C)  Samples from cell lines co-expressing the Bax BH3 domain (T56C, dark 
purple) mutant and Bcl-XL cys null (cyan), BH3 (M83C, dark green) or groove (Q125C, 
cyan) mutants. D) Samples from cell lines co-expressing the Bax groove (V95C, light 
purple) mutant and Bcl-XL cys null, BH3 or groove mutants. Dashed black lines 
separate the different mutant combinations. Digitonin-permeabilised cells were treated 
with either 10 or 50 nM tBid M97A to induce formation of Mode 2 complexes. 
Following solubilisation and isolation of the heavy membranes with Triton X-100 
(indicated by TX) or digitonin (in the case of tBid M97A-treated samples), disulphide 
bond formation was induced with the oxidant CuPhe. Successful cross-links between 
Bcl-XL and Bax that resulted in a band shift from monomer (M) to heterodimer (HD) 
are represented schematically above their corresponding lanes. Near complete 
cross-links (where almost all immunoprecipitated Bax runs as a heterodimer) and 
incomplete cross-links are indicated by solid and dashed yellow lines, respectively. 
The tBid mutant M97A induced the formation of Mode 2 complexes of Bax and Bcl-XL 
on mitochondria. Wild type (WT) tBid, on the other hand, should both activate Bax and 
inhibit Mode 2 complex formation of Bax with Bcl-XL. 
To compare the effect of tBid WT and tBid M97A, and to confirm the BH3:groove 
heterodimer formation in a third independent experiment, digitonin-permeabilised cells 
expressing reciprocal BH3:groove mutant combinations of Bax and Bcl-XL were 
treated with increasing concentrations of tBid WT or M97A and cross-linked with 
CuPhe (Figure 30). As expected, samples treated with mutant tBid M97A 
immunoprecipitated more Bax than those treated with tBid WT (Figure 30C). A faint 
heterodimer band is present in the Bcl-XL BH3 and Bax groove mutant combination 
samples treated with tBid M97A across all concentrations (Figure 30C). Poor IP of the 
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Bcl-XL Q125C and Bax T56C samples treated with 50 nM tBid WT was likely due to 
experimental error, during either the IP step or gel loading (Figure 30C, lower panel). 
Thus, a small population of Bax:Bcl-XL heterodimers involve an interaction between 
the Bcl-XL BH3 and the Bax groove. Because all Bax T56C (BH3 domain) is 
cross-linked to the Bcl-XL groove after tBid M97A treatment, it seems likely that the 
small heterodimer population of Bcl-XL BH3 linked to the Bax groove are indeed 
BH3:groove heterodimers. These BH3:groove heterodimers are rare in comparison to 
heterodimers that only exhibit the canonical Bax BH3 to Bcl-XL cross-link, as 










Figure 30. tBid WT- vs. tBid M97A-induced Bax:Bcl-XL heterodimerisation. 
A) Structural model and B) schematic representation of the proposed Bax:Bcl-XL core 
domain heterodimer based on the structure of the Bax core dimer (PDB code: 4BDU) 
coloured as indicated in the figure key. Sites of single cysteine mutations are shown as 
sticks in yellow. C) Immunoblots of proteins immunoprecipitated with FLAG M2 beads 
from isolated heavy membranes of MEFs expressing the combination of Bax groove 
(V95C, light purple) and Bcl-XL BH3 (M83C, green) or Bcl-XL groove (Q125C, cyan) 
and Bax BH3 (T56C, dark purple), probed with anti-HA (upper panel) or 
anti-FLAG (lower panel). Digitonin-permeabilised cells were untreated or treated with 
10, 50 or 100 nM tBid WT or M97A, and heavy membranes were solubilised and 
isolated in digitonin. Disulphide bond formation was induced with CuPhe. Dashed 
black lines separate the different combinations of Bax and Bcl-XL mutants. Successful 
cross-links between Bcl-XL and Bax resulted in a band shift from monomer (M) to 
heterodimer (HD). 
Taken together, these three independent experiments reveal the existence of a minor 
population of Bax:Bcl-XL BH3:groove heterodimers. Given the structural and 
functional homogeneity of Bax and Bak, I went on to look for a similar population of 
Bak:Bcl-XL heterodimers. 
4.2 Disulphide Cross-linking of Bcl-XL and Bak 
Like Bax, Bak is sequestered in Mode 2 complexes by Bcl-XL (Willis et al., 2005). To 
determine whether Bak also forms BH3:groove heterodimers with Bcl-XL, I performed 
cysteine cross-linking studies using combinations of Bak and Bcl-XL with single 
cysteine mutations in either their BH3 domains or hydrophobic grooves. 
The structural model of a core domain heterodimer of Bak:Bcl-XL is shown in 
Figure 31A along with a schematic representation in Figure 31B. As with Bax, MEFs 
expressing different combinations of Bak and Bcl-XL single cysteine mutants were 
permeabilised with digitonin. Permeabilised cells were treated with 50 nM tBid M97A 
to induce Mode 2 complex formation (Figure 31D) or left untreated (Figure 31C). 
Heavy membranes were isolated and oxidised with CuPhe to induce disulphide bond 
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formation between cysteine pairs in close proximity. Immunoprecipitation was 
performed with FLAG M2 beads to pull down Bcl-XL with any Bak associated. 
Treatment with tBid M97A resulted in co-IP of Bak with Bcl-XL (Figure 31D), 
whereas very little Bak was pulled down without tBid treatment (Figure 31C). The cys 
null Bcl-XL variant failed to IP any Bak (Figure 31C and D, upper panels) in this 
experiment, despite detectable expression (Figure 31C and D, lower panels). This 
suggests that cys null Bcl-XL may be unable to heterodimerise with Bak. Conversely, 
with Bcl-XL acting as an internal loading control (Figure 31D, lower panel), it appeared 
that significantly larger amounts of Bak were pulled down by the Bcl-XL BH3 (M83C) 
mutant (Figure 31D, upper panel). Interestingly, the M83C mutant also showed 
smearing and higher molecular weight band laddering (Figure 31C and D, lower 
panels). A band consistent with the molecular weight of a Bak:Bcl-XL heterodimer 
demonstrated cross-link formation between the Bak BH3 domain and the Bcl-XL 
groove, with a slightly more efficient cross-link between Bak M71C and Bcl-XL S122C 
than with Q125C (Figure 31D). An extremely faint heterodimer band appeared in the 
sample containing the reciprocal Bcl-XL BH3 domain (M83C) and Bak groove 
(Y110C) mutants in the HA blot (Figure 31D, upper panel). The band was clearer and 
of the correct size in the FLAG blot for Bcl-XL (Figure 31D, lower panel, indicated 
with a *). Whether or not this constitutes a genuine Bak:Bcl-XL BH3:groove 
heterodimer requires repetition of this experiment. A second band (indicated with a #) 
appeared at a lower molecular weight in some lanes of the Bcl-XL blot where proteins 
had been treated with tBid M97A (Figure 31D, lower panel). Puzzlingly, the band did 
not appear in the Bak blots for the same samples (Figure 31D, upper panel), nor did it 
appear consistently for particular Bcl-XL variants (Figure 31D, lower panel). What this 










Figure 31. BH3:groove cysteine cross-linking of Bak and Bcl-XL. A) Structural model 
and B) schematic representation of the proposed Bak:Bcl-XL core domain heterodimer 
based on the structure of the Bak core dimer (PDB code: 4U2V) coloured as indicated 
in the figure key. Sites of single cysteine mutations are shown as sticks in yellow. 
C) and D) Immunoblots of proteins immunoprecipitated with FLAG M2 beads from 
isolated heavy membranes of MEFs expressing the combination of Bak groove (Y110C 
or K113C, light purple) and Bcl-XL BH3 (M83C, green) or Bcl-XL groove (S122C or 
Q125C, cyan) and Bak BH3 (M71C, dark purple) mutants probed with anti-HA (upper 
panels) or anti-FLAG (lower panels). Dashed black lines separate different Bak and 
Bcl-XL mutant combinations. Digitonin-permeabilised cells expressing cysteine mutant 
combinations were left untreated (C) or treated with 50 nM tBid M97A (D). Heavy 
membranes from these cells were solubilised and isolated in digitonin, and disulphide 
bond formation was induced with CuPhe. Successful cross-links between Bcl-XL and 
Bak resulted in a band shift from monomer (M) to heterodimer (HD). Complete 
cross-links (where all immunoprecipitated Bak runs as a heterodimer) and incomplete 
cross-links are indicated by solid and dashed yellow lines, respectively. 
4.3 Discussion 
Pro-survival proteins inhibit apoptosis in two ways. Mode 1 involves binding and 
sequestering of activator BH3-only proteins by the canonical binding of the BH3 
domain to the pro-survival groove (Llambi et al., 2011). In Mode 2, activated effector 
proteins Bax and Bak are sequestered, again via canonical binding of the Bax/Bak BH3 
domain to the hydrophobic groove of the pro-survival proteins (Llambi et al., 2011). 
Beyond pro-apoptotic BH3 domains binding to the hydrophobic groove of pro-survival 
proteins, little is known about the topology of Mode 2 complexes in the context of a 
membrane. Here, I provide novel insights into the topology of a small population of 
Mode 2 inhibitory complexes of the pro-survival protein Bcl-XL and Bax or Bak with 
full-length proteins in their native environment on the MOM. 
Despite a highly similar fold, pro-survival proteins and pro-apoptotic effector proteins 
exhibit opposing functions. A possible explanation for this difference in function is that 
BH3-binding could induce metastable states of Bax and Bak but form stable complexes 
with pro-survival proteins (Czabotar et al., 2013). Evidence for this is seen in crystal 
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structures of Bax in complex with Bid, Bim or Bax BH3 peptides, where large internal 
cavities are created in the Bax protein (Czabotar et al., 2013; Robin et al., 2015). Such 
cavities can destabilise proteins and are not observed in structures of complexes of 
pro-survival proteins and BH3 peptides (Baase et al., 2010; Czabotar et al., 2013; 
Robin et al., 2015). 
Activator BH3-only protein binding induces large conformational changes in Bax and 
Bak (Brouwer et al., 2014; Czabotar et al., 2013; Robin et al., 2015). One of these 
changes, essential for MOMP, is the separation of the core (α2-5) and latch (α6-8) 
domains. In solution and working with truncated protein, BH3 peptide-induced 
activation of Bax and Bak (in the presence of detergent) results in the formation of an 
off-pathway domain-swapped dimer where the latch of one molecule wraps around the 
core of an adjacent molecule. The resulting domain-swapped dimer consists of two 
monomer-like globules connected at the junction of α-helices 5 and 6. Of all the 
pro-survival proteins, only Bcl-XL has been observed in the same domain-swapped 
conformation (Denisov et al., 2007; Follis et al., 2013; O'Neill et al., 2006; Rajan et al., 
2015; Tanaka et al., 2013). 
The ability to unlatch may be unique to Bcl-XL among pro-survival proteins, though 
whether it occurs in a physiological setting remains to be proven. If Bcl-XL was able to 
unlatch in cells, it could form pseudo-symmetrical BH3:groove heterodimers with Bax 
and/or Bak, in the same fashion as Bax/Bak BH3:groove homodimers discussed in 
Chapter 2 and Chapter 3. The aim of this chapter was to identify these complexes if 
they exist on mitochondria. 
The cysteine cross-linking data presented here agree with other cross-linking studies 
that show the BH3 domain of Bax binds to the hydrophobic groove of Bcl-XL 
(Figure 28, Figure 29 and Figure 30) (Ding et al., 2014). Both that study and my work 
confirm that the canonical BH3:groove interaction seen in the crystal structure of the 
Bax BH3 domain with C-terminally truncated Bcl-XL occurs between full-length 
proteins on the MOM (Czabotar et al., 2011). In addition, I show for the first time that 
the BH3 domain of full-length Bak binds to the hydrophobic groove of full-length 
Bcl-XL on the MOM (Figure 31), as predicted by the now 20-year old structure of the 
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first example of a BH3:groove complex between Bcl-XL and the Bak BH3 peptide 
(Sattler et al., 1997). 
In initial experiments, heavy membrane fractions containing mitochondria were 
incubated with Triton X-100 detergent to increase association of Bax and Bcl-XL 
(Hsu and Youle, 1998), thereby increasing the chance of detecting low abundance 
cross-links (Figure 28 and Figure 29). The cross-linking pattern showed that the 
canonical Bax BH3 to Bcl-XL groove interaction occurs in the Triton X-100-induced 
Bax:Bcl-XL complexes. Heterodimer formation caused by this detergent therefore 
preserves the most important and physiologically relevant interaction. Digitonin was 
used as a control detergent, as it should not artificially promote Bax:Bcl-XL association. 
Somewhat surprisingly, even in digitonin samples Bax was pulled down by Bcl-XL and 
was bound via its BH3 domain to the groove of Bcl-XL (Figure 28C). This was not the 
case in a later experiment where Bax was only pulled down in samples that had been 
treated with tBid (Figure 30C). Given that the Bax:Bcl-XL complexes were more 
evident after an apoptotic stimulus (tBid M97A treatment), this indicates that cells in 
the experiment depicted in Figure 28 were likely stressed prior to induction of 
cross-linking by CuPhe, possibly due to overgrowth. Together, these data suggest that 
Bax:Bcl-XL complexes are limited in healthy cells and that Mode 2 complexes 
predominantly occur following apoptotic stress and activation of Bax. 
Nevertheless, in all 3 experiments with Bax, a small population of Bax:Bcl-XL 
heterodimers could be cross-linked via the Bcl-XL BH3 to the Bax hydrophobic groove. 
Moreover, because the BH3 domain of all Bax pulled down with Bcl-XL in samples 
treated with tBid M97A were linked to the Bcl-XL groove (Figure 30C), it seems likely 
that this small population of heterodimers are BH3:groove heterodimers. 
Whether these BH3:groove heterodimers form within endogenous populations of 
Bax:Bcl-XL heterodimers requires further investigation. More importantly, whether 
they play a physiologically relevant role also remains unclear. One way to investigate 
this could be with core:latch-locked cysteine mutants of Bcl-XL. The importance of 
dissociation of the Bax/Bak latch domain from the core was demonstrated by locking 
them together with a disulphide bond between α-helices 5 and 6 (Brouwer et al., 2014; 
Czabotar et al., 2013). Disulphide locked Bax and Bak could not release cytochrome c 
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from isolated mitochondria (Brouwer et al., 2014; Czabotar et al., 2013). A similar 
experiment could be performed by locking α-helices 5 and 6 of Bcl-XL and assessing 
its ability to inhibit cytochrome c release from isolated mitochondria after treatment 
with BH3-only proteins. 
The possibility of Bak:Bcl-XL BH3:groove heterodimers has not been demonstrated 
conclusively in these experiments, despite a hint of a heterodimer band in 
Figure 31C and D. It is possible that Bcl-XL only forms pseudo-symmetrical 
BH3:groove heterodimers with Bax but not Bak. Alternatively, the pairing of cysteine 
residues in the groove of Bcl-XL and the BH3 domain of Bak may not be optimal to 
link these sites. Repeated experiments with these Bak mutants, and perhaps other 
BH3/groove mutants, are required to confirm BH3:groove heterodimers of Bak and 
Bcl-XL. 
Interestingly, far greater amounts of Bak seemed to be pulled down by the Bcl-XL 
mutant M83C compared to groove mutants, and the cys null mutant did not pull down 
any Bak (Figure 31D). The cys null Bcl-XL mutant also pulled down less Bax after 
treatment with tBid M97A compared to the BH3 and groove mutants 
(Figure 29C and D). Based on the relative levels of Bcl-XL pulled down for each 
mutant, it appears that expression of cys null Bcl-XL is lower in comparison to other 
variants. A blot of the total lysate with loading controls would be useful to determine 
whether this is actually the case, and future experiments could include Bcl-XL WT as 
an additional control. In addition to pulling down more Bak, Bcl-XL M83C showed 
laddering (lower panels of Figure 29C and D, Figure 30C and Figure 31C and D) and 
smearing (lower panels of Figure 31C and D), possibly indicating cross-links to 
proteins other than itself or Bax or Bak. Residue M83 is solvent exposed in structures 
of Bcl-XL, and it would be interesting to identify any proteins that cross-link with 
Bcl-XL before and after treatment with tBid via mass spectrometry.  
Pseudo-symmetrical BH3:groove heterodimer formation has a number of implications 
for our understanding of Bcl-2 family protein dynamics on the MOM. Such 
heterodimers would presumably be significantly more difficult to disrupt than a simple 
pro-apoptotic BH3 in pro-survival groove complex. This could explain why Mode 2 
complexes are less easily derepressed than Mode 1 complexes (Llambi et al., 2011), as 
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BH3-only proteins would be unable to form reciprocal BH3:groove heterodimers. The 
structural features that distinguish the pro-apoptotic proteins Bak and Bax from their 
structurally similar pro-survival relatives are currently poorly understood. The fact that 
Bcl-XL can also form (pseudo)symmetrical BH3:groove dimers suggests that the 
difference may lie in the inability of heterodimeric Bcl-XL complexes to further 
oligomerise. BH3:groove heterodimers may even act to disrupt the growth of Bak and 
Bax oligomers by capping the ends of nascent oligomers such that they can no longer 
propagate. Bcl-XL is implicated in retrotranslocation of Bax and Bak from the MOM 
to the cytosol (Edlich et al., 2011; Todt et al., 2015; Todt et al., 2013). If BH3:groove 
heterodimers embed in the MOM similar to BH3:groove homodimers, their formation 
would presumably influence retrotranslocation. Further work is required to understand 
these heterodimers and their significance in the Bcl-2 protein family interactome. 
The BH3-binding grooves of pro-survival proteins have been the subject of large drug 
discovery programs that aim to prevent Mode 1 and 2 inhibition of cell death by 
overexpressed pro-survival proteins in cancerous cells. Recently, the first clinical 
success story has emerged from these efforts in the form of ABT-199 
(venetoclax/Venclexta), a Bcl-2-specific inhibitor recently approved for the treatment 
of relapsed 17p-deleted chronic lymphocytic leukaemia (Roberts et al., 2016). Looking 
beyond the hydrophobic grooves of pro-survival proteins for other interactions that are 
targetable with drugs may lead to further development of therapeutics to target cells 
that are resistant to death. Other interaction surfaces that are specific to a single 
pro-survival protein may create opportunities for new drug classes that target only one 
type of pro-survival protein. The work presented here is one such attempt to look 
beyond the pro-survival groove, and provides a base for further research into 
BH3:groove heterodimers. 
4.4 Methodology 
4.4.1 Generation of Cell Lines 
SV40-immortalised bax-/-bak-/- MEFs were retrovirally co-transduced with 
combinations of human Bax or Bak single cysteine mutants with an N-terminal HA tag 
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in internal ribosome entry site (IRES)-GFP expression constructs and human Bcl-XL 
single cysteine mutants with an N-terminal FLAG tag in IRES-hygromycin expression 
constructs. The Bax and Bak cysteine mutants used were from previous work 
(Dewson et al., 2008; Dewson et al., 2012). The Bcl-XL BH3 mutant M83C was 
designed based on the structure of the Bax BH3:groove homodimer (PDB code: 4BDU 
(Czabotar et al., 2013)) with the Bcl-XL BH3 helix superposed over the Bax BH3 helix. 
Bcl-XL groove mutant constructs had been previously designed by Grant Dewson and 
Ruth Kluck based on the BH3:groove homodimer cross-linking studies and structures 
of Bcl-XL in complex with the BH3 domains of Bax and Bak (Czabotar et al., 2011; 
Dewson et al., 2008; Dewson et al., 2012; Sattler et al., 1997). Polyclonal 
GFP-positive, hygromycin-resistant cell lines were established by GFP-positive cell 
sorting by fluorescence activated cell sorting (FACS) in a flow cytometer followed by 
application of hygromycin selection as described previously (Dewson et al., 2008). 
4.4.2 Isolation of Heavy Membranes and Disulphide Cross-linking 
MEF cell lines were grown to confluency, harvested by centrifugation at 1,500 rpm for 
5 minutes at 4°C, and washed with ice cold phosphate buffered saline (PBS). The cells 
were permeabilised by resuspending in M-phase egg lysis buffer (MELB) + protease 
inhibitors with 0.025% digitonin and incubated on ice for 10 minutes. Permeabilisation 
was verified by trypan blue staining. At this point, where indicated, permeabilised cells 
were treated with tBid M97A or tBid WT for 30 minutes at 30°C. The samples were 
centrifuged at 13,000 rpm for 5 minutes at 4°C and the cytosolic fraction (supernatant) 
was discarded. The heavy membrane pellet fraction was resuspended in MELB + 
protease inhibitors with either 1% digitonin or 1% Triton X-100 and incubated on ice 
for 30 minutes to solubilise membranes. Samples were then centrifuged at 13,000 rpm 
for 5 minutes at 4°C to pellet cell debris. The supernatant was collected and the oxidant 
CuPhe was added to a concentration of 1 mM. Samples were incubated for 30 minutes 
on ice and the reaction was quenched with either 10 mM NEM or 10 mM EDTA and 




Sepharose and FLAG M2 beads were washed 3 times in MELB with a final wash in 
MELB with 1% digitonin or Triton X-100. Samples were pre-cleared in a 1:1 slurry of 
sepharose:MELB for 1 hour at 4°C on a rotator. The samples were pulse spun in a 
centrifuge to pellet beads and the supernatant was transferred to a new tube. A 1:1 slurry 
of FLAG M2:MELB was added to the sample and incubated for 1 hour at 4°C on a 
rotator. Samples were pulse spun in a centrifuge to pellet beads and the supernatant was 
discarded. The beads were washed 3 times with MELB with a final wash in MELB with 
1% digitonin or Triton X-100. The beads were incubated with 3xFLAG peptide for 
30 minutes at 4°C on a rotator to elute bound protein. Samples were pulse spun to pellet 
beads and supernatant was retrieved for analysis by SDS-PAGE and immunoblotting. 
4.4.4 SDS-PAGE 
Proteins were heated at 95°C for 5 minutes in non-reducing protein loading dye. After 
heating, samples were loaded into pre-cast NuPAGE 12% Bis-Tris gels (Life 
Technologies). Gels were electrophoresed in MES running buffer for 40 minutes at 
200 V. Molecular weight of protein bands was estimated using SeeBlue Plus2 
Prestained Protein Standard (Life Technologies). 
4.4.5 Immunoblotting 
SDS-PAGE gels were transferred to polyvinylidene fluoride (PVDF) membranes by 
Western transfer. The PVDF membranes were blocked overnight in 5% skim milk in 
TBS-T. After incubation, membranes were washed with TBS-T then incubated with 
either in house anti-FLAG or Roche anti-HA primary antibodies at 1/1000 for 1 hour 
at room temperature on a roller. The membranes were washed 3 times over 30 minutes 
with TBS-T at room temperature on a rocker, then incubated for 1 hour at room 
temperature with an anti-rat secondary antibody at 1/3000 (Southern Biotech). The 
membranes were washed again 3 times over 30 minutes with TBS-T at room 
temperature on a rocker, then washed once with TBS. The Biorad Clarity developing 
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reagent was added to blots for 5 minutes. Excess reagent was removed and the 






Structural and Functional Characterisation of Bok 
Among the Bcl-2 family of proteins, Bok is one of the most controversial in regard to 
its function. It shares sequence homology with Bak and Bax and induces apoptosis upon 
overexpression (Hsu et al., 1997). As such, Bok was originally proposed to be a third 
pro-apoptotic effector protein. 
Several groups working on Bok have reported conflicting data on Bok-induced 
apoptosis. Some groups report a dependency of Bok on Bak and Bax for MOMP 
(Carpio et al., 2015, 2016; Echeverry et al., 2013; Fernandez-Marrero et al., 2016) 
while others report Bak/Bax-independent apoptosis (Einsele-Scholz et al., 2016; 
Llambi et al., 2016). Disentangling these results and establishing the physiological role 
of Bok has proven difficult. 
Structural information is needed in order to better investigate the role of Bok. An X-ray 
crystal structure or NMR structure would pave the way for site-directed mutagenesis 
studies to help determine the function of Bok. In this chapter, I detail the expression of 
several human Bok (hBok) constructs, as well as the rat and chicken Bok homologues 
(rBok and cBok, respectively). I present the first X-ray crystal structure of the cBok 
homologue, as well as in vitro studies of cBok function. 
5.1 Production of Recombinant Bok 
Before I began my work on Bok, expression and purification of recombinant Bok had 
not been reported. Several vectors (pTYB1, pET28a-GFP, pWALDO, pET32a, 
pGEX-6P-3 and pET15b) containing full-length and truncated human, rat and chicken 
Bok constructs were tested for expression in E. coli (data not shown). Of the vectors 
tested, only pGEX-6P-3 successfully produced recombinant Bok protein. Using this 
vector, that encodes an N-terminal GST tag for solubility and purification, I expressed 
and purified several full-length and truncated constructs of hBok, rBok and cBok (listed 
in Table 8). In all cases, the removal of the hydrophobic C-terminal TM helix was 
necessary for expression. TM domain removal is a common tactic for recombinant 
expression of Bcl-2 family proteins. Replacing cysteine residues with serine has 
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improved yields and stability of constructs of Bak and Bax (Brouwer et al., 2014; 
Czabotar et al., 2013). The native hBok sequence contains 5 cysteine residues at 
positions conserved in rBok. Four of the 5 cysteines are conserved in cBok, with a 
serine replacing hBok residue C67 in the BH3 domain. Chicken Bok has a 5th cysteine, 
C35, that is a glycine is hBok and rBok. Cysteineless constructs of full length and 
truncated hBok, rBok and cBok did not express (data not shown). 











Homo sapiens - - No N/A N/A 
Homo sapiens ΔN18 ΔC22 Yes No N/A 
Homo sapiens - ΔC22 Yes No N/A 
Homo sapiens ΔN18 ΔC26 Yes Yes No 
Homo sapiens - ΔC26 Yes No N/A 
Homo sapiens ΔN18 ΔC32 Yes Yes No 
Homo sapiens - ΔC32 Yes Yes No 
Rattus norvegicus - - No N/A N/A 
Rattus norvegicus ΔN18 ΔC32 Yes Yes No 
Rattus norvegicus - ΔC32 Yes Yes No 
Gallus gallus - - No N/A N/A 
Gallus gallus ΔN18 - No N/A N/A 
Gallus gallus - ΔC32 No N/A N/A 
Gallus gallus ΔN18 ΔC32 Yes Yes Yes 
Proteins were purified by affinity chromatography on glutathione agarose bead 
columns. On-column cleavage was performed with PreScission protease to remove the 
GST tag, and proteins were further purified by GF on an S75 10/300 column. 
Representative chromatograms are presented along with SDS-PAGE gels of peak 
fractions in Figure 32. An extra purification step on a Mono S 5/50 GL cation exchange 
column was performed in some cases prior to crystallisation trials (e.g. for cBok 






Figure 32. Purification of recombinant Bok. A), C) and E) Chromatogram traces of 
hBok ΔN18ΔC32, rBok ΔN18ΔC32 and cBok ΔN18ΔC32 run on an S75 10/300 column. 
G) Chromatogram trace of cBok ΔN18ΔC32 eluted from a Mono S cation exchange 
column with an increasing salt gradient (% buffer B, green line). B), D), F) and H) 
Corresponding SDS-PAGE gels demonstrating purity of peak fractions from 
purification steps. Some gels also include the prior GST purification step, L = filtered 
lysate, F = GST column flowthrough, W = GST column wash, PC = pre-column sample 
prior to GF column run. In the case of cBok, the large amount of protein overloaded 
both columns in the purification steps. However, highly pure protein was still obtained. 
With access to pure recombinant protein, I began structural and functional 
characterisation of Bok. 
5.2 X-ray Crystal Structure of Chicken Bok 
Multi-BH domain containing pro-apoptotic and pro-survival Bcl-2 proteins share a 
remarkably similar fold despite their opposing functions. Bok possesses all four BH 
domains, but whether it assumes the Bcl-2 fold is unknown. To determine the structure 
of Bok, I performed crystallisation screens using several different constructs of hBok 
and rBok (Table 8). Additionally, I performed reductive lysine methylation on the 
hBok and rBok ΔN18ΔC32, but no crystals were obtained with this strategy. 
After extensive trials with human and rat Bok failed to produce crystals, I turned to the 
cBok homologue. Bok shows high cross-species conservation, and cBok shares 81% 
sequence identity and 90% similarity with hBok (Figure 33) (Zhang et al., 2000). 
Chicken Bok ΔN18ΔC32 expressed in large quantities and was purified by GF and 
cation exchange chromatography (Figure 32E and G). Following purification, cBok 
ΔN18ΔC32 readily crystallised within hours of setting up crystal trays. The best 
diffracting crystals were obtained from drops containing cBok at 7 mg/ml in 22.5% 
PEG 3350, 0.09 M trisodium citrate [pH 3.5] and 3% ethylene glycol. The crystal 
belonged to the monoclinic space group P21 and the structure was solved by molecular 
replacement. The model that produced the best solution was created from a 
domain-swapped Bax dimer (PDB code: 4BD8 (Czabotar et al., 2013)). A monomeric 
globule of Bax was generated from the α1-5 helices (core domain plus α1) of one Bax 
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polypeptide and the α6-8 helices (latch domain) of the partner chain. Two copies of the 
search model were placed in the asymmetric unit. Initial model building was performed 
with PHENIX Autobuild (Terwilliger et al., 2008) and once the majority of both copies 
was built the structure was refined by iterative rounds of building in COOT 
(Emsley and Cowtan, 2004) and refinement in PHENIX (Adams et al., 2010) to 1.8 Å 
(crystallographic statistics are presented in Table 9). 
 
Figure 33. Sequence identity and similarity between human and chicken Bok. The 
aligned sequences of human and chicken Bok demonstrate a high level of sequence 
identity and similarity. Identical residues between the two sequences are shown in the 
consensus sequence, while “+” indicates similar residues. The N- and C- terminal 




Table 9. Data collection and refinement statistics for cBok ΔN18ΔC32. 
Wavelength 0.9537 
Resolution range 36.53 ‑ 1.799 (1.863 ‑ 1.799) 
Space group P 1 21 1 
Unit cell 41.559 59.62 64.083 90 96.258 90 
Total reflections 110754 (10384) 
Unique reflections 28655 (2803) 
Multiplicity 3.9 (3.7) 
Completeness (%) 98.50 (95.75) 
Mean I/sigma(I) 12.93 (0.80) 
Wilson B-factor 31.21 
R-merge 0.06552 (2.155) 
R-meas 0.0757 (2.503) 
CC1/2 0.999 (0.593) 
CC* 1 (0.863) 
Reflections used in refinement 28603 (2797) 
Reflections used for R-free 1996 (195) 
R-work 0.1948 (0.4300) 
R-free 0.2316 (0.4750) 
Protein residues 309 
RMS(bonds) 0.005 
RMS(angles) 0.66 
Ramachandran favoured (%) 97.03 
Ramachandran allowed (%) 2.97 
Ramachandran outliers (%) 0 
Rotamer outliers (%) 0.78 
Clashscore 11.49 








Both copies of cBok assumed the canonical Bcl-2 helical bundle fold. Chain B of the 
cBok structure is compared to Bak (PDB code: 2IMT (Moldoveanu et al., 2006)) in an 
overlay of the two proteins presented in Figure 34A. Chains A and B of the cBok 
structure are overlayed in Figure 34B. The two copies are very similar in fold with 
notable exceptions at the junction of the α2 and α3 helices, the α3 helix and the 
canonical hydrophobic groove. Chain A displayed two helical turns separated by a 
convoluted fold at helix α3, whereas chain B possessed a recognisable α3 helix. Helix 
α2 of chain B was kinked near the α2/α3 junction and a hole through the protein was 
observed between this area and the hydrophobic α5 helix (Figure 34C). The hole itself 
is hydrophobic and collapsed in chain A, resulting in distortion of α3 (Figure 34D). In 
chain B, the hydrophobic BH3-binding groove was occluded by residues Q92 and Q113 
that form reciprocal hydrogen bonds between the donor and acceptor groups of each 
side chain (Figure 35A). Chain A adopted a more open conformation in the groove 
with the collapse of α3 (Figure 35B). B-factors in α3 and the loop to α4 were higher 











Figure 34. X-ray crystal structure of chicken Bok ΔN18ΔC32. A) Chain B from the 
crystal structure of cBok ΔN18ΔC32 (coloured sky blue) overlayed with Bak (coloured 
plum, PDB code: 2IMT (Moldoveanu et al., 2006)). Helices α1 to α8 are labelled. 
B) Overlay of chain A (coloured light green) and chain B from cBok ΔN18ΔC32 crystal 
structure. C) and D) Surface representation of chains B and A, respectively. A hole 
through chain B, bounded by α-helices 2, 3 and 5, is labelled. E) and F) Chains B and 
A, respectively, of the cBok structure coloured by B-factor from low (blue) to high (red). 
The highest B-factors are observed around α3 and the α3 to α4 loop. 
 
Figure 35. Differences in BH3 helix kinking and groove occlusion between the two 
copies of cBok. A) Chain B from the crystal structure of cBok ΔN18ΔC32 shown in 
cartoon representation with a transparent surface. Residues P83, Q92 and Q113 are 
shown as sticks. The canonical hydrophobic groove of chain B is occluded by residues 
Q92 and Q113 that form hydrogen bonds between α3 and α4. B) Chain A represented 
in the same way as chain B. The collapse of α3 in chain A results in the breaking of 
hydrogen bonds between Q92 and Q113 and an open conformation for the hydrophobic 
groove. The collapse also relieves the severe kinking of the C-terminus of the α2 BH3 
helix in chain B. 
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Taken together, these observations suggest that cBok may be flexible and dynamic in 
this region. An atypical proline at position 83 could be the cause of instability 
(Figure 35). This proline is unique to Bok among human Bcl-2 family proteins, but is 
highly conserved among Bok homologues, even in evolutionarily distant organisms 
such as fruit flies and zebrafish.  
The dynamic nature of the α2/α3 junction and α3 helix is potentially of interest because 
of its proximity to the BH3 domain. BH3 domain exposure is an important step in the 
activation of Bak and Bax (Dewson et al., 2008; Dewson et al., 2012). The BH3 domain 
helix α2 of both copies of cBok make crystal contacts and have low B-factors in the 
structure (Figure 34E and F). However, if this region were constantly being exposed 
in the cell it could provide a rationale for the proposed constitutive activity of Bok 
(Llambi et al., 2016). 
Liposome dye release assays have been used to demonstrate the constitutive activity of 
hBok (Fernandez-Marrero et al., 2017; Llambi et al., 2016). With the structure of cBok 
now available, I set out to compare the function of these homologous proteins and 
determine whether cBok recapitulates hBok auto-activity in vitro. 
5.3 Membrane Permeabilisation by Bok 
Liposomal systems are used to measure the membrane-permeabilising activity of both 
Bak and Bax in vitro. In these systems, self-quenching dyes such as carboxyfluorescein 
are encapsulated in liposomes with a lipid composition resembling the MOM. 
Membrane permeabilisation is measured by fluorescence increase as dye is released 
from the liposomes. Human Bok has been shown to form pores in liposomes mimicking 
the MOM or, to a lesser extent, the ER (Fernandez-Marrero et al., 2017; Llambi et al., 
2016).  
To investigate the membrane activity of cBok, I took a similar approach to that later 
outlined in Llambi et al. 2016. Because Bok could not be produced with an intact TM 
domain, I used a C-terminally truncated version of cBok where the TM anchor was 
replaced with a His-tag. This approach has also been used to target both Bak and hBok 
to MOM-mimicking liposomes doped with 5% nickel-chelating lipid (Llambi et al., 
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2016; Oh et al., 2010). The N-terminal 18 residues, predicted to be a region of disorder 
by secondary structure predictions, were removed in one of the constructs. 
Given its pro-apoptotic activity but primarily ER-based localisation, cBok was tested 
on MOM- and ER-mimicking liposomes (MOMmix and ERmix, respectively). The 
composition of the MOMmix liposomes was based on a published protocol 
(Kuwana et al., 2002). ERmix liposomes were based on the composition of rat liver ER 
(Keenan and Morre, 1970). Recombinant cBok or hBak constructs with C-terminal 
His-tags were added to MOMmix or ERmix liposomes doped with 5% nickel-chelating 
lipid and incubated for 2 hours with or without Bid BH3 peptide. Liposome 
permeabilisation was measured by fluorescence caused by release of the 
carboxyfluorescein dye from liposomes. Percentage maximum release was calculated 
by normalising with liposomes with or without Bid peptide as 0% release and liposomes 
with 3% CHAPS as 100% release. 
On both MOMmix and ERmix liposomes, hBak DN22DC25-6xHis demonstrated Bid 
BH3 peptide-dependent permeabilisation (Figure 36A and B). Contrastingly, and in 
agreement with work on hBok, both cBok constructs caused the same level of 
permeabilisation of MOM-mimicking membranes regardless of the presence of Bid 
peptide (Figure 36A) (Fernandez-Marrero et al., 2017; Llambi et al., 2016). 
Interestingly, cBok permeabilised ERmix liposomes to a similar degree as unstimulated 
hBak, suggesting the constitutive BH3 peptide-independent activity of cBok is 
dependent on lipid composition (Figure 36B). Lipid composition dependence has also 
been observed in liposome permeabilisation experiments with hBok, where higher 
concentrations of hBok were required to permeabilise ER-mimicking membranes 
compared to MOM-mimicking membranes (Fernandez-Marrero et al., 2017). A small 
difference was observed between hBak DN22DC25-6xHis and cBok DC32-6xHis on 
ERmix liposomes, though this result should be interpreted with caution due to the use 





Figure 36. Membrane activity of Bok on liposomes. A) and B) Liposome 
permeabilisation by cBok and hBak as measured by carboxyfluorescein dye release 
from MOMmix (A) and ERmix (B) liposomes, both doped with 5% NTA(Ni) lipid. 50 nM 
cBok DN18DC32-6xHis, cBok DC32-6xHis or hBak DN22DC25-6xHis was incubated 
with liposomes for 2 hours with or without Bid BH3 peptide followed by measurement 
of fluorescence. Data are represented as mean ± SEM of percentage maximum dye 
release, n=3. Data were analysed by two-way ANOVA comparing every mean to every 
other mean, and multiplicity adjusted p-values (Wright, 1992) were calculated with 




Like hBok, cBok permeabilised liposomes mimicking the MOM and its activity was 
not enhanced by the activating BH3 peptide of Bid. ER-mimicking liposomes were 
permeabilised to a lesser degree with the same amount of cBok, and the level of 
permeabilisation was commensurate with unstimulated hBak. The similarity in 
sequence and function of hBok and cBok suggest that the crystal structure of the latter 
represents a good model of the former. 
5.4 Discussion 
The literature on Bok is plagued with apparent contradictions. Build-up of Bok upon 
proteasome inhibition leads to apoptosis in Bak/Bax DKO cells (Llambi et al., 2016), 
but C-terminally truncated Bok that binds to isolated mitochondria does not cause 
MOMP (Fernandez-Marrero et al., 2017). A role for Bok in induction of intrinsic 
apoptosis in response to ER stress has been reported but hotly disputed (Carpio et al., 
2015, 2016; Fernandez-Marrero et al., 2016). These contradictions, compounded with 
a lack of structural information, have continued to dog the field even with the recent 
upturn in publications on Bok. 
Here, I present the first structure of Bok that will contribute to understanding this 
perplexing protein. Chicken Bok adopted the canonical Bcl-2 alpha-helical bundle fold, 
consistent with the presence of all four BH domains. The structure overlayed well with 
the pro-apoptotic protein Bak, but displayed interesting deviations that may explain the 
constitutive activity of Bok. First and foremost, the two copies of cBok differed 
markedly around the α2/α3 junction and canonical hydrophobic groove. The difference 
between the copies suggests that the protein may be dynamic and flexible in this region 
in solution and potentially on the MOM or ER membrane. 
An atypical proline (P83) in Bok at the α2/α3 junction may be the cause of instability. 
Proline is unique among amino acids in that the α-amino group is fused to the side 
chain, forming a pyrrolidine ring. The lack of a free amide proton to participate in 
hydrogen bonding and the steric bulk of the pyrrolidine ring causes proline residues to 
often break or kink helices if present beyond the 3rd or 4th position in the helix 
(Woolfson and Williams, 1990). In helix initiation, prolines are favoured at the 
Ncap + 1 position; that is, the residue following the residue whose backbone carbonyl 
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oxygen atom forms the first hydrogen bond with the amide of the i + 4 residue 
(Kim and Kang, 1999; Richardson and Richardson, 1988). Indeed, in both the A and B 
chains of the cBok structure, P83 is at the Ncap + 1 position of the α3 helix. The 
perturbations of the structure, including formation of a hole through chain B, kinking 
of the C-terminus of α2 in chain B, collapse of α3 in chain A, and high B-factors, point 
to dynamic flexibility in this region. The hydrophobic hole and the collapse or 
formation of α3 is unlikely to be due to crystal contacts, because the α3 is bordered by 
solvent and not in proximity to protein. Kinking of the BH3 domain helix α2 is 
particularly interesting given the importance of BH3 exposure in Bak and Bax 
activation and homodimer formation (Alsop et al., 2015; Dewson et al., 2008; 
Dewson et al., 2012). In both copies of the cBok structure, the α2 BH3 helix of one 
copy is held in by the α1-2 loop of the other copy and α-helices 4 and 6 of a 
symmetry-related chain. Without these stabilising crystal contacts, it is possible that the 
BH3 domain of Bok may be constantly exposed in solution or on the membrane. 
Moreover, the hydrophobic hole seen through chain B next to the BH3 domain is 
potentially destabilising in a similar way to the cavities induced by activator BH3 
peptides in Bax and Bak ((Czabotar et al., 2013; Robin et al., 2015) and unpublished 
work from the Czabotar and Colman labs by Jason Brouwer). 
Another interesting disparity between the two cBok copies is the “openness” of the 
canonical hydrophobic groove. The α3 helix in chain B is in close proximity to α4, with 
glutamine residues Q92 and Q113 forming hydrogen bonds between the helices and 
occluding the groove. These hydrogen bonds are broken with the collapse of α3 in 
chain A, resulting in a more open groove. Whether cBok adopts both of these 
conformations in solution or at the membrane is unclear. Nevertheless, the possibility 
of switching between an open or occluded groove has implications for BH3 domain 
binding, be it to an activator BH3 domain or the BH3 domain of another Bok molecule. 
The groove of Bok would need to be able to receive the BH3 domain of a partner Bok 
molecule if, like Bak and Bax, Bok forms BH3:groove homodimers prior to 
oligomerisation. 
The groove of Bok differs from other Bcl-2 proteins in the highly conserved BH1 
domain. The primary sequence is NWGR in the BH1 domain of almost all other human 
multi-BH domain Bcl-2 proteins. Only Bok and another very poorly characterised Bcl-2 
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protein, Bcl-RAMBO, differ in the BH1 motif, with threonine and lysine replacing the 
asparagine and arginine, respectively. TWGK is also present in chicken Bok, as well as 
most other Bok homologues. The change in residues makes little difference in the fold 
when comparing the monomeric structures of hBak (PDB code: 2IMT 
(Moldoveanu et al., 2006)) and cBok (both copies). However, on BH3 domain binding, 
the salt bridge formed with the conserved aspartate in the BH3 domain would have 
different geometry with lysine as opposed to arginine in the BH1 domain (Donald et al., 
2011). On top of this, the guanidinium group of arginine is able to form multiple 
interactions with different residues, whereas the lysyl side chain is more restricted in 
the number of interactions possible. Whether or not this difference would be significant 
enough to affect function requires further investigation, but may explain why Bok is 
not activated by BH3 peptides (Llambi et al., 2016). 
Human Bok permeabilises MOM-mimicking liposomes in the absence of BH3-peptide 
stimulation, and its activity is not enhanced by the BH3 peptides of Bid, Bim, PUMA, 
Bmf, Bad or Noxa (Llambi et al., 2016). Here, I show that cBok also permeabilises 
MOM-mimicking liposomes, and its activity is not enhanced by the BH3 peptide of the 
activator BH3-only protein Bid. Furthermore, higher concentrations of hBok were 
required to permeabilise ER-mix liposomes compared to MOM-mix liposomes 
(Fernandez-Marrero et al., 2017). I observed similar differences in permeabilisation by 
cBok. In the absence of Bid peptide, cBok was far more active than hBak on 
MOM-mimicking liposomes but not ER-mimicking liposomes. Differences in the lipid 
composition of MOM- and ER-mix liposomes may be responsible for the decreased 
pore-forming activity on ER-mimicking liposomes seen here for cBok and in published 
work for hBok (Fernandez-Marrero et al., 2017). For example, MOM-mix liposomes 
contain cardiolipin, a mitochondrion-specific, negatively charged phospholipid that 
induces negative membrane curvature, while ER-mix liposomes contain LysoPC that 
induces positive curvature. The data presented here are consistent with the idea that 
Bok may form toroidal pores which are influenced by the intrinsic curvature of bilayers 
(Fernandez-Marrero et al., 2017). 
Given the similarities in sequence (81% identity) and function between hBok and cBok, 
the structure of cBok likely represents a good model in the absence of an hBok structure. 
With a structure of Bok in hand, structure-based site-directed mutagenesis becomes 
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possible. As discussed, the α2/α3 junction, hydrophobic groove and BH1 domains are 
regions of particular interest based on the cBok structure. In particular, mutation of 
proline 83 or replacing the α2/α3 junction with the equivalent region on Bak could be 
useful for understanding why Bok appears to be auto-active. Additionally, mutation of 
the lysine in the BH1 domain to arginine could provide interesting insights into the 
importance of conservation of salt bridge geometry to BH3 domain binding, 
BH3-mediated activation, and homodimerisation of pro-apoptotic effector proteins. 
5.5 Methodology 
5.5.1 Cloning, Expression and Purification of hBok, rBok and cBok 
Different constructs of the wild type sequence of rBok and sequences of hBok and cBok 
codon-optimised for expression in E. coli were cloned into the pGEX-6P-3 expression 
vector and transformed into either Rosetta, ER2566 or BL21 (DE3) E. coli cells. Cells 
were grown at 37°C in SB to an O.D. (600 nm) of ~1.0 and induced to express overnight 
at 18°C with 1 mM IPTG. Cells were lysed in GST buffer pH [8.0] and lysates were 
filtered through a 0.45 µm pore size filter then passed over a glutathione agarose 
column. The column was washed with GST buffer and Bok was cleaved from the GST 
fusion partner on-column over 3 nights at 4°C with PreScission Protease (0.02 mg/mL). 
Bok was eluted from the column in GST buffer then purified by GF (S75 10/300) in 
TBS pH [8.0]. Purification of some constructs for crystallisation involved an extra 
purification step on a Mono S 5/50 GL cation exchange column in 20 mM HEPES 
pH [7.0] with a shallow gradient from 0.03 to 1 M NaCl. 
5.5.2 SDS-PAGE 
Proteins were heated at 95°C for 5 minutes with reducing protein loading dye. After 
heating, samples were loaded into pre-cast NuPAGE 12% Bis-Tris gels (Life 
Technologies). Gels were electrophoresed in MES running buffer for 40 minutes at 
200V. Gels were fixed and stained with Coomassie stain (2% Coomassie R250 Brilliant 
Blue w/v, 10% acetic acid v/v, 40% ethanol v/v) for 30 minutes before removal of 
excess Coomassie with a destaining buffer (10% acetic acid v/v, 40% ethanol v/v). 
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Molecular weight of protein bands was estimated using SeeBlue Plus2 Prestained 
Protein Standard (Life Technologies). 
5.5.3 Crystallisation, Data Collection, and Processing 
Crystallisation trials were performed in 96-well sitting drop plates at the CSIRO C3 
facility in Parkville. Chicken Bok DN18DC32 crystallized at 7 mg/ml in 22.5% PEG 
3350, 90 mM trisodium citrate [pH 3.5], 3% ethylene glycol. Crystals were frozen in 
well solution supplemented with 20% ethylene glycol and X-ray data were collected at 
the MX2 beamline of the Australian Synchrotron. Data were processed with XDS 
(Kabsch, 2010) and the structure was solved by molecular replacement by searching 
for two monomeric globules created from the Bax domain-swapped dimer (PDB code: 
4BD8 (Czabotar et al., 2013)) in PHASER (McCoy et al., 2007). The monomeric 
globule of Bax consisted of the α1-5 helices of one Bax polypeptide and the α6-8 helices 
of the partner chain. Initial model building was performed in PHENIX Autobuild 
(Terwilliger et al., 2008) and the structure was refined with iterative rounds of building 
in COOT (Emsley and Cowtan, 2004) and refinement in PHENIX (Adams et al., 2010). 
5.5.4 Structure Analysis and Figure Generation 
Molecular graphics for structural figures were generated in PyMOL (Delano, 2002). 
5.5.5 Liposome Release Assay 
Lipid mixtures mimicking the composition of the MOM (46% POPC, 
25% 18:1 (D9-Cis) PE, 11% Liver PI, 10% 18:1 phosphatidylserine (PS) and 
8% 18:1 cardiolipin) or the ER (61% POPC, 19% 18:1 (D9-Cis) PE, 9% Liver PI, 
4% 16:0 LysoPC, 4% Brain, Porcine sphingomyelin, 3% 18:1 PS) were doped with 5% 
18:1 DGS-NTA(Ni) lipid and dried in chloroform and 0.01% butylated hydroxytoluene 
under N2 gas, and then resuspended in SUV buffer (10 mM HEPES pH [7.5], 135 mM 
KCl, 1 mM MgCl2) containing 50 mM 5(6)-carboxy-fluorescein. Liposomes were 
extruded through a 100 nm pore size membrane and passed over a PD10 desalting 
column to remove excess dye. Liposomes (4 μg/mL) were incubated with recombinant 
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cBok or hBak with or without human Bid BH3 peptide for 2 hours at room temperature. 
5(6)-carboxy-fluorescein fluorescence was measured with an excitation wavelength of 
485 nm and an emission wavelength of 535 nm. Statistical analyses were performed 
with Tukey’s test using GraphPad Prism version 7 for Mac, GraphPad Software, La 






Conclusions and Future Directions 
Multi-BH domain pro-apoptotic effector proteins play a pivotal role in development 
and tissue homeostasis, and their dysregulation is a feature of many diseases including 
cancer, autoimmunity and neurodegenerative disease (Czabotar et al., 2014). Despite 
their importance, many questions remain surrounding the function and mechanisms of 
action of these proteins. While much progress has been made in understanding how 
Bak and Bax become activated and homodimerise at the molecular level, our 
knowledge of oligomerisation, interactions with the membrane and MOMP remains 
largely macromolecular. Far less still is known regarding Bok and its role in the cell. 
The aim of this thesis was to better understand the structure and function of these 
proteins and how they are regulated at the molecular level. 
How Bak and Bax oligomerise and cause MOMP is one of the most outstanding 
unanswered questions in the field of intrinsic apoptosis. I therefore find the structures 
and results presented in Chapter 2 to be the most exciting aspect of this thesis, as they 
could lead to a paradigm shift in a field that has traditionally focused on protein:protein 
interactions. Despite the primary localisation of most Bcl-2 family proteins at the 
MOM, structures of these proteins in complex with lipid were lacking before this work. 
Although the role of lipids has been explored to some extent, it is mainly in the context 
of the properties of the membrane bilayer rather than how individual lipid molecules 
could influence oligomerisation or pore formation (Basanez et al., 2002; Bleicken et al., 
2013a; Kuwana et al., 2002; Landeta et al., 2011; Terrones et al., 2004). The consistent 
binding of lipid to the α5/α5’ grooves and the cross-linking of Bak homodimers by lipid 
acyl chains in the cylinder structure suggest that oligomerisation of Bak could be 
mediated by lipid. Inter-dimer interfaces mediated by lipid provide a sensible 
alternative to protein:protein interfaces in Bak (or Bax) oligomers that have been 
extensively searched for without success. 
Phospholipase-induced dissociation of Bak oligomers supports a role for lipid in the 
structural integrity of the oligomers, but does not conclusively demonstrate a 
requirement for lipids at interfaces between homodimers. Experiments involving 
mutation of the lipid binding site or investigation of the requirement of lipid for 
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oligomerisation via native mass spectrometry would better confirm or disprove the 
lipid-mediated oligomerisation hypothesis (Gupta et al., 2017). Mutation of the lipid 
binding site could also affect the way Bak interacts with the membrane in terms of 
membrane disruption and pore edge stabilisation, as theorised in Figure 22. Evidence 
that the membrane itself is likely just as important in the function of Bak and Bax as 
the proteins themselves continues to build. This work contributes to a more 
lipid-involved view of MOMP by Bak and Bax. 
While the BH3:groove fold of Bax core homodimers had been confirmed by X-ray 
crystallography (Czabotar et al., 2013), a picture of the molecular interactions that 
govern this fold at atomic resolution was missing before this work. The 2.4 Å structure 
in Chapter 3 fills this gap in our knowledge of Bax homodimerisation. High-resolution 
structural information is almost mandatory for modern drug-design programs, and 
homodimerised Bax and Bak represent potentially unique targets. Stabilising or 
destabilising homodimers could be a novel therapeutic avenue for treating diseases such 
as cancer and autoimmune/degenerative disorders characterised by insufficient or 
excessive apoptosis, respectively. 
Work with the Bax core domain construct also presented a tantalising piece of 
information; i.e. as with Bak, Bax core domains associate with lipid. It was both 
exciting and disappointing that crystals of these complexes could be produced but were 
heavily twinned. Future work to decrease or prevent twinning in these crystals could be 
very important, as demonstration of the existence of analogous lipid binding sites on 
Bax would lend weight to the lipid-mediated oligomerisation hypothesis proposed here 
for Bak. 
Pro-survival proteins inhibit activated Bak and Bax by forming Mode 2 complexes. 
These complexes involve binding of the Bak/Bax BH3 domain to the pro-survival 
protein hydrophobic groove, but beyond this interaction little is known of the topology 
of Mode 2 complexes on membranes. In Chapter 4, I showed that the Bcl-XL BH3 
domain can be cross-linked to the Bax hydrophobic groove in cells, suggesting that 
some Mode 2 complexes may be pseudo-symmetrical BH3:groove heterodimers. The 
physiological relevance of conformational changes in Bcl-XL during apoptosis, such as 
unlatching of the core and latch domains, could be investigated with cysteine-pinned 
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Bcl-XL on isolated mitochondria, as performed previously for Bax and Bak 
(Brouwer et al., 2014; Czabotar et al., 2013). Is the ability to form BH3:groove 
heterodimers unique to Bcl-XL? A more extensive cysteine cross-linking study with 
multiple pro-survival proteins and Bak and Bax would answer this question. In addition, 
assessing changes in susceptibility to digestion with specific proteases (such as 
proteinase K, as used to assess Bak conformational change (Iyer et al., 2016)) would 
be useful for determining whether pro-survival proteins undergo significant 
conformational change before, during, or after activation of Bak and Bax. Finally, an 
X-ray crystal structure of a Bax:Bcl-XL BH3:groove core heterodimer would be useful 
in better understanding these Mode 2 complexes. 
The significance of such complexes in cells was not investigated here, but could provide 
novel targets for therapeutic manipulation of apoptosis. Cancer cells can become 
addicted to pro-survival Bcl-2 family proteins in order to restrain Bak and Bax at the 
MOM and prevent apoptosis. Mode 2 complexes represent the last line of defence in 
preventing MOMP and apoptosis. Recent studies hint at the importance of Mode 2 
complex formation for the survival of certain cancers (Dai et al., 2015; Inoue-
Yamauchi et al., 2017). The existence of such complexes may determine the drug 
sensitivity of a tumour (Dai et al., 2015). Even in certain non-pathological settings, 
Mode 2 complex formation is essential for cell survival. For example, platelet survival 
and thymic T-cell development, two processes heavily reliant on Bcl-XL (Ma et al., 
1995; Mason et al., 2007; Motoyama et al., 1995), are impaired when Mode 2 
interactions are disrupted with a single point mutation in Bak that prevents it from 
binding to Bcl-XL (Lee et al., 2016). There is still much to learn with regard to topology 
of Mode 2 complexes that will inform our understanding of their physiological and 
pathophysiological roles. The work in Chapter 4 contributes to this understanding and 
raises further questions for future work. 
Of the multi-domain pro-apoptotic Bcl-2 family proteins, our understanding of Bok 
lags far behind Bak and Bax. This can be attributed in part to the lack of a clear 
phenotype in Bok knockout mice or cells, and the lack of a recombinant expression 
system to discern the function of Bok in vivo and in vitro, respectively. In Chapter 5, 
I provide a method for expressing and purifying recombinant human, rat and chicken 
Bok for functional and structural studies. I show that recombinant chicken Bok 
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recapitulates the constitutive activity of human Bok on liposomal membranes observed 
by other groups (Fernandez-Marrero et al., 2017; Llambi et al., 2016). The crystal 
structure of chicken Bok confirms that the protein adopts the canonical Bcl-2 fold with 
a few interesting anomalies that may explain its constitutive activity. In particular, the 
distorted fold around the α2/α3 junction and differences between Bok monomers in the 
asymmetric unit of the crystal suggest instability in the region. The hole observed 
through one monomer in the structure is reminiscent of the destabilising cavities seen 
in Bax and Bak upon activator BH3 binding ((Czabotar et al., 2013; Robin et al., 2015) 
Jason Brouwer, unpublished), and could result in constitutive exposure of the BH3 
domain. Future work could involve mutational probing of this region to determine its 
functional significance. Alleviating the tension via mutation may prevent the 
constitutive activity of Bok and turn it into a Bak/Bax-like protein that responds to 
BH3-only protein activation. 
We know Bok is able to permeabilise membranes, but does it unlatch and form 
BH3:groove homodimers like Bak and Bax? The development of an expression system 
for recombinant Bok detailed here will allow us to answer questions regarding its 
function, including what the similarities and differences are between Bok, Bak and Bax. 
Dysfunction of the intrinsic apoptotic pathway is a feature common to many diseases 
and a better understanding of the molecular interactions and mechanisms that govern 
apoptosis is essential for the development of novel therapies. Taken together, the results 
in this thesis further our understanding of the multi-BH domain pro-apoptotic effector 





Adams, P.D., Afonine, P.V., Bunkoczi, G., Chen, V.B., Davis, I.W., Echols, N., Headd, 
J.J., Hung, L.W., Kapral, G.J., Grosse-Kunstleve, R.W., et al. (2010). PHENIX: a 
comprehensive Python-based system for macromolecular structure solution. Acta 
Crystallogr D Biol Crystallogr 66, 213-221. 
Alsop, A.E., Fennell, S.C., Bartolo, R.C., Tan, I.K., Dewson, G., and Kluck, R.M. 
(2015). Dissociation of Bak alpha1 helix from the core and latch domains is required 
for apoptosis. Nat Commun 6, 6841. 
Aluvila, S., Mandal, T., Hustedt, E., Fajer, P., Choe, J.Y., and Oh, K.J. (2014). 
Organization of the mitochondrial apoptotic BAK pore: oligomerization of the BAK 
homodimers. J Biol Chem 289, 2537-2551. 
Arbour, N., Vanderluit, J.L., Le Grand, J.N., Jahani-Asl, A., Ruzhynsky, V.A., Cheung, 
E.C., Kelly, M.A., MacKenzie, A.E., Park, D.S., Opferman, J.T., et al. (2008). Mcl-1 
is a key regulator of apoptosis during CNS development and after DNA damage. J 
Neurosci 28, 6068-6078. 
Baase, W.A., Liu, L., Tronrud, D.E., and Matthews, B.W. (2010). Lessons from the 
lysozyme of phage T4. Protein Sci 19, 631-641. 
Bakhshi, A., Jensen, J.P., Goldman, P., Wright, J.J., McBride, O.W., Epstein, A.L., and 
Korsmeyer, S.J. (1985). Cloning the chromosomal breakpoint of t(14;18) human 
lymphomas: clustering around JH on chromosome 14 and near a transcriptional unit on 
18. Cell 41, 899-906. 
Bakhshi, A., Wright, J.J., Graninger, W., Seto, M., Owens, J., Cossman, J., Jensen, J.P., 
Goldman, P., and Korsmeyer, S.J. (1987). Mechanism of the t(14;18) chromosomal 
translocation: structural analysis of both derivative 14 and 18 reciprocal partners. Proc 
Natl Acad Sci U S A 84, 2396-2400. 
Balali-Mood, K., Bond, P.J., and Sansom, M.S. (2009). Interaction of monotopic 
membrane enzymes with a lipid bilayer: a coarse-grained MD simulation study. 
Biochemistry 48, 2135-2145. 
Bartholomeusz, G., Wu, Y., Ali Seyed, M., Xia, W., Kwong, K.Y., Hortobagyi, G., and 
Hung, M.C. (2006). Nuclear translocation of the pro-apoptotic Bcl-2 family member 
Bok induces apoptosis. Mol Carcinog 45, 73-83. 
Basanez, G., Nechushtan, A., Drozhinin, O., Chanturiya, A., Choe, E., Tutt, S., Wood, 
K.A., Hsu, Y.T., Zimmerberg, J., and Youle, R.J. (1999). Bax, but not Bcl-xL, 
decreases the lifetime of planar phospholipid bilayer membranes at subnanomolar 
concentrations. Proceedings of the National Academy of Sciences 96, 5492-5497. 
 
167 
Basanez, G., Sharpe, J.C., Galanis, J., Brandt, T.B., Hardwick, J.M., and Zimmerberg, 
J. (2002). Bax-type apoptotic proteins porate pure lipid bilayers through a mechanism 
sensitive to intrinsic monolayer curvature. J Biol Chem 277, 49360-49365. 
Biasini, M., Bienert, S., Waterhouse, A., Arnold, K., Studer, G., Schmidt, T., Kiefer, 
F., Gallo Cassarino, T., Bertoni, M., Bordoli, L., et al. (2014). SWISS-MODEL: 
modelling protein tertiary and quaternary structure using evolutionary information. 
Nucleic Acids Res 42, W252-258. 
Bleicken, S., Classen, M., Padmavathi, P.V., Ishikawa, T., Zeth, K., Steinhoff, H.J., and 
Bordignon, E. (2010). Molecular details of Bax activation, oligomerization, and 
membrane insertion. J Biol Chem 285, 6636-6647. 
Bleicken, S., Jeschke, G., Stegmueller, C., Salvador-Gallego, R., Garcia-Saez, A.J., and 
Bordignon, E. (2014). Structural model of active Bax at the membrane. Mol Cell 56, 
496-505. 
Bleicken, S., Landeta, O., Landajuela, A., Basanez, G., and Garcia-Saez, A.J. (2013a). 
Proapoptotic Bax and Bak proteins form stable protein-permeable pores of tunable size. 
J Biol Chem 288, 33241-33252. 
Bleicken, S., Wagner, C., and Garcia-Saez, A.J. (2013b). Mechanistic differences in the 
membrane activity of Bax and Bcl-xL correlate with their opposing roles in apoptosis. 
Biophys J 104, 421-431. 
Boise, L.H., Gonzalez-Garcia, M., Postema, C.E., Ding, L., Lindsten, T., Turka, L.A., 
Mao, X., Nunez, G., and Thompson, C.B. (1993). bcl-x, a bcl-2-related gene that 
functions as a dominant regulator of apoptotic cell death. Cell 74, 597-608. 
Boot-Handford, R.P., Michaelidis, T.M., Hillarby, M.C., Zambelli, A., Denton, J., 
Hoyland, J.A., Freemont, A.J., Grant, M.E., and Wallis, G.A. (1998). The bcl-2 
knockout mouse exhibits marked changes in osteoblast phenotype and collagen 
deposition in bone as well as a mild growth plate phenotype. Int J Exp Pathol 79, 329-
335. 
Bouillet, P., Metcalf, D., Huang, D.C., Tarlinton, D.M., Kay, T.W., Kontgen, F., 
Adams, J.M., and Strasser, A. (1999). Proapoptotic Bcl-2 relative Bim required for 
certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity. 
Science 286, 1735-1738. 
Brouwer, J.M., Westphal, D., Dewson, G., Robin, A.Y., Uren, R.T., Bartolo, R., 
Thompson, G.V., Colman, P.M., Kluck, R.M., and Czabotar, P.E. (2014). Bak core and 
latch domains separate during activation, and freed core domains form symmetric 
homodimers. Mol Cell 55, 938-946. 
Campelo, F., McMahon, H.T., and Kozlov, M.M. (2008). The hydrophobic insertion 
mechanism of membrane curvature generation by proteins. Biophys J 95, 2325-2339. 
 
168 
Carpio, M.A., Michaud, M., Zhou, W., Fisher, J.K., Walensky, L.D., and Katz, S.G. 
(2015). BCL-2 family member BOK promotes apoptosis in response to endoplasmic 
reticulum stress. Proc Natl Acad Sci U S A 112, 7201-7206. 
Carpio, M.A., Michaud, M., Zhou, W., Fisher, J.K., Walensky, L.D., and Katz, S.G. 
(2016). Reply to Fernandez-Marrero et al.: Role of BOK at the intersection of 
endoplasmic reticulum stress and apoptosis regulation. Proc Natl Acad Sci U S A 113, 
E494-495. 
Certo, M., Del Gaizo Moore, V., Nishino, M., Wei, G., Korsmeyer, S., Armstrong, S.A., 
and Letai, A. (2006). Mitochondria primed by death signals determine cellular 
addiction to antiapoptotic BCL-2 family members. Cancer Cell 9, 351-365. 
Chautan, M., Chazal, G., Cecconi, F., Gruss, P., and Golstein, P. (1999). Interdigital 
cell death can occur through a necrotic and caspase-independent pathway. Curr Biol 9, 
967-970. 
Chen, L., Willis, S.N., Wei, A., Smith, B.J., Fletcher, J.I., Hinds, M.G., Colman, P.M., 
Day, C.L., Adams, J.M., and Huang, D.C. (2005). Differential targeting of prosurvival 
Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function. 
Mol Cell 17, 393-403. 
Chittenden, T., Flemington, C., Houghton, A.B., Ebb, R.G., Gallo, G.J., Elangovan, B., 
Chinnadurai, G., and Lutz, R.J. (1995a). A conserved domain in Bak, distinct from BH1 
and BH2, mediates cell death and protein binding functions. EMBO J 14, 5589-5596. 
Chittenden, T., Harrington, E.A., O'Connor, R., Flemington, C., Lutz, R.J., Evan, G.I., 
and Guild, B.C. (1995b). Induction of apoptosis by the Bcl-2 homologue Bak. Nature 
374, 733-736. 
Cleary, M.L., Smith, S.D., and Sklar, J. (1986). Cloning and structural analysis of 
cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the 
t(14;18) translocation. Cell 47, 19-28. 
Cosentino, K., and Garcia-Saez, A.J. (2017). Bax and Bak Pores: Are We Closing the 
Circle? Trends Cell Biol 27, 266-275. 
Czabotar, P.E., Lee, E.F., Thompson, G.V., Wardak, A.Z., Fairlie, W.D., and Colman, 
P.M. (2011). Mutation to Bax beyond the BH3 domain disrupts interactions with pro-
survival proteins and promotes apoptosis. J Biol Chem 286, 7123-7131. 
Czabotar, P.E., Lee, E.F., van Delft, M.F., Day, C.L., Smith, B.J., Huang, D.C., Fairlie, 
W.D., Hinds, M.G., and Colman, P.M. (2007). Structural insights into the degradation 
of Mcl-1 induced by BH3 domains. Proc Natl Acad Sci U S A 104, 6217-6222. 
 
169 
Czabotar, P.E., Lessene, G., Strasser, A., and Adams, J.M. (2014). Control of apoptosis 
by the BCL-2 protein family: implications for physiology and therapy. Nat Rev Mol 
Cell Biol 15, 49-63. 
Czabotar, P.E., Westphal, D., Dewson, G., Ma, S., Hockings, C., Fairlie, W.D., Lee, 
E.F., Yao, S., Robin, A.Y., Smith, B.J., et al. (2013). Bax crystal structures reveal how 
BH3 domains activate Bax and nucleate its oligomerization to induce apoptosis. Cell 
152, 519-531. 
D'Orsi, B., Engel, T., Pfeiffer, S., Nandi, S., Kaufmann, T., Henshall, D.C., and Prehn, 
J.H. (2016). Bok Is Not Pro-Apoptotic But Suppresses Poly ADP-Ribose Polymerase-
Dependent Cell Death Pathways and Protects against Excitotoxic and Seizure-Induced 
Neuronal Injury. J Neurosci 36, 4564-4578. 
Dai, H., Ding, H., Meng, X.W., Peterson, K.L., Schneider, P.A., Karp, J.E., and 
Kaufmann, S.H. (2015). Constitutive BAK activation as a determinant of drug 
sensitivity in malignant lymphohematopoietic cells. Genes Dev 29, 2140-2152. 
Day, C.L., Smits, C., Fan, F.C., Lee, E.F., Fairlie, W.D., and Hinds, M.G. (2008). 
Structure of the BH3 domains from the p53-inducible BH3-only proteins Noxa and 
Puma in complex with Mcl-1. J Mol Biol 380, 958-971. 
Delano, W.L. (2002). The PyMOL Molecular Graphics System. 
Denisov, A.Y., Sprules, T., Fraser, J., Kozlov, G., and Gehring, K. (2007). Heat-
induced dimerization of BCL-xL through alpha-helix swapping. Biochemistry 46, 734-
740. 
Dewson, G. (2015). Investigating Bak/Bax activating conformation change by 
immunoprecipitation. Cold Spring Harbor protocols 2015, 472-476. 
Dewson, G., Kratina, T., Czabotar, P., Day, C.L., Adams, J.M., and Kluck, R.M. 
(2009). Bak activation for apoptosis involves oligomerization of dimers via their alpha6 
helices. Mol Cell 36, 696-703. 
Dewson, G., Kratina, T., Sim, H.W., Puthalakath, H., Adams, J.M., Colman, P.M., and 
Kluck, R.M. (2008). To trigger apoptosis, Bak exposes its BH3 domain and 
homodimerizes via BH3:groove interactions. Mol Cell 30, 369-380. 
Dewson, G., Ma, S., Frederick, P., Hockings, C., Tan, I., Kratina, T., and Kluck, R.M. 
(2012). Bax dimerizes via a symmetric BH3:groove interface during apoptosis. Cell 
Death Differ 19, 661-670. 
Ding, J., Mooers, B.H., Zhang, Z., Kale, J., Falcone, D., McNichol, J., Huang, B., 
Zhang, X.C., Xing, C., Andrews, D.W., et al. (2014). After embedding in membranes 
antiapoptotic Bcl-XL protein binds both Bcl-2 homology region 3 and helix 1 of 
 
170 
proapoptotic Bax protein to inhibit apoptotic mitochondrial permeabilization. J Biol 
Chem 289, 11873-11896. 
Ding, J., Zhang, Z., Roberts, G.J., Falcone, M., Miao, Y., Shao, Y., Zhang, X.C., 
Andrews, D.W., and Lin, J. (2010). Bcl-2 and Bax interact via the BH1-3 groove-BH3 
motif interface and a novel interface involving the BH4 motif. J Biol Chem 285, 28749-
28763. 
Dlugosz, P.J., Billen, L.P., Annis, M.G., Zhu, W., Zhang, Z., Lin, J., Leber, B., and 
Andrews, D.W. (2006). Bcl-2 changes conformation to inhibit Bax oligomerization. 
EMBO J 25, 2287-2296. 
Donald, J.E., Kulp, D.W., and DeGrado, W.F. (2011). Salt bridges: geometrically 
specific, designable interactions. Proteins 79, 898-915. 
Dzhagalov, I., St John, A., and He, Y.W. (2007). The antiapoptotic protein Mcl-1 is 
essential for the survival of neutrophils but not macrophages. Blood 109, 1620-1626. 
Echeverry, N., Bachmann, D., Ke, F., Strasser, A., Simon, H.U., and Kaufmann, T. 
(2013). Intracellular localization of the BCL-2 family member BOK and functional 
implications. Cell Death Differ 20, 785-799. 
Edlich, F., Banerjee, S., Suzuki, M., Cleland, M.M., Arnoult, D., Wang, C., Neutzner, 
A., Tjandra, N., and Youle, R.J. (2011). Bcl-x(L) retrotranslocates Bax from the 
mitochondria into the cytosol. Cell 145, 104-116. 
Einsele-Scholz, S., Malmsheimer, S., Bertram, K., Stehle, D., Johanning, J., Manz, M., 
Daniel, P.T., Gillissen, B.F., Schulze-Osthoff, K., and Essmann, F. (2016). Bok is a 
genuine multi-BH-domain protein that triggers apoptosis in the absence of Bax and 
Bak. J Cell Sci 129, 2213-2223. 
Ekert, P.G., Read, S.H., Silke, J., Marsden, V.S., Kaufmann, H., Hawkins, C.J., Gerl, 
R., Kumar, S., and Vaux, D.L. (2004). Apaf-1 and caspase-9 accelerate apoptosis, but 
do not determine whether factor-deprived or drug-treated cells die. J Cell Biol 165, 835-
842. 
Ellis, H.M., and Horvitz, H.R. (1986). Genetic control of programmed cell death in the 
nematode C. elegans. Cell 44, 817-829. 
Emsley, P., and Cowtan, K. (2004). Coot: model-building tools for molecular graphics. 
Acta Crystallogr D Biol Crystallogr 60, 2126-2132. 
Epand, R.F., Martinou, J.C., Montessuit, S., Epand, R.M., and Yip, C.M. (2002). Direct 
evidence for membrane pore formation by the apoptotic protein Bax. Biochem Biophys 
Res Commun 298, 744-749. 
 
171 
Evans, P.R., and Murshudov, G.N. (2013). How good are my data and what is the 
resolution? Acta Crystallogr D Biol Crystallogr 69, 1204-1214. 
Fahy, E., Cotter, D., Sud, M., and Subramaniam, S. (2011). Lipid classification, 
structures and tools. Biochim Biophys Acta 1811, 637-647. 
Farrow, S.N., White, J.H., Martinou, I., Raven, T., Pun, K.T., Grinham, C.J., Martinou, 
J.C., and Brown, R. (1995). Cloning of a bcl-2 homologue by interaction with 
adenovirus E1B 19K. Nature 374, 731-733. 
Fedorov, L.M., Schmittwolf, C., Amann, K., Thomas, W.H., Muller, A.M., Schubert, 
H., Domen, J., and Kneitz, B. (2006). Renal failure causes early death of bcl-2 deficient 
mice. Mech Ageing Dev 127, 600-609. 
Fernandez-Marrero, Y., Bleicken, S., Das, K.K., Bachmann, D., Kaufmann, T., and 
Garcia-Saez, A.J. (2017). The membrane activity of BOK involves formation of large, 
stable toroidal pores and is promoted by cBID. Febs J 284, 711-724. 
Fernandez-Marrero, Y., Ke, F., Echeverry, N., Bouillet, P., Bachmann, D., Strasser, A., 
and Kaufmann, T. (2016). Is BOK required for apoptosis induced by endoplasmic 
reticulum stress? Proc Natl Acad Sci U S A 113, E492-493. 
Fire, E., Gulla, S.V., Grant, R.A., and Keating, A.E. (2010). Mcl-1-Bim complexes 
accommodate surprising point mutations via minor structural changes. Protein Sci 19, 
507-519. 
Fletcher, J.I., Meusburger, S., Hawkins, C.J., Riglar, D.T., Lee, E.F., Fairlie, W.D., 
Huang, D.C., and Adams, J.M. (2008). Apoptosis is triggered when prosurvival Bcl-2 
proteins cannot restrain Bax. Proc Natl Acad Sci U S A 105, 18081-18087. 
Follis, A.V., Chipuk, J.E., Fisher, J.C., Yun, M.K., Grace, C.R., Nourse, A., Baran, K., 
Ou, L., Min, L., White, S.W., et al. (2013). PUMA binding induces partial unfolding 
within BCL-xL to disrupt p53 binding and promote apoptosis. Nat Chem Biol 9, 163-
168. 
Fowler, P.W., Balali-Mood, K., Deol, S., Coveney, P.V., and Sansom, M.S. (2007). 
Monotopic enzymes and lipid bilayers: a comparative study. Biochemistry 46, 3108-
3115. 
Fuchs, B., Suss, R., Teuber, K., Eibisch, M., and Schiller, J. (2011). Lipid analysis by 
thin-layer chromatography--a review of the current state. J Chromatogr A 1218, 2754-
2774. 
Garcia-Saez, A.J., Chiantia, S., Salgado, J., and Schwille, P. (2007). Pore formation by 
a Bax-derived peptide: effect on the line tension of the membrane probed by AFM. 
Biophys J 93, 103-112. 
 
172 
Gavathiotis, E., Suzuki, M., Davis, M.L., Pitter, K., Bird, G.H., Katz, S.G., Tu, H.C., 
Kim, H., Cheng, E.H., Tjandra, N., et al. (2008). BAX activation is initiated at a novel 
interaction site. Nature 455, 1076-1081. 
Gelin, M., Delfosse, V., Allemand, F., Hoh, F., Sallaz-Damaz, Y., Pirocchi, M., 
Bourguet, W., Ferrer, J.L., Labesse, G., and Guichou, J.F. (2015). Combining 'dry' co-
crystallization and in situ diffraction to facilitate ligand screening by X-ray 
crystallography. Acta Crystallogr D Biol Crystallogr 71, 1777-1787. 
Ghavami, S., Shojaei, S., Yeganeh, B., Ande, S.R., Jangamreddy, J.R., Mehrpour, M., 
Christoffersson, J., Chaabane, W., Moghadam, A.R., Kashani, H.H., et al. (2014). 
Autophagy and apoptosis dysfunction in neurodegenerative disorders. Prog Neurobiol 
112, 24-49. 
Gilbert, R.J. (2016). Protein-lipid interactions and non-lamellar lipidic structures in 
membrane pore formation and membrane fusion. Biochim Biophys Acta 1858, 487-
499. 
Gilbert, R.J., Dalla Serra, M., Froelich, C.J., Wallace, M.I., and Anderluh, G. (2014). 
Membrane pore formation at protein-lipid interfaces. Trends Biochem Sci 39, 510-516. 
Gillies, L.A., Du, H., Peters, B., Knudson, C.M., Newmeyer, D.D., and Kuwana, T. 
(2015). Visual and functional demonstration of growing Bax-induced pores in 
mitochondrial outer membranes. Mol Biol Cell 26, 339-349. 
Glucksmann, A. (1951). Cell deaths in normal vertebrate ontogeny. Biol Rev Camb 
Philos Soc 26, 59-86. 
Griffiths, G.J., Dubrez, L., Morgan, C.P., Jones, N.A., Whitehouse, J., Corfe, B.M., 
Dive, C., and Hickman, J.A. (1999). Cell damage-induced conformational changes of 
the pro-apoptotic protein Bak in vivo precede the onset of apoptosis. J Cell Biol 144, 
903-914. 
Grosse, L., Wurm, C.A., Bruser, C., Neumann, D., Jans, D.C., and Jakobs, S. (2016). 
Bax assembles into large ring-like structures remodeling the mitochondrial outer 
membrane in apoptosis. EMBO J 35, 402-413. 
Gruner, S.M. (1985). Intrinsic curvature hypothesis for biomembrane lipid 
composition: a role for nonbilayer lipids. Proc Natl Acad Sci U S A 82, 3665-3669. 
Gupta, K., Donlan, J.A.C., Hopper, J.T.S., Uzdavinys, P., Landreh, M., Struwe, W.B., 
Drew, D., Baldwin, A.J., Stansfeld, P.J., and Robinson, C.V. (2017). The role of 
interfacial lipids in stabilizing membrane protein oligomers. Nature 541, 421-424. 
Hanahan, D., and Weinberg, R.A. (2011). Hallmarks of cancer: the next generation. 
Cell 144, 646-674. 
 
173 
Happo, L., Strasser, A., and Cory, S. (2012). BH3-only proteins in apoptosis at a glance. 
J Cell Sci 125, 1081-1087. 
Haschka, M.D., and Villunger, A. (2017). There is something about BOK we just don't 
get yet. Febs J 284, 708-710. 
Hengartner, M.O., and Horvitz, H.R. (1994). C. elegans cell survival gene ced-9 
encodes a functional homolog of the mammalian proto-oncogene bcl-2. Cell 76, 665-
676. 
Horie, C., Suzuki, H., Sakaguchi, M., and Mihara, K. (2002). Characterization of signal 
that directs C-tail-anchored proteins to mammalian mitochondrial outer membrane. 
Mol Biol Cell 13, 1615-1625. 
Hsu, S.Y., Kaipia, A., McGee, E., Lomeli, M., and Hsueh, A.J. (1997). Bok is a pro-
apoptotic Bcl-2 protein with restricted expression in reproductive tissues and 
heterodimerizes with selective anti-apoptotic Bcl-2 family members. Proc Natl Acad 
Sci U S A 94, 12401-12406. 
Hsu, Y.T., and Youle, R.J. (1998). Bax in murine thymus is a soluble monomeric 
protein that displays differential detergent-induced conformations. Journal of 
Biological Chemistry 273, 10777-10783. 
Hunte, C., and Richers, S. (2008). Lipids and membrane protein structures. Curr Opin 
Struct Biol 18, 406-411. 
Iacovache, I., Bischofberger, M., and van der Goot, F.G. (2010). Structure and 
assembly of pore-forming proteins. Curr Opin Struct Biol 20, 241-246. 
Inohara, N., Ekhterae, D., Garcia, I., Carrio, R., Merino, J., Merry, A., Chen, S., and 
Nunez, G. (1998). Mtd, a novel Bcl-2 family member activates apoptosis in the absence 
of heterodimerization with Bcl-2 and Bcl-X-L. Journal of Biological Chemistry 273, 
8705-8710. 
Inoue-Yamauchi, A., Jeng, P.S., Kim, K., Chen, H.C., Han, S., Ganesan, Y.T., 
Ishizawa, K., Jebiwott, S., Dong, Y., Pietanza, M.C., et al. (2017). Targeting the 
differential addiction to anti-apoptotic BCL-2 family for cancer therapy. Nat Commun 
8, 16078. 
Iyer, S., Anwari, K., Alsop, A.E., Yuen, W.S., Huang, D.C., Carroll, J., Smith, N.A., 
Smith, B.J., Dewson, G., and Kluck, R.M. (2016). Identification of an activation site in 
Bak and mitochondrial Bax triggered by antibodies. Nat Commun 7, 11734. 
Iyer, S., Bell, F., Westphal, D., Anwari, K., Gulbis, J., Smith, B.J., Dewson, G., and 
Kluck, R.M. (2015). Bak apoptotic pores involve a flexible C-terminal region and 




Kabsch, W. (2010). Xds. Acta Crystallogr D Biol Crystallogr 66, 125-132. 
Karatekin, E., Sandre, O., Guitouni, H., Borghi, N., Puech, P.H., and Brochard-Wyart, 
F. (2003). Cascades of transient pores in giant vesicles: line tension and transport. 
Biophys J 84, 1734-1749. 
Kaufmann, T., Schlipf, S., Sanz, J., Neubert, K., Stein, R., and Borner, C. (2003). 
Characterization of the signal that directs Bcl-x(L), but not Bcl-2, to the mitochondrial 
outer membrane. J Cell Biol 160, 53-64. 
Ke, F., Bouillet, P., Kaufmann, T., Strasser, A., Kerr, J., and Voss, A.K. (2013). 
Consequences of the combined loss of BOK and BAK or BOK and BAX. Cell Death 
Dis 4, e650. 
Ke, F., Voss, A., Kerr, J.B., O'Reilly, L.A., Tai, L., Echeverry, N., Bouillet, P., Strasser, 
A., and Kaufmann, T. (2012). BCL-2 family member BOK is widely expressed but its 
loss has only minimal impact in mice. Cell Death Differ 19, 915-925. 
Keenan, T.W., and Morre, D.J. (1970). Phospholipid class and fatty acid composition 
of golgi apparatus isolated from rat liver and comparison with other cell fractions. 
Biochemistry 9, 19-25. 
Kerr, J.F. (1971). Shrinkage necrosis: a distinct mode of cellular death. J Pathol 105, 
13-20. 
Kerr, J.F., Wyllie, A.H., and Currie, A.R. (1972). Apoptosis: a basic biological 
phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26, 239-
257. 
Kiefer, M.C., Brauer, M.J., Powers, V.C., Wu, J.J., Umansky, S.R., Tomei, L.D., and 
Barr, P.J. (1995). Modulation of apoptosis by the widely distributed Bcl-2 homologue 
Bak. Nature 374, 736-739. 
Kim, M.K., and Kang, Y.K. (1999). Positional preference of proline in alpha-helices. 
Protein Sci 8, 1492-1499. 
Kirby, N.M., Mudie, S.T., Hawley, A.M., Cookson, D.J., Mertens, H.D.T., Cowieson, 
N., and Samardzic-Boban, V. (2013). A low-background-intensity focusing small-
angle X-ray scattering undulator beamline. J Appl Crystallogr 46, 1670-1680. 
Kluck, R.M., Bossy-Wetzel, E., Green, D.R., and Newmeyer, D.D. (1997). The release 
of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. 
Science 275, 1132-1136. 
 
175 
Knudson, C.M., Tung, K.S., Tourtellotte, W.G., Brown, G.A., and Korsmeyer, S.J. 
(1995). Bax-deficient mice with lymphoid hyperplasia and male germ cell death. 
Science 270, 96-99. 
Konarev, P.V., Volkov, V.V., Sokolova, A.V., Koch, M.H.J., and Svergun, D.I. (2003). 
PRIMUS: a Windows PC-based system for small-angle scattering data analysis. J Appl 
Crystallogr 36, 1277-1282. 
Kozopas, K.M., Yang, T., Buchan, H.L., Zhou, P., and Craig, R.W. (1993). MCL1, a 
gene expressed in programmed myeloid cell differentiation, has sequence similarity to 
BCL2. Proc Natl Acad Sci U S A 90, 3516-3520. 
Kuwana, T., Bouchier-Hayes, L., Chipuk, J.E., Bonzon, C., Sullivan, B.A., Green, 
D.R., and Newmeyer, D.D. (2005). BH3 domains of BH3-only proteins differentially 
regulate Bax-mediated mitochondrial membrane permeabilization both directly and 
indirectly. Mol Cell 17, 525-535. 
Kuwana, T., Mackey, M.R., Perkins, G., Ellisman, M.H., Latterich, M., Schneiter, R., 
Green, D.R., and Newmeyer, D.D. (2002). Bid, Bax, and lipids cooperate to form 
supramolecular openings in the outer mitochondrial membrane. Cell 111, 331-342. 
Kuwana, T., Olson, N.H., Kiosses, W.B., Peters, B., and Newmeyer, D.D. (2016). Pro-
apoptotic Bax molecules densely populate the edges of membrane pores. Sci Rep 6, 
27299. 
Kvansakul, M., and Hinds, M.G. (2013). Structural biology of the Bcl-2 family and its 
mimicry by viral proteins. Cell Death Dis 4, e909. 
Lamkanfi, M., and Dixit, V.M. (2010). Manipulation of host cell death pathways during 
microbial infections. Cell Host Microbe 8, 44-54. 
Landeta, O., Landajuela, A., Gil, D., Taneva, S., Di Primo, C., Sot, B., Valle, M., 
Frolov, V.A., and Basanez, G. (2011). Reconstitution of proapoptotic BAK function in 
liposomes reveals a dual role for mitochondrial lipids in the BAK-driven membrane 
permeabilization process. J Biol Chem 286, 8213-8230. 
Lee, E.F., Grabow, S., Chappaz, S., Dewson, G., Hockings, C., Kluck, R.M., Debrincat, 
M.A., Gray, D.H., Witkowski, M.T., Evangelista, M., et al. (2016). Physiological 
restraint of Bak by Bcl-xL is essential for cell survival. Gene Dev 30. 
Lee, E.F., Sadowsky, J.D., Smith, B.J., Czabotar, P.E., Peterson-Kaufman, K.J., 
Colman, P.M., Gellman, S.H., and Fairlie, W.D. (2009). High-resolution structural 
characterization of a helical alpha/beta-peptide foldamer bound to the anti-apoptotic 
protein Bcl-xL. Angew Chem Int Ed Engl 48, 4318-4322. 
Lindsten, T., Ross, A.J., King, A., Zong, W.X., Rathmell, J.C., Shiels, H.A., Ulrich, E., 
Waymire, K.G., Mahar, P., Frauwirth, K., et al. (2000). The combined functions of 
 
176 
proapoptotic Bcl-2 family members bak and bax are essential for normal development 
of multiple tissues. Mol Cell 6, 1389-1399. 
Llambi, F., Moldoveanu, T., Tait, S.W., Bouchier-Hayes, L., Temirov, J., McCormick, 
L.L., Dillon, C.P., and Green, D.R. (2011). A unified model of mammalian BCL-2 
protein family interactions at the mitochondria. Mol Cell 44, 517-531. 
Llambi, F., Wang, Y.M., Victor, B., Yang, M., Schneider, D.M., Gingras, S., Parsons, 
M.J., Zheng, J.H., Brown, S.A., Pelletier, S., et al. (2016). BOK Is a Non-canonical 
BCL-2 Family Effector of Apoptosis Regulated by ER-Associated Degradation. Cell 
165, 421-433. 
Lockshin, R.A., and Williams, C.M. (1965). Programmed Cell Death--I. Cytology of 
Degeneration in the Intersegmental Muscles of the Pernyi Silkmoth. J Insect Physiol 
11, 123-133. 
Lydic, T.A., Busik, J.V., and Reid, G.E. (2014). A monophasic extraction strategy for 
the simultaneous lipidome analysis of polar and nonpolar retina lipids. J Lipid Res 55, 
1797-1809. 
Ma, A., Pena, J.C., Chang, B., Margosian, E., Davidson, L., Alt, F.W., and Thompson, 
C.B. (1995). Bclx regulates the survival of double-positive thymocytes. Proc Natl Acad 
Sci U S A 92, 4763-4767. 
Ma, S., Hockings, C., Anwari, K., Kratina, T., Fennell, S., Lazarou, M., Ryan, M.T., 
Kluck, R.M., and Dewson, G. (2013). Assembly of the Bak apoptotic pore: a critical 
role for the Bak protein alpha6 helix in the multimerization of homodimers during 
apoptosis. J Biol Chem 288, 26027-26038. 
Mandal, T., Shin, S., Aluvila, S., Chen, H.C., Grieve, C., Choe, J.Y., Cheng, E.H., 
Hustedt, E.J., and Oh, K.J. (2016). Assembly of Bak homodimers into higher order 
homooligomers in the mitochondrial apoptotic pore. Sci Rep 6, 30763. 
Mason, K.D., Carpinelli, M.R., Fletcher, J.I., Collinge, J.E., Hilton, A.A., Ellis, S., 
Kelly, P.N., Ekert, P.G., Metcalf, D., Roberts, A.W., et al. (2007). Programmed 
anuclear cell death delimits platelet life span. Cell 128, 1173-1186. 
May, S. (2000). A molecular model for the line tension of lipid membranes. Eur Phys 
J E 3, 37-44. 
McCoy, A.J., Grosse-Kunstleve, R.W., Adams, P.D., Winn, M.D., Storoni, L.C., and 
Read, R.J. (2007). Phaser crystallographic software. J Appl Crystallogr 40, 658-674. 




Moldoveanu, T., Grace, C.R., Llambi, F., Nourse, A., Fitzgerald, P., Gehring, K., 
Kriwacki, R.W., and Green, D.R. (2013). BID-induced structural changes in BAK 
promote apoptosis. Nat Struct Mol Biol 20, 589-597. 
Moldoveanu, T., Liu, Q., Tocilj, A., Watson, M., Shore, G., and Gehring, K. (2006). 
The X-ray structure of a BAK homodimer reveals an inhibitory zinc binding site. Mol 
Cell 24, 677-688. 
Moriarty, N.W., Grosse-Kunstleve, R.W., and Adams, P.D. (2009). electronic Ligand 
Builder and Optimization Workbench (eLBOW): a tool for ligand coordinate and 
restraint generation. Acta Crystallogr D Biol Crystallogr 65, 1074-1080. 
Motoyama, N., Wang, F., Roth, K.A., Sawa, H., Nakayama, K., Nakayama, K., 
Negishi, I., Senju, S., Zhang, Q., Fujii, S., et al. (1995). Massive cell death of immature 
hematopoietic cells and neurons in Bcl-x-deficient mice. Science 267, 1506-1510. 
Muchmore, S.W., Sattler, M., Liang, H., Meadows, R.P., Harlan, J.E., Yoon, H.S., 
Nettesheim, D., Chang, B.S., Thompson, C.B., Wong, S.L., et al. (1996). X-ray and 
NMR structure of human Bcl-xL, an inhibitor of programmed cell death. Nature 381, 
335-341. 
Mueller, M., Grauschopf, U., Maier, T., Glockshuber, R., and Ban, N. (2009). The 
structure of a cytolytic alpha-helical toxin pore reveals its assembly mechanism. Nature 
459, 726-730. 
Murshudov, G.N., Vagin, A.A., and Dodson, E.J. (1997). Refinement of 
macromolecular structures by the maximum-likelihood method. Acta Crystallogr D 
Biol Crystallogr 53, 240-255. 
Nasu, Y., Benke, A., Arakawa, S., Yoshida, G.J., Kawamura, G., Manley, S., Shimizu, 
S., and Ozawa, T. (2016). In Situ Characterization of Bak Clusters Responsible for Cell 
Death Using Single Molecule Localization Microscopy. Sci Rep 6, 27505. 
O'Neill, J.W., Manion, M.K., Maguire, B., and Hockenbery, D.M. (2006). BCL-XL 
dimerization by three-dimensional domain swapping. J Mol Biol 356, 367-381. 
O'Neill, K.L., Huang, K., Zhang, J., Chen, Y., and Luo, X. (2016). Inactivation of 
prosurvival Bcl-2 proteins activates Bax/Bak through the outer mitochondrial 
membrane. Gene Dev 30, 973-988. 
Oh, K.J., Singh, P., Lee, K., Foss, K., Lee, S., Park, M., Lee, S., Aluvila, S., Park, M., 
Singh, P., et al. (2010). Conformational changes in BAK, a pore-forming proapoptotic 
Bcl-2 family member, upon membrane insertion and direct evidence for the existence 




Okamoto, T., Zobel, K., Fedorova, A., Quan, C., Yang, H., Fairbrother, W.J., Huang, 
D.C.S., Smith, B.J., Deshayes, K., and Czabotar, P.E. (2013). Stabilizing the Pro-
Apoptotic Bim BH3 Helix (BimSAHB) Does Not Necessarily Enhance Affinity or 
Biological Activity. Biopolymers 100, 308-308. 
Oltvai, Z.N., Milliman, C.L., and Korsmeyer, S.J. (1993). Bcl-2 heterodimerizes in vivo 
with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74, 609-
619. 
Opferman, J.T., Iwasaki, H., Ong, C.C., Suh, H., Mizuno, S., Akashi, K., and 
Korsmeyer, S.J. (2005). Obligate role of anti-apoptotic MCL-1 in the survival of 
hematopoietic stem cells. Science 307, 1101-1104. 
Opferman, J.T., Letai, A., Beard, C., Sorcinelli, M.D., Ong, C.C., and Korsmeyer, S.J. 
(2003). Development and maintenance of B and T lymphocytes requires antiapoptotic 
MCL-1. Nature 426, 671-676. 
Ottina, E., Grespi, F., Tischner, D., Soratroi, C., Geley, S., Ploner, A., Reichardt, H.M., 
Villunger, A., and Herold, M.J. (2012). Targeting antiapoptotic A1/Bfl-1 by in vivo 
RNAi reveals multiple roles in leukocyte development in mice. Blood 119, 6032-6042. 
Pakula, A.A., and Simon, M.I. (1992). Determination of transmembrane protein 
structure by disulfide cross-linking: the Escherichia coli Tar receptor. Proc Natl Acad 
Sci U S A 89, 4144-4148. 
Palsdottir, H., and Hunte, C. (2004). Lipids in membrane protein structures. Biochim 
Biophys Acta 1666, 2-18. 
Pan, R., Hogdal, L.J., Benito, J.M., Bucci, D., Han, L., Borthakur, G., Cortes, J., 
DeAngelo, D.J., Debose, L., Mu, H., et al. (2014). Selective BCL-2 inhibition by ABT-
199 causes on-target cell death in acute myeloid leukemia. Cancer Discov 4, 362-375. 
Peng, R., Tong, J.S., Li, H., Yue, B., Zou, F., Yu, J., and Zhang, L. (2013). Targeting 
Bax interaction sites reveals that only homo-oligomerization sites are essential for its 
activation. Cell Death Differ 20, 744-754. 
Petros, A.M., Nettesheim, D.G., Wang, Y., Olejniczak, E.T., Meadows, R.P., Mack, J., 
Swift, K., Matayoshi, E.D., Zhang, H., Thompson, C.B., et al. (2000). Rationale for 
Bcl-xL/Bad peptide complex formation from structure, mutagenesis, and biophysical 
studies. Protein Sci 9, 2528-2534. 
Pettersen, E.F., Goddard, T.D., Huang, C.C., Couch, G.S., Greenblatt, D.M., Meng, 
E.C., and Ferrin, T.E. (2004). UCSF Chimera--a visualization system for exploratory 
research and analysis. Journal of computational chemistry 25, 1605-1612. 
Plotly Technologies Inc. (2015). Collaborative data science (Montreal, QC). 
 
179 
Print, C.G., Loveland, K.L., Gibson, L., Meehan, T., Stylianou, A., Wreford, N., de 
Kretser, D., Metcalf, D., Kontgen, F., Adams, J.M., et al. (1998). Apoptosis regulator 
bcl-w is essential for spermatogenesis but appears otherwise redundant. Proc Natl Acad 
Sci U S A 95, 12424-12431. 
Qian, S., Wang, W., Yang, L., and Huang, H.W. (2008). Structure of transmembrane 
pore induced by Bax-derived peptide: evidence for lipidic pores. Proc Natl Acad Sci U 
S A 105, 17379-17383. 
R Core Team (2016). R: A language and environment for statistical computing (Vienna, 
Austria: R Foundation for Statistical Computing). 
Rajagopal, B.S., Edzuma, A.N., Hough, M.A., Blundell, K.L., Kagan, V.E., Kapralov, 
A.A., Fraser, L.A., Butt, J.N., Silkstone, G.G., Wilson, M.T., et al. (2013). The 
hydrogen-peroxide-induced radical behaviour in human cytochrome c-phospholipid 
complexes: implications for the enhanced pro-apoptotic activity of the G41S mutant. 
Biochem J 456, 441-452. 
Rajan, S., Choi, M., Nguyen, Q.T., Ye, H., Liu, W., Toh, H.T., Kang, C., Kamariah, 
N., Li, C., Huang, H., et al. (2015). Structural transition in Bcl-xL and its potential 
association with mitochondrial calcium ion transport. Sci Rep 5, 10609. 
Rautureau, G.J., Day, C.L., and Hinds, M.G. (2010). The structure of Boo/Diva reveals 
a divergent Bcl-2 protein. Proteins 78, 2181-2186. 
Rautureau, G.J., Yabal, M., Yang, H., Huang, D.C., Kvansakul, M., and Hinds, M.G. 
(2012). The restricted binding repertoire of Bcl-B leaves Bim as the universal BH3-
only prosurvival Bcl-2 protein antagonist. Cell Death Dis 3, e443. 
Richardson, J.S., and Richardson, D.C. (1988). Amino-Acid Preferences for Specific 
Locations at the Ends of Alpha-Helices. Science 240, 1648-1652. 
Rinkenberger, J.L., Horning, S., Klocke, B., Roth, K., and Korsmeyer, S.J. (2000). Mcl-
1 deficiency results in peri-implantation embryonic lethality. Genes Dev 14, 23-27. 
Roberts, A.W., Davids, M.S., Pagel, J.M., Kahl, B.S., Puvvada, S.D., Gerecitano, J.F., 
Kipps, T.J., Anderson, M.A., Brown, J.R., Gressick, L., et al. (2016). Targeting BCL2 
with Venetoclax in Relapsed Chronic Lymphocytic Leukemia. N Engl J Med 374, 311-
322. 
Robin, A.Y., Krishna Kumar, K., Westphal, D., Wardak, A.Z., Thompson, G.V., 
Dewson, G., Colman, P.M., and Czabotar, P.E. (2015). Crystal structure of Bax bound 




Salvador-Gallego, R., Mund, M., Cosentino, K., Schneider, J., Unsay, J., Schraermeyer, 
U., Engelhardt, J., Ries, J., and Garcia-Saez, A.J. (2016). Bax assembly into rings and 
arcs in apoptotic mitochondria is linked to membrane pores. EMBO J 35, 389-401. 
Sattler, M., Liang, H., Nettesheim, D., Meadows, R.P., Harlan, J.E., Eberstadt, M., 
Yoon, H.S., Shuker, S.B., Chang, B.S., Minn, A.J., et al. (1997). Structure of Bcl-xL-
Bak peptide complex: recognition between regulators of apoptosis. Science 275, 983-
986. 
Saunders, J.W., Jr. (1966). Death in embryonic systems. Science 154, 604-612. 
Schafer, B., Quispe, J., Choudhary, V., Chipuk, J.E., Ajero, T.G., Du, H., Schneiter, R., 
and Kuwana, T. (2009). Mitochondrial outer membrane proteins assist Bid in Bax-
mediated lipidic pore formation. Mol Biol Cell 20, 2276-2285. 
Schellenberg, B., Wang, P., Keeble, J.A., Rodriguez-Enriquez, R., Walker, S., Owens, 
T.W., Foster, F., Tanianis-Hughes, J., Brennan, K., Streuli, C.H., et al. (2013). Bax 
exists in a dynamic equilibrium between the cytosol and mitochondria to control 
apoptotic priming. Mol Cell 49, 959-971. 
Schulman, J.J., Wright, F.A., Han, X., Zluhan, E.J., Szczesniak, L.M., and 
Wojcikiewicz, R.J. (2016). The Stability and Expression Level of Bok Are Governed 
by Binding to Inositol 1,4,5-Trisphosphate Receptors. J Biol Chem 291, 11820-11828. 
Schulman, J.J., Wright, F.A., Kaufmann, T., and Wojcikiewicz, R.J. (2013). The Bcl-2 
protein family member Bok binds to the coupling domain of inositol 1,4,5-
trisphosphate receptors and protects them from proteolytic cleavage. J Biol Chem 288, 
25340-25349. 
Shinzawa-Itoh, K., Aoyama, H., Muramoto, K., Terada, H., Kurauchi, T., Tadehara, Y., 
Yamasaki, A., Sugimura, T., Kurono, S., Tsujimoto, K., et al. (2007). Structures and 
physiological roles of 13 integral lipids of bovine heart cytochrome c oxidase. EMBO 
J 26, 1713-1725. 
Simmons, M.J., Fan, G., Zong, W.X., Degenhardt, K., White, E., and Gelinas, C. 
(2008). Bfl-1/A1 functions, similar to Mcl-1, as a selective tBid and Bak antagonist. 
Oncogene 27, 1421-1428. 
Smits, C., Czabotar, P.E., Hinds, M.G., and Day, C.L. (2008). Structural plasticity 
underpins promiscuous binding of the prosurvival protein A1. Structure 16, 818-829. 
Song, L., Hobaugh, M.R., Shustak, C., Cheley, S., Bayley, H., and Gouaux, J.E. (1996). 
Structure of staphylococcal alpha-hemolysin, a heptameric transmembrane pore. 
Science 274, 1859-1866. 
Sonnen, A.F., Plitzko, J.M., and Gilbert, R.J. (2014). Incomplete pneumolysin 
oligomers form membrane pores. Open Biol 4, 140044. 
 
181 
Souers, A.J., Leverson, J.D., Boghaert, E.R., Ackler, S.L., Catron, N.D., Chen, J., 
Dayton, B.D., Ding, H., Enschede, S.H., Fairbrother, W.J., et al. (2013). ABT-199, a 
potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing 
platelets. Nat Med 19, 202-208. 
Subburaj, Y., Cosentino, K., Axmann, M., Pedrueza-Villalmanzo, E., Hermann, E., 
Bleicken, S., Spatz, J., and Garcia-Saez, A.J. (2015). Bax monomers form dimer units 
in the membrane that further self-assemble into multiple oligomeric species. Nat 
Commun 6, 8042. 
Sulston, J.E., and Horvitz, H.R. (1977). Post-embryonic cell lineages of the nematode, 
Caenorhabditis elegans. Dev Biol 56, 110-156. 
Suzuki, M., Youle, R.J., and Tjandra, N. (2000). Structure of Bax: coregulation of dimer 
formation and intracellular localization. Cell 103, 645-654. 
Svergun, D., Barberato, C., and Koch, M.H.J. (1995). CRYSOL - A program to 
evaluate x-ray solution scattering of biological macromolecules from atomic 
coordinates. J Appl Crystallogr 28, 768-773. 
Svergun, D.I. (1992). Determination of the Regularization Parameter in Indirect-
Transform Methods Using Perceptual Criteria. J Appl Crystallogr 25, 495-503. 
Tanaka, K., Caaveiro, J.M., Morante, K., Gonzalez-Manas, J.M., and Tsumoto, K. 
(2015). Structural basis for self-assembly of a cytolytic pore lined by protein and lipid. 
Nat Commun 6, 6337. 
Tanaka, Y., Aikawa, K., Nishida, G., Homma, M., Sogabe, S., Igaki, S., Hayano, Y., 
Sameshima, T., Miyahisa, I., Kawamoto, T., et al. (2013). Discovery of potent Mcl-
1/Bcl-xL dual inhibitors by using a hybridization strategy based on structural analysis 
of target proteins. J Med Chem 56, 9635-9645. 
Terrones, O., Antonsson, B., Yamaguchi, H., Wang, H.G., Liu, J., Lee, R.M., 
Herrmann, A., and Basanez, G. (2004). Lipidic pore formation by the concerted action 
of proapoptotic BAX and tBID. J Biol Chem 279, 30081-30091. 
Terwilliger, T.C., Grosse-Kunstleve, R.W., Afonine, P.V., Moriarty, N.W., Zwart, 
P.H., Hung, L.W., Read, R.J., and Adams, P.D. (2008). Iterative model building, 
structure refinement and density modification with the PHENIX AutoBuild wizard. 
Acta Crystallogr D Biol Crystallogr 64, 61-69. 
Thomas, R.L., Roberts, D.J., Kubli, D.A., Lee, Y., Quinsay, M.N., Owens, J.B., 
Fischer, K.M., Sussman, M.A., Miyamoto, S., and Gustafsson, A.B. (2013). Loss of 




Todt, F., Cakir, Z., Reichenbach, F., Emschermann, F., Lauterwasser, J., Kaiser, A., 
Ichim, G., Tait, S.W., Frank, S., Langer, H.F., et al. (2015). Differential 
retrotranslocation of mitochondrial Bax and Bak. EMBO J 34, 67-80. 
Todt, F., Cakir, Z., Reichenbach, F., Youle, R.J., and Edlich, F. (2013). The C-terminal 
helix of Bcl-x(L) mediates Bax retrotranslocation from the mitochondria. Cell Death 
Differ 20, 333-342. 
Tsujimoto, Y., Finger, L.R., Yunis, J., Nowell, P.C., and Croce, C.M. (1984). Cloning 
of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome 
translocation. Science 226, 1097-1099. 
Ujwal, R., and Bowie, J.U. (2011). Crystallizing membrane proteins using lipidic 
bicelles. Methods 55, 337-341. 
Uren, R.T., O'Hely, M., Iyer, S., Bartolo, R., Shi, M.X., Brouwer, J.M., Alsop, A.E., 
Dewson, G., and Kluck, R.M. (2017). Disordered clusters of Bak dimers rupture 
mitochondria during apoptosis. Elife 6. 
Vaux, D.L., Cory, S., and Adams, J.M. (1988). Bcl-2 gene promotes haemopoietic cell 
survival and cooperates with c-myc to immortalize pre-B cells. Nature 335, 440-442. 
Vaux, D.L., Weissman, I.L., and Kim, S.K. (1992). Prevention of programmed cell 
death in Caenorhabditis elegans by human bcl-2. Science 258, 1955-1957. 
Veis, D.J., Sorenson, C.M., Shutter, J.R., and Korsmeyer, S.J. (1993). Bcl-2-deficient 
mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and 
hypopigmented hair. Cell 75, 229-240. 
Vick, B., Weber, A., Urbanik, T., Maass, T., Teufel, A., Krammer, P.H., Opferman, 
J.T., Schuchmann, M., Galle, P.R., and Schulze-Bergkamen, H. (2009). Knockout of 
myeloid cell leukemia-1 induces liver damage and increases apoptosis susceptibility of 
murine hepatocytes. Hepatology 49, 627-636. 
Walter, P., and Ron, D. (2011). The unfolded protein response: from stress pathway to 
homeostatic regulation. Science 334, 1081-1086. 
Wang, K., Gross, A., Waksman, G., and Korsmeyer, S.J. (1998). Mutagenesis of the 
BH3 domain of BAX identifies residues critical for dimerization and killing. Mol Cell 
Biol 18, 6083-6089. 
Wang, X., Bathina, M., Lynch, J., Koss, B., Calabrese, C., Frase, S., Schuetz, J.D., 
Rehg, J.E., and Opferman, J.T. (2013). Deletion of MCL-1 causes lethal cardiac failure 
and mitochondrial dysfunction. Genes Dev 27, 1351-1364. 
 
183 
Wei, M.C., Zong, W.X., Cheng, E.H., Lindsten, T., Panoutsakopoulou, V., Ross, A.J., 
Roth, K.A., MacGregor, G.R., Thompson, C.B., and Korsmeyer, S.J. (2001). 
Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and 
death. Science 292, 727-730. 
Weijman, J.F., Kumar, A., Jamieson, S.A., King, C.M., Caradoc-Davies, T.T., 
Ledgerwood, E.C., Murphy, J.M., and Mace, P.D. (2017). Structural basis of 
autoregulatory scaffolding by apoptosis signal-regulating kinase 1. Proc Natl Acad Sci 
U S A 114, E2096-E2105. 
Westphal, D., Dewson, G., Menard, M., Frederick, P., Iyer, S., Bartolo, R., Gibson, L., 
Czabotar, P.E., Smith, B.J., Adams, J.M., et al. (2014). Apoptotic pore formation is 
associated with in-plane insertion of Bak or Bax central helices into the mitochondrial 
outer membrane. Proc Natl Acad Sci U S A 111, E4076-4085. 
Willis, S.N., Chen, L., Dewson, G., Wei, A., Naik, E., Fletcher, J.I., Adams, J.M., and 
Huang, D.C. (2005). Proapoptotic Bak is sequestered by Mcl-1 and Bcl-xL, but not Bcl-
2, until displaced by BH3-only proteins. Genes Dev 19, 1294-1305. 
Willis, S.N., Fletcher, J.I., Kaufmann, T., van Delft, M.F., Chen, L., Czabotar, P.E., 
Ierino, H., Lee, E.F., Fairlie, W.D., Bouillet, P., et al. (2007). Apoptosis initiated when 
BH3 ligands engage multiple Bcl-2 homologs, not Bax or Bak. Science 315, 856-859. 
Woolfson, D.N., and Williams, D.H. (1990). The influence of proline residues on alpha-
helical structure. FEBS Lett 277, 185-188. 
Wright, S.P. (1992). Adjusted P-Values for Simultaneous Inference. Biometrics 48, 
1005-1013. 
Yeagle, P.L. (2014). Non-covalent binding of membrane lipids to membrane proteins. 
Biochim Biophys Acta 1838, 1548-1559. 
Yin, X.M., Oltvai, Z.N., and Korsmeyer, S.J. (1994). BH1 and BH2 domains of Bcl-2 
are required for inhibition of apoptosis and heterodimerization with Bax. Nature 369, 
321-323. 
Zhang, H., Holzgreve, W., and De Geyter, C. (2000). Evolutionarily conserved Bok 
proteins in the Bcl-2 family. FEBS Lett 480, 311-313. 
Zhang, Z., Subramaniam, S., Kale, J., Liao, C., Huang, B., Brahmbhatt, H., Condon, 
S.G., Lapolla, S.M., Hays, F.A., Ding, J., et al. (2016). BH3-in-groove dimerization 
initiates and helix 9 dimerization expands Bax pore assembly in membranes. EMBO J 
35, 208-236. 
Zhou, L., and Chang, D.C. (2008). Dynamics and structure of the Bax-Bak complex 





Methodology for Mass Spectrometric Analysis of Bak Samples 
Mass spectrometric analysis of purified Bak(α2-5), crystallised Bak(α2-5), and 
crystallised Bax(α2-5) samples was performed by Yepy Rustam (Bio21 Molecular 
Science and Biotechnology Institute) under the supervision of Gavin Reid (Bio21 
Molecular Science and Biotechnology Institute). 
Monophasic Lipid Extraction 
Lipids were extracted from samples of purified Bak(α2-5) hexamer, crushed Bak(α2-5) 
crystals, and crushed Bax(α2-5) crystals using a modified monophasic lipid extraction 
procedure (Lydic et al., 2014). Methanol and water were added to each sample and a 
blank to a final volume of 200 µL containing 40% methanol. Internal standards 
(25 pmol each) dissolved together in 60 µL of Milli-Q water, 460 µL of methanol, and 
285 µL of chloroform were then added to all tubes. Samples were incubated on a 
ThermoMix at 1,000 rpm for 30 minutes at room temperature. The precipitate was 
separated by centrifugation at 14,000 rpm for 15 minutes and supernatants were 
transferred into new tubes. Solvent was completely evaporated under vacuum and lipid 
extracts were resuspended in 500 µL of 2-propanol/methanol/chloroform (4/2/1 v/v/v). 
Lipid extracts were transferred into 2 mL glass vials and stored in a -80°C freezer prior 
to mass spectrometry analysis. 
Mass Spectrometry Analyses 
Lipid extracts were introduced to an ultrahigh-resolution/accurate mass Thermo 
Scientific model Orbitrap Fusion™ Lumos™ Tribrid™ Mass Spectrometer (San Jose, 
CA) using an Advion Triversa Nanomate nESI source (Advion, Ithaca, NY) with a 
spray voltage of 1.0 kV and a gas pressure of 0.3 psi. The Ion Transfer Tube temperature 
was set to 150°C and RF Lens was set to 40%. Mass spectra were acquired in positive 
ionisation mode using orbitrap detector with maximum mass resolving power of 
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500,000 in the m/z range of 300-2000 for 2 minutes (approximately 115 scans). To 
confirm the glycerophospholipid headgroups and elucidate the acyl-chain structure of 
the lipids, higher-energy collision-induced dissociation (HCD) was applied to 
monoisotopically isolated precursor ions in negative ionisation mode (120,000 mass 
resolving power), using an optimised collision energy for each lipid class. 
Peak Finding, Lipid Identification, and Quantification 
Lipid identification and peak quantification were performed with LipidSearch 5.0α 
software (Thermo Fisher Scientific, USA and Mitsui Knowledge Industry, Japan). The 
program assigned lipid sum composition based on exact mass and 13C isotope 
distribution found in mass spectra. Lipid classification and nomenclature based on the 
LIPID MAPS consortium were used (Fahy et al., 2011). Lipid identification parameters 
used were 1 ppm of parent tolerance and parent threshold of 10 times of noise 
background intensity. Product ions in HCD-MS/MS spectrum were analysed to 
determine acyl chain structure. Further data analysis using R was performed to calculate 
molar ratio of lipids/protein by normalising peak intensity against corresponding 
internal standard peak intensity and protein content (R Core Team, 2016). Charts were 
produced using the plotly package for R (Plotly Technologies Inc., 2015). 
Methodology for Small-angle X-ray Scattering Experiment on Bak 
Small-angle X-ray scattering data were collected with James Murphy (Walter and Eliza 
Hall Institute) and analyses performed by James Murphy. 
Small-angle X-ray Scattering Measurements and Analysis 
SAXS data collection was performed at the Australian Synchrotron SAXS/WAXS 
beamline using an inline GF chromatography setup with co-flow (Kirby et al., 2013), 
as detailed in (Weijman et al., 2017). Fifty µL of purified recombinant Bak(α2-5) at 
17 mg/mL was injected onto an inline S200 5/150 GF column and eluted at a flow rate 
of 0.2 mL/min via a 1.5 mm glass capillary positioned in the X-ray beam in 200 mM 
NaCl, 20 mM HEPES [pH 7.5], 5% v/v glycerol at 12°C. Scattering data were collected 
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in 2 second exposures over the course of the elution, and nine 2D intensity plots with 
superimposable scatter intensities from the peak of the size exclusion chromatography 
run were radially averaged, normalised to sample transmission, and background 
subtracted (as estimated from 20 averaged scatter profiles from earlier in the elution) 
using the Scatterbrain software (Stephen Mudie, Australian Synchrotron). Guinier 
analysis of data was performed using PRIMUS (Konarev et al., 2003). An indirect 
Fourier transform was performed with GNOM to obtain the pairwise distance 
distribution function, P(r), and the maximum dimension, Dmax, of the scattering 
particle (Svergun, 1992). Theoretical scattering curves were calculated in CRYSOL 
from atomic coordinates of the Bak(α2-5) cylinder crystal structure lacking lipids or 
containing modeled E. coli lipids, and compared with the experimental scattering curve 
(Svergun et al., 1995). 
